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ABSTRACT
of
The present study was undertaken to evaluate the use precision-cut liver slices as a system 
for studying xenobiotic metabolism. Comparison of two culture systems, namely the dynamic organ 
culture system (DOCS), and the multiwell plate (12-well) system, using morphological and 
biochemical parameters, showed that the 12-well plate system is superior to the DOCS. The present 
study also demonstrates that increasing the number of slices from one to two per incubation does not 
lead to a proportional increase in metabolic activity, and this approach is, therefore, not suitable for 
scaling up the system.
Cytochrome P450 activity was lost in precision-cut rat and human liver slices during long 
culture periods with a substantial loss occurring during the first 24 hours of culture, but the rate of 
decline was isoform-specific. The loss in cytochrome P450 activities was not always mirrored by 
their apoprotein levels, the majority of whichj were still detectable even after 72 hours of culture.
Determination of cytosolic and microsomal protein content revealed that the latter declined 
more rapidly in culture as compared with the cytosolic protein. The rat and human cytosolic Phase II 
drug metabolising enzymes were far more stable than the microsomal Phase II enzymes and the 
Phase I cytochromes P450 in long-term culture. Although the activity of all enzymes declined with 
culture time, the rate of loss differed among the various enzymes.
Histological examination of commercially available human liver slices showed that the cells 
were preserved well at time of receipt and during culture. Human liver slices metabolised 7- 
ethoxycoumarin for up to 72 hours, although there was a significant decline in the levels of 
metabolites after 24 hours of culture. A large inter- and intra- variation was also noted.
Precision-cut liver slices were finally used to investigate the role of individual cytochrome 
P450 isoforms in the metabolism of the endogenous substrate, melatonin. The present study clearly 
demonstrates that the CYPIA family is responsible of the metabolism of exogenous levels of 
melatonin.
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For life, liver is one of the essential organs of the body. Mammals survive subtotal 
hepatectomy due to their extra-ordinary regenerative powers and their ability to tolerate the 
increased metabolic demands. The fimctional complexity and diversity of the liver are 
rivalled only by the central nervous system. Due to its unique physiology, biochemistry and 
anatomy the liver is therefore, particularly susceptible to toxic injury. Chemically-induced 
injury to the liver is likely to arise due to its capacity to biotransform a broad spectrum of 
chemicals. Toxicological studies of the nature of cellular damage encompassing structural, 
biochemical and physiological changes are therefore, essential.
1.1 INTRODUCTION TO DRUG METABOLISM
Humans and other animals are constantly exposed to foreign materials both naturally- 
occurring and man-made. Generally speaking, the more lipophilic compounds are readily 
absorbed through the skin, across the lungs or via the gastrointestinal tract. Unless an 
effective means of elimination are present, constant exposure to such compounds could lead 
to accumulation of the liphophilic compounds within the organism. Chemicals may be 
excreted via different routes e.g. urinary, biliary, expired air and perspiration. With the 
exception of exhalation, the elimination of compounds from the body largely depends on 
their water solubility. This particularly applies to non-volatile chemicals that are 
predominantly eliminated in the urine and faeces. Unlike water-soluble compounds, 
lipophilic compounds that are present in these excretory fluids have a tendency to diffrise 
into cellular membrane and are thus reabsorbed. Lipophilic xenobiotics are therefore, 
readily absorbed but poorly excreted.
In order to survive, organisms have developed a number of biochemical processes, which 
are responsible for the conversion of lipophilic compounds to more hydrophilic metabolites.
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This process is known as biotransformation, and is usually enzymatic in nature. 
Biotransformation may be defined as "the sum of the processes by which a foreign chemical 
is subjected to chemical change by living organisms". The end result of the 
biotransformation reaction (s) is that the metabolites are chemically distinct from the parent 
compounds, and more water-soluble.
1.1.1 Phase I and Phase II Biotransformation
Almost any foreign chemical entering the body, whether it be an environmental toxin or a 
clinical drug, is metabolised by one or more of the drug metabolising enzymes. These 
enzyme systems, which also have an important endogenous role in maintaining cellular 
homeostasis, generally have wide substrate specificities such that each is capable of 
metabolising a variety of structurally diverse chemicals. The enzymes, which are involved 
in drug metabolism, are subdivided into two classes Phase I and Phase U. Phase I enzymes 
catalyse ftmctionalisation reactions where, in most cases a reactive centre is produced in the 
substrate so that it can participate in subsequent Phase U metabolism. In contrast, Phase II 
reactions are conjugative, involving the addition of a hydrophilic moiety to the molecule to 
facilitate its excretion from the body.
Phase I  Reactions: Involve oxidation, reduction, hydrolysis and hydration. These reactions 
are mediated by a number of enzymes including alcohol dehydrogenase and xanthine 
oxidase. One of the most important of this class of enzymes, however, is the microsomal 
mixed-function oxidase, cytochrome P450. This ubiquitous class o f enzymes play a central 
role in the oxidative metabolism of structurally diverse xenobiotics and also has an 
important endogenous role in the synthesis and/or degradation of many important 
biosynthetic intermediates. In most cases, the product of these Phase I reactions contain
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chemically reactive fimctional groups e.g. -OH, -NH2, -SH, -COOH, which form the 
reactive centre for interactions with Phase II enzymes.
Phase II Reactions: Several distinct enzyme systems are again responsible for the Phase II 
metabolism of a structurally diverse range of chemicals resulting in the generation of water- 
soluble products which are excreted in bile or urine. Examples of common Phase II 
reactions are glucuronidation, catalysed by the UDP-glucuronyltransferases, and glutathione 
conjugation, catalysed by the glutathione S-transferases. Many of the compounds e.g. 
phénobarbital and 3-methylcholanthrene, which are powerfiil modulators of cytochrome 
P450 expression can also influence the expression of Phase II enzymes such as glutathione 
S-transferase. Therefore, the effect of a particular xenobiotic can not be considered simply 
in terms of its Phase I metabolism. Similarly, the xenobiotie-mediated induction of specific 
isoenzymes e.g. a hepatie P450, will alter the overall enzyme profile of the cell, and may 
thus affect cellular homeostasis.
1.1.2 Localisation of Biotransformation Enzymes
Almost every tissue tested has shown activity towards some foreign chemicals. However, 
these activities are limited with respect to the diversity of chemicals they can handle, and as 
a result their contribution to the overall biotransformation of xenobiotics is limited. A 
primary fimction of the liver is to receive and process chemicals absorbed from the 
gastrointestinal tract before they are distributed to other tissues. Because of this the liver 
has developed the ability to readily extract foreign substances from the blood and to 
chemically modify many of these substances before they are stored, secreted into bile, or 
released into the general circulation. Therefore, the enzymes that catalyse the 
biotransformation of foreign compounds are located mainly in the liver.
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The Phase I enzymes, those involved in the addition of functional groups, are located 
primarily in the smooth endoplasmic reticulum, a network of interconnected channels 
present in the cytoplasm of most cells. Since the endoplasmic reticulum is a contiguous 
membrane composed o f lipids and proteins, these enzymes are membrane bound. Within a 
lipoprotein matrix, the presence of enzymes is crucial, as the lipophilic substrates will 
preferentially partition the hpid membranes, the site of biotransformation.
If the liver is removed and homogenised, the tubular endoplasmic reticulum breaks up, 
fragments of the membrane are joined to form mierovesieles. These are known as 
microsomes, which can be isolated by differential centrifugation of the liver homogenate. If 
the supernatant fraction that results from eentrifiigation of the homogenate at 9000 x g (to 
remove nuclei, mitochondria, and lysosomes etc.) undergoes a fiirther centrifugation at 
105,000x g, a pellet highly enriched in microsomes is precipitated, which contains many of 
the enzymes involved in Phase I biotransformation. The resulting supernatant is referred to 
as the cytosol, and contains many of the enzymes involved in Phase II biotransformation. 
The term cytosolic or microsomal enzymes, simply indicates the subcellular location o f the 
enzyme.
1.2 The Cytochrome P450 Mono-Oxygenase Superfamily
The immune system acts as the first line of defence against a large variety of infectious 
microbial agents- viruses, bacteria, fimgi and parasites present in our environment. The 
cytochrome P450 enzymes may also be considered as another line of defence but against 
foreign chemicals such as environmental pollutants and pharmacological agents.
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Cytochrome P450 is the generic name for the superfamily of haem-containing mono­
oxygenases, which like many other Phase I enzymes are located in the endoplasmic 
reticulum of mammalian cells. These enzymes play a major role in the metabolism of 
exogenous, as well as endogenous substances such as steroids, fat-soluble vitamins, fatty 
acids, eicosanoids and alkaloids. They are present in every cell type in the body with the 
exception of erythrocytes and skeletal muscle cells. It is also important to note that the 
toxicity of a compound may actually be increased, rather than decreased by the P450 
enzyme system.
1.2.1 Evolution
Cytochrome P450 genes are thought to have been present early in evolution. An 
evolutionary tree has been constructed based on the amino acid sequences of the 
cytochromes P450 (Nelson and Strobel, 1987). There are two main divisions in this 
pylogenetic tree, the first occurring, approximately 1400 million years ago, during the 
separation of eukaryotic and prokaryotic cytochromes P450 and the second separating the 
catalytic enzymes involved in the metabolism of endogenous versus exogenous substrates, 
occurring approximately 100 miUion years ago. Following the first divergence between 
microsomal and mitochondrial species, approximately 1360 million years ago, the number 
of microsomal proteins has increased greatly. This is thought to have occurred in response 
to environmental challenge and may have coincided with vertebrate adaptation to a 
terrestrial environment. Mitochondrial P450s are primarily involved in endogenous 
metabolism, catalysing reactions such as steroid oxidation, and have therefore, diversed to a 
lesser extent.
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1.2.2 Nomenclature
Previously, nearly every laboratory involved in P450 purification, developed its own 
nomenclature system and naturally this created a lot of confusion. Now a standard 
nomenclature system is widely used. The recommendations for the naming of P450 include 
the symbol “CTP” denoting cytochrome P450, an Arabic number designating the P450 
family, a letter indicating the subfamily when two or more subfamilies are known to exist 
within that family, and an Arabic numeral representing the individual gene (as shown 
below).
For example: CYP 1 A 1
JTheP450^nil^J
^ubfemilyj
In order to prevent incorrect namings or duphcation of gene names and confusion in the 
literature, the “P450 nomenclature Committee” now requests from researchers the 
deduced amino acid sequence of any newly discovered P450 cDNA or gene.
1.2.3 Research History
Great progress has been made in cytochrome P450 research in the last thirty years. In the 
60’s, studies by Omura and Sato (1964) demonstrated the haemoprotein nature of 
cytochrome P450. The first indication for the existence of multiple forms o f cytochrome 
P450 came from in vivo induction studies in animals investigating differential effects on the 
metabolism of various substrates. The 70’s focused on the purification and characterisation
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of several cytochrome P450 species from animals, discovery of the Ah receptor that 
mediates the induction of some P450 proteins, and thorough mechanistic studies to describe 
the events in the cytochrome P450 catalytic cycle. Molecular biology technology was 
predominantly used in the 80’s to study cytochrome P450 gene structure, function and 
regulation (Eamshaw et ah, 1988; Nebert and Gonzalez, 1987; Fujii-Kuriyama et al., 1982). 
Major advances were also made on purification, characterisation and cloning of human 
cytochrome P450s, and the mechanisms of regulation of human cytochrome P450 genes. 
The knowledge obtained so far; is applied, in the 90’s to metabolism, drug discovery and 
drug development.
1.2.4 The CYP 1 Family
This appears to be one of the smallest families consisting of two subfamilies, namely 
CYPl A and CYP IB. The latter has only recently been described and therefore, at present, 
very little is known regarding its regulation and substrate specificity. In contrast CYPl A 
was first described in the late 1960s and considerable amount of research has been carried 
out since in order to understand its contribution to xenobiotic metabolism.
The CYPIA family consists of two isoforms, CYPlAl and CYP1A2. This family is 
involved in the metabolism of substrates with planar molecular structures (Lewis et ah, 
1986). A characteristic of this cytochrome P450 is its ability to metabolise chemicals at 
sites, which lead to the formation of highly reactive electrophiles. With the exception of 
only a few compounds such as 1,3-dinitropyrene (Shimada and Guengerich, 1990) and the 
food additives furylfiiramide (Shimada et al., 1990) this family of enzymes almost always 
directs the metabolism of a compound towards the formation of reactive metabolites, a 
process also known as bioactivation (loannides and Parke, 1990). No other P450 family is
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as sensitive to induction as are the proteins that make up the CYPl family. Studies have 
shown that a single intraperitoneal dose of as little as 50 pg/kg of benzo(a)pyrene in rats, 
doubled the hepatic ethoxyresorufin 0-deethylase activity (Philhpson et al., 1984). CYPl 
induction in animals has been associated with an increase in toxicity and carcinogenicity 
(loannides et al., 1993; Ayrton et al., 1990a and b; loannides and Parke, 1990).
In humans, CYPl is inducible in the hver as well as other tissues such as the lung and 
placenta (Pasanen et al, 1990; Vahakangas et al., 1989; Sesardic et al., 1988; Song et al, 
1985). Induction has been demonstrated following administration of therapeutic drugs such 
as omeprazole (Rost et al, 1992; Diaz et al, 1990). However, of the current drugs used at 
therapeutic concentrations only very few interact with the CYPl family. Studies have 
shown that the two proteins (CYPlAl and 1A2) share extensive structural similarities and 
thus similar substrate specificities (Yun et al, 1991; Butler et al, 1989a and b; Shimada et 
al, 1989). There is apparent similarity in substrate specificity between the human and 
rodent CYPIA proteins suggesting toxicological data concerning this family can, in theory, 
be extrapolated to humans.
Human cancer risk has often been linked to polymorphism in cytochrome P450 proteins 
(Kadlubar eta l, 1992; Nebert, 1991). In relation to the CYPl family, polymorphism could 
play a role in the marked difference in susceptibility to chemical carcinogens e.g. the 
susceptibility of humans to tobacco-linked lung cancers. Studies have shown that smokers 
who develop lung cancer show high CYPlAl activity and suggested that genotyping for 
CYPlAl polymorphism may be used as a tool to identify high risk subjects (Bartsch et al, 
1992; Karki et al, 1987). CYPlAl activity in breast tissue has also been linked to human 
breast cancer (Pyykko et al, 1991).
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1.2.5 The CYP2 Family
This is the largest cytochrome P450 family, consisting of a number of subfamilies which, 
are involved in xenobiotic metabolism.
L2.5.1 The CYP2A Subfamily
The role of this subfamily in xenobiotic metabolism appears to be very limited. It is 
involved in endogenous metabolism of steroids such as the 7a-hydroxylation of 
testosterone. CYP2A1 and CYP2A2 are cytochrome P450 gene products found in rats 
whereas CYP2A6 is present in humans.
Testosterone 7a-hydroxylase activity is thought to be a reliable marker for the catalytic 
monitoring of rat liver CYP2A1, accounting for over 90 % of total testosterone oxidation 
activity (Aoyama et al, 1990; Waxman et a l, 1990). CYP2A1 is expressed in rat testis 
as well as in the liver (Sonderfan et a l, 1989). However, neither CYP2A1 nor 7a- 
hydroxylase activity has been detected in kidney, lung, brain or prostate (Sonderfan et 
a l, 1989; Yeowell et a l, 1988). CYP2A2 constitutes 2-3% of total liver microsomal 
P450 (Matsunaga et a l, 1988; Jansson et a l, 1985). There is an 88% similarity 
between CYP2A2 and CYP2A1 amino acid sequences (Matsunaga et a l, 1988). 
Although these two isoforms are structurally similar, there are differences in their 
catalytic properties. 15a-Hydroxytestosterone is the major testosterone metabolite 
formed by CYP2A2, accounting for 40-50 % of its testosterone oxidation activity 
(Jansson et a l, 1985; Korzekwa et a l, 1990), and is, therefore, a useful marker for 
CYP2A2. In male rats, CYP2A2 is not activated until the onset of puberty (Arlotto et 
a l, 1989; Waxman et a l, 1988; Swinney et a l, 1987; Jansson et a l, 1985) suggesting 
that CYP2A2 expression may be regulated by gonadal hormones. Studies have shown
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that treatment of adult male rats with known P450 inducers such as P-naphthoflavone, 
phénobarbital, dexamethasone, clofibrate and 3-methylcholanthrene, does not increase 
CYP2A2 liver protein content (Arlotto et al., 1989; Waxman et al., 1988; Swinney et al., 
1987).
The human P450 form in the CYP2A subfamily is CYP2A6. CYP2A6 is a protein 
involved in carcinogen activation, which makes up only 1% of the total P450 in human 
hver. Its main substrate is coumarin, the 7-hydroxylation of which appears to be a useful 
diagnostic reaction for human CYP2A6 (Yamano et ah, 1990). Human liver microsomal 
coumarin 7-hydroxylation activity varies immensely between individuals. Activity can 
range from <1 to 4750 pmol products formed per min per mg microsomal protein (Pearce et 
al., 1992; Yamazaki et al., 1992). There is no evidence, to date, that CYP2A6 is subject to 
genetic polymorphism (Eichelbaum and Gross, 1990); therefore, the large inter-individual 
variation in the level of this P450 form in human liver may be due to exposure to drugs and 
other chemicals which are capable of inducing CYP2A6. Examples of such inducers are: 
phénobarbital, dexamethasone or rifampicin (Dalet-Beluche et al., 1992; Maurice et al., 
1992).
The role of CYP2A in xenobiotic and drug metabolism has not been comprehensively 
investigated. However, studies have shown that CYP2A is involved in the activation of 
diethylnitrosamine (Crespi et al., 1990) and other carcinogens such as 6-aminochrysene and 
aflatoxin Bi (Yun et al., 1991).
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L2.5.2 The CYP2B Subfamily
Although this subfamily is involved in the metabolism of endogenous steroids such as 
testosterone and androstenedione and is thought that it may play a role in the homeostatic 
control of steroid hormone levels (Zimniak and Waxman, 1993; Waxman and Azaroff,
1992), the primary role of CYP2B appears to be the metabolism of exogenous chemicals. 
This subfamily has wide substrate specificity in that it can bind to both planar and globular 
molecules. Like the CYPIA family, it metabolises polycyclic aromatic hydrocarbons, but, 
in contrast to CYPIA, does not generate electrophihc reactive intermediates. In addition, 
many aromatic amines and amides are substrates of both subfamihes, but CYP2B catalyses 
ring hydroxylations and forms inactive products whilst CYPIA is involved in bioactivation 
as it catalyses their N-oxidation (Astrom and De Pierre, 1985; Hammons et al., 1985). 
Although studies have shown that a small number of compounds such as cyclophosphamide 
(Marinello et al., 1984), and 4,4(bis)methylene chloroaniline (MOCA) (Guengerich, 1987) 
can actually be activated by CYP2B, in rodents this subfamily is generally responsible for 
the deactivation of many drugs, e.g. barbiturates (loannides and Parke, 1990).
Pentoxyresorufin is a relatively specific substrate commonly used as a probe to identify 
CYP2B in most species (rat, mouse, and rabbit) (Lubet et al., 1985). Low levels of CYP2B 
are expressed in untreated animals, however, following pretreatment with phénobarbital, 
high levels of these isoenzyme are present in rat, mouse and rabbit liver (Waxman and 
Azaroff, 1992). It has been estimated that the human isoform, 2B6, constitutes no more than 
2% of the human hepatic P450, consequently, since it is poorly expressed in humans and it 
appears to play a minimal role in xenobiotic metabolism. (Gonzalez and Gelboin, 1994; 
Nedelcheva and Gut, 1994; Shimada et al., 1994). In humans the highest levels of CYP2B
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have been detected in individuals who have received anticonvulsant therapy (phénobarbital 
of phenytoin) (Forrester et al., 1992).
1.2.5.3 The CYP2CSubfamily
To date 28 enzymes of the 2C subfamily, have been identified and, therefore, it constitutes 
the largest P450 subfamily in any given mammalian species (Nelson et al., 1993). 
CYP2C6, 2C11, 2C12, 2C13, 2C22, 2C23 and 2C24 are P450 gene products found in rats 
whereas, CYP2C8,2C9/10, 2C18 and 2C19 are found in humans. This subfamily plays an 
important part in the metabolism of many therapeutic drugs and contains isoforms that are 
subject to genetic polymorphism, leading to slow and fast metabolisers of drugs such as 
tolbutamide and mephenytoin (Goldstein and de Morais, 1994).
1.Z5.4 The CYP2D Subfamily
The human isoform, CYP2D6, accounts for approximately 2% of the total P450 in human 
liver (Shimada et ah, 1994), but surprisingly plays a major role in dug metabolism with 
about 30 % of therapeutic drugs currently being metabohsed by the CYP2D. Studies have 
shown that the catalytic ability of CYP2D6-mediated metabolism in humans is modulated 
by genetic factors (Mikus et. al., 1994; Meyer 1991); genetic polymorphism is also found in 
rats. The rat has six genes, namely CYP2D1 through CYP2D5, and CYP2D18 (Sakamoto 
et al., 1995; Matsunaga et al., 1990; Gonzalez et ah, 1987). In relation to human, CYP2D1 
is the closest to CYP2D6 enzymically.
CYP2D1 has the ability to metabolise debrisoquine, bufiiralol and other substrates related to 
the human drug oxidation polymorphism (Gonzalez et al., 1987; Larrey et al., 1984).
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CYP2D2 can catalyse the 2- and 16a-hydroxylation of oestrogen (Sugita et al., 1988). The 
catalytic activities of CYP2D3, CYP2D4, CYP2D5 and CYP2D18 remain unknown.
To date this protein has not been linked to the activation of carcinogens (Aoyama et al., 
1990; Shimada flf/., 1989; ^oW etal., 1985).
L2,5»5 The CYP2Esubfamily
Only one gene has been detected in the CYP2E subfamily in the rat, mouse and human and, 
compared to other P450 isozymes, CYP2E1 levels in human liver is not very high. In the 
liver, this isoform is induced by ethanol and isoniazid. CYP2E1 metabolises a diverse set 
of structurally different chemicals such as short-chain alcohols and organic solvents e.g. 
ether and chloroform. Its contribution to the metabolism of drugs is modest and restricted 
to anaesthetics such as enflurane and other drugs like isoniazid. CYP2E also plays a 
dominant role in the metabolism of small carcinogenic compounds such as jbenzenq. 
nitrosoamines like dimethylnitrosarnine and nitrosopyrrolidine and halogenated 
hydrocarbons such as carbon tetrachloride and vinyl chloride (Guengerich et al, 1991).
A characteristic of CYP2E is its ability to generate reactive oxygen species (Ronis et al, 
1996) which have been associated with many human diseases such as cancer, 
cardiovascular disease and diabetes mellitus.
1.2.6 The CYP3 Family
Isoenzymes of the CYP3 family are known to metabolise the majority of drugs in clinical 
use and also to form the major proportion of the human hepatic P450 complement (Shimada 
et al, 1994) and, therefore, plays a vital role in the metabolism of xenobiotics. Substrates
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include drugs such as erythromycin, cyclosporin, tamoxifen, warfarin, nifedipine and 
lovastatin. Although involved in the metabolic activation of a number of carcinogens 
(Gonzalez and Gelboin, 1994; Guengerich and Shimada, 1991) such as benzo(a)pyrene, 
aflatoxin B l, dapsone and pyrrolizidine alkaloids, enzymes of the CYP3 family are 
primarily associated with deactivation of a large variety of structurally diverse chemicals. 
The major form in humans is CYP3A4 which is strongly inducible by barbiturates, 
dexamethasone, rifampicin and troleandomycin, whilst the rat CYP3 family consists of 2 
forms I namely CYP3Al and CYP3A2.
1.2.7 The CYP4 Family
The CYP4A family consists of six subfamilies, of which three, namely CYP4A, CYP4B
and CYP4F are found in humans and rats (Nelson et al., 1993). Of these subfamilies,
. ! .only the CYP4A has been extensively studied. The major role of this subfam ily,the 
metabolism of endogenous substrates such as fatty acids and eicosanoids. The interest in
this P450 family emanates from the observation that peroxisomal proliferators, a group 
of non-genotoxic rodent carcinogens that increase the number and size of peroxisomes 
and cause hyperplasia, also induce this enzyme.
b
CYP4A activity in the liver is enhanced by hypolipidaemic drugs such as clof^ate and 
ciprofibrate, and anti-inflammatories such as ibuprofen (Lake and Lewis, 1996; Rekka et 
al, 1994).
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1.3 ALTERNATIVES TO IN VIVO STUDIES
Following chemically-induced insult, hepatotoxicity may be assessed and evaluated using 
either in vivo or in vitro techniques. The ethical problems in utilising humans in in vivo 
toxicity studies are quite obvious. Use of human tissue for in vitro studies requires 
permission from appropriate ethical committees. In addition, waiting for a suitable donor is 
time consuming, so for convenience animals are still used with the intention of 
extrapolating the data to humans.
In vivo studies require large numbers of animals, are extremely costly, time consuming, and 
may provide limited understanding of the mechanisms of toxicity. Hormonal and 
physiological influences such as blood flow may also obscure the actual mechanism of 
toxicity in an in vivo system. Much effort has, therefore, been devoted to the development 
of in vitro systems for assessing the hepatic effects of xenobiotics.
Many different experimental models are used to study drug metabohsm. In vivo 
experiments allow the determination of overall biotransformation. To study hepatic 
metabolism in vitro, different systems such as: subcellular fractions, isolated hepatocytes 
either in primary culture or in suspension have been used (Bissel et al., 1973). Most studies 
have used isolated hver microsomes, this being an appropriate model to study reactions 
located in the endoplasmic reticulum, such as oxidation or glucuronidation; however, this 
system requires the addition of cofectors and does not include enzymes like 
sulphotransferase which have cytoplasmic location (DeJong and Wolring, 1980). Isolated 
hepatocytes have an advantage in this respect, in that they provide a more physiological 
system, as transport across the cell membrane and competition between all the metabolic 
reactions are stih present. However, freshly isolated hepatocytes have a short life of about
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3-6 hours (Wolthuis and Kepner, 1978), and consequently the best model for long-term 
studies on drug metabolism appears to be cultured hver cells. However, like ah other 
techniques, the use of hepatocytes also has its limitations. Collagenase digestion is 
routinely used in hepatocyte preparation, and this process usually results in damaged 
cellular membranes, interference with ceh-to-ceh contact (communication) and thus the 
intercellular transport system, fohowed by loss of stratification and fimctional identity (Dich 
and Grunnet, 1990). These factors may influence the actual effect of the toxicant (Ichihara 
et ah, 1980; Grisham 1979). However, the cell membranes may be regenerated during early 
stages of culture in monolayer cultured hepatocytes (Dich and Grunnet, 1990; Fry and 
Bridges, 1979; Guzelian et al, 1977; Bissel et al, 1973). Furthermore, hepatocytes 
undergo dedififerentiation and cytochrome P450 content and activity decrease over longer 
periods of culture (24 hours) (Gugen-Guihouzo and Guillouzo, 1983).
Approximately 30-35% of the cehs in the hver is nonparenchymal cells such as Kupffer 
cehs, endothehal cells, fat storing cells and pit cehs. Hepatic nonparenchymal cells have 
largely been ignored in xenobiotic metabohsm and, in studies of the mechanisms of 
hepatotoxicity due to their small size relative to hepatocytes. However, it is thought that 
these cehs may play a role in pathophysiologic processes leading to toxicity. Exposure to 
hepatotoxic chemicals leads to the “activation” of nonparenchymal cells, releasing large 
quantities of highly reactive mediators such as: superoxide anion and hydrogen peroxide, 
eicosianoids and proteolytic enzymes which have the ability to damage hepatic tissue 
(Laskin, 1990). Therefore, an in vitro system would be preferable if all cell types are 
present, in order to elucidate mechanisms of toxicity as well as study xenobiotic 
metabohsm.
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Although in vitro systems reduce the number of animals used and eliminate unnecessary 
factors, they are limiting in other aspects. To alleviate these problems associated with 
hepatocyte culture, culture systems were further developed employing liver slices. There 
are several factors that make the use of tissue slices an attractive alternative in vitro 
technique. The major advantage is the presence of all cell types in the organ, normal 
cellular communication and cellular interactions are present. Regardless of the species or 
the type of organ, the actual tissue slice preparation is similar allowing studies among 
different species to be carried out easily. Approximately 50 slices can be obtained from a 
rat (250 g) liver, allowing more than one study to be carried out at the same time, 
emphasising also on the economical advantage of this system with respect to in vivo studies. 
Most importantly, depending on availability, human tissue can be used without the 
experimental difficulties associated with the hepatocyte cultures.
1.4 PRECISION-CUT LIVER SLICES
The tissue slice technique was introduced more than 70 years ago by Otto Warburg 
(Warburg, 1923). Yamamoto and Macllvain (1966), demonstrated that mammalian brain 
slices can be kept alive and electrically excitable, extending the application of tissue slice 
technique into the domains of neurophysiology and neuropharmacology (Richards and 
Teggy, 1977; Richards and Sercombe, 1970; 1968). However, more recently their 
application has also extended to nephrotoxicity (Phelps et ah, 1987), cardiac toxicology 
(Parrish et al, 1992), pneumotoxicity (Fisher et ah, 1994) and ecotoxicity (Singh et ah, 
1996).
Historically liver slices hold an important place in the study of drug metabolism (Storey, 
1950), but their use declined following the introduction of the successful method for
Chapter 1: Introduction_______________   19
isolation of hepatocytes (Berry and Friend, 1972). Liver shces continued to be used in 
studies concerned with the effect of insulin on carbohydrate metabolism (Davidson and 
Berliner, 1974), the conjugation of bile acids (DeBelle et al., 1976), amino acid 
incorporation and protein secretion (Peters, 1983) and lipid peroxidation (Sano et al., 1986). 
Recent studies suggest that precision-cut tissue slices may be a useful technique in 
toxicological and biotransformation studies (Tables 1.1 and 1.2). Preparation of human 
liver slices appears to be less complicated than the isolation of human hepatocytes, so that 
liver slices may be of great value in comparative metabolism studies during drug 
development.
The use of precision-cut liver slices is a rapidly developing technique for the study of the 
coupled Phase 1 and Phase 11 hepatic biotransformation of xenobiotics. Despite its 
applicability, a major initial obstacle in their use was the difficulty in the rapid preparation 
of thin slices of uniform thickness and shape, under conditions, which minimise tissue 
trauma. Earlier attenq)ts of producing fiver slices utilised various techniques ranging form 
manual preparation, using a razor blade and a guide to the Stadie-Riggs microtome 
(Elshove et ah, 1963; Stadie and Riggs, 1944). In addition automated methods such as the 
Mcllwain tissue chopper and the Oxford Vitratome were also used (Mcllwain and Buddie, 
1953; Clouser, 1977). These systems resulted in low viability as a consequence of trauma, 
inconsistencies in slice thickness and poor incubation systems (Smith et ah, 1986). The 
development of a mechanical sheer capable of producing precision-cut fiver slices has 
alleviated a number of these problems (Krumdieck et ah, 1980). The Krumdieck tissue 
sheer is designed to yield reproducible results, minimise the time taken for preparation of 
slices, minimise mechanical trauma to tissue and operate in a controlled environment.
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Recently a cheaper and mechanically less complex alternative instrument has been
developed by Brendel and colleagues.
Chemicals References
Aflatoxin Bi Leeman et ah, 1995
Allyl alcohol Smith a/., 1987; 
Price et al, 1996
Bromobenzene Smith era/., 1987; 
Fisher e/a/., 1988
Carbon tetrachloride AznetaL, 1990b; 1990c
Chlorobenzene 1 Fisher e/a/., 1990; 1993
Chloroform Azri e/a/., 1990a
Cadmium Sarkare/a/., 1994
Cocaine Connors et ah, 1990
Coumarin Lake etal., 1995; 
Price e/a/., 1996
Cresol Thompson e/a/., 1994
Dezflurane Ghantous et al., 1991
Dichlorobenzene Fisher e/a/., 1991a
Enflurane Ghantous et al., 1990b
Halothane Ghantous e/a/., 1992b, 1992c; 1990a 
Browne/a/., 1992
4-Hydroxyphenylacetone Thompson e/a/., 1996
Isoflurane Ghantous et al., 1990b
Menadione Price etal., 1996; 
Leeman e/a/., 1995
Paracetamol Beals and McLean, 1995
Retinoic acid Leeman e/a/., 1995
Sevoflurane Ghantous e/a/., 1990b: 1992a
Valproic Acid Fisher etal., 1991b
Table 1.1: Chemicals examined in Precision-cut liver slices
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Compound References
Aflatoxin Bi Heinonen e/a/., 1996
p-Aminobenzoic Acid Gunawardhana et a l , 1991
3-[2-(Benzoxazol-2-yl) Ethyl-6- 
Methylpyridin-2(1H) one (L-696,229) 
L-689, 502
Balani et al, 1995
Chlorobenzenes Barr etal, 1991a, 1991b
Coumarin Steensmae/a/., 1994; 
Lake etal., 1995
Cyclosporin A Vickers etal, 1992
Desflurane Ghantous et a l , 1991
Diazepam Dogterom and Rothuizen, 
1993
Dichlorobenzenes Fisher etal, 1990
2,6-Dinitrotoluene Chapman e/a/., 1993
7-Ethoxycoumarin and 7- Barr etal, 1991a, 1991b;
hydroxycoumarin Steensma et ah, 1994; 
Ball e/a/., 1996
4-Hydroxyphenylacetone : 
(analogue of paracetamol)
Thompson e/a/., 1996
Halothane Ghantous etal, 1990a
Lidocaine Olingae/a/., 1993; 
Parker e/a/., 1996
Olanzapine Murphy e/a/., 1998
Paracetamol Miller e/a/., 1993
Tacrolimus Uedae/a/., 1996
Taxol Harris eta l, 1994
Tolbutamide Dogterom and Rothuizan, 
1993
Sevoflurane Ghantous et ah, 1992a
Somatostatin analogue Connors et ah, 1996
Table 1,2: Metabolism studies using Precision-cut tissue slices
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1.4.1 Preparation of Precision-Cut Tissue Slices
At present there are a number of commercially available tissue sheers. The two commonly 
uses are the Krumdieck tissue sheer and the Brendel Vitron tissue sheer.
L4,L1 The Krumdieck tissue slicer
This is designed to rapidly produce aseptic thin tissue shces of uniform and reproducible 
thickness, of approximately 60 to 1000 microns, at a maximum rate of one shce every 3 
to 4 seconds, with minimal damage to the cut surfaces of shces. The instrument operates 
submerged in an appropriate buffer solution with respect to tonicity, pH, temperature, 
oxygenation, and lubrication properties according to the type of tissue being sectioned in 
order to maintain viability.
The Krumdieck tissue sheer consists of three main components (Figure 1.1):
(a) the microtome assembly (Figure 1.2)
(b) the reservoir assembly
(c) the electrical housing
To avoid contamination during long-term culture, the microtome and the reservoir with 
the glass trap can be sterilised. Under such conditions, the instrument is controlled via a 
footswitch in order to maintain the sterility of gloved hands. The instrument may be 
operated in two modes: (a) the blade oscillates continuously, producing one shce after 
another without interruption, (b) after half o f every operating cycle, the blade’s 
movement is interrupted in order to reduce damage to the cut surfaces.
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Figure 1.1: The Krumdieck tissue slicer. This apparatus consists o f three main 
components: (a) microtome assembly, (b) reservoir assembly, and (c) electrical housing.
11 12
O
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Figure 1.2: The main parts of the microtome assembly of the Krumdieck tissue slicer.
Drive shaft assembly (I), flush button (2), graduated knob (3), spring clip (4), insert (5), 
stainless steel weights (6), plunger (7), blade holder (8), blade (9), wedge and the vertical 
holding post (10), tissue-holding adaptor (II), tissue holding arm (base) (12), pinch clamp 
(13), glass trap containing strainer (14), andflow regulation knob (15).
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Cylindrical cores (10 or 8 mm diameter) are cut from the excised tissue using a length of 
sharpened thin-walled stainless steel tubing mounted on a drill-press or a hand held coring 
tool. These cores fit into an insert of equal size and are held in place over the oscillating 
blade with a weighted piston. The cutting process is done by a rapidly oscillating 
disposable blade driven by a motor that also powers the impeller. The impeller provides 
an internal current to rapidly remove the cut shce and carry it to a reservoir (the glass 
trap). This system provides a continuous lubrication, thus eliminating adhesion of the 
tissue to the blade and the resulting wear and tear. The thickness of the shce depends on 
the setting on the sheer in addition to the type of tissue and the number of weighted pistons. 
The optimal shce thickness has been found to be about 250 pm (Parrish et al, 1995), which 
is thought to be thin enough to allow diffrision of gases and nutrient exchange. However, 
the major advantage of such an instrument is the uniformity of the shces in thickness and 
weight, minimising artifactual changes as a result o f variation in shce thickness.
L4,L2 The Brendel-Vitwn tissue slicer
The Brendel-Vitron tissue sheer is semi-automated. Shces are produced by a rotating blade 
and the buffer is continuously oxygenated via a gas supply.
Recent studies have compared the two commercially available tissue sheers in terms of 
xenobiotic metabohsm and toxicity. Little difference in toxicity of cadmium chloride in rat 
hver shces has been reported utilising these two instruments (Breen et al., 1996). Studies 
by Price et al. (1998b), have shown no significant differences in levels of protein, 
potassium, total glutathione (i.e. GSH and GSSG), reduced glutathione (GSH) and 
cytochrome P450, 7-ethoxyresorufin 0-deethylase and 7-benzoxyresorufin 0-debenzylase
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activities in freshly cut rat liver slices produced by the two tissue slicers. Liver slices 
produced by the Brendel-Vitron tissue slicer however, had significantly greater levels of 
oxidised glutathione (GSSG).
1.4.2 Maintenance of Precision-cut Liver Slices
Early attenç)ts to maintain adult rat liver in culture have proven extremely difficult. 
Because of the high metabolic requirement of this tissue, it has been difficult to provide 
proper oxygenation in order to allow for the morphological and biochemical maintenance of 
the entire culture for more than several hours. Cell degeneration, either at the centre or on 
the side of the tissue exposed to the medium, has consistently been observed. It has been 
shown that the thickness of the outer surviving zone of cells, usually 200-300 pm, is 
dependent on the oxygen tension (Hart et al., 1983; Campbell and Siddle, 1971; Trowell 
1959). Increasing the oxygen tension in culture can, in part, increase the viability of thicker 
liver slices for up to 6 hours, but the increased oxygen was reported to be toxic to cells 
within 24 hours (Campbell and Hales, 1971).
1.4.3 Incubation Systems
Banding necrosis is observed in slices cultured using the static culture technique of Trowell 
(1959); to alleviate this problem a dynamic organ culture system (roller incubation system) 
was developed (Smith et al., 1985). The static system does not allow uniform diffusion of 
gases and nutrients but, in contrast, the roller culture shakes the culture media allowing cells 
to increase surface area leading to enhanced respiratory gas and waste exchange. The 
design of the roller culture system allows the slices to rotate out of the medium, providing 
sufficient oxygen to all cells and eliminating culture-induced changes in the integrity of 
slices. This incubation system increases the sensitivity of biochemical markers to assess
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toxicant-induced injury, since potassium and lactate dehydrogenase (LDH) are not lost from 
selected cells as a result of inadequate culture conditions. The morphological changes 
observed by Smith et al. (1985), when slices were incubated in static culture, were 
prevented by the dynamic roller culture system (Sipes et al., 1987).
The roller system rotates a shce, adhering to a stainless-steel mesh, through the incubation 
media and atmosphere of the vial, in cycles. Until very recently, this technique has been 
used fairly successfiilly, particularly in studies of the toxic effects of volatile substances 
(Dale et ah, 1988; Ghantous et ah, 1990b; 1991). The disadvantage of this system is that 
the slice does not have a continuous contact with the incubation medium in which the test 
substance is dissolved. For metabolism studies, a system is preferred whereby slices are 
permanently exposed to the compound under examination; furthermore, the release of 
metabolites from slices into the medium should not be interrupted. For this reason, a 
modified dynamic system based on Trowell's incubation system (1959) was developed. In 
this system slices are placed on wire supports in a covered 24-weU plastic culture plate on a 
gyratory shaker. These plates are continuously gassed with 95% O2 / 5% CO2 and, to 
maintain a constant temperature, they are placed on aluminium heating blocks (Dogterom, 
1993; Connors et ah, 1990). Dogterom (1993) developed a simple incubation system for 
metabolism studies with precision-cut liver slices, which involves submersion of tissue 
slices in culture medium in 12-well culture plates. The plates are then placed on a gyratory 
shaker housed in an incubator. Using this system of incubation, slices have been kept viable 
for at least 11 hr, which appears to be long enough for metabolism studies.
Studies have shown that shce thickness is an important factor in studies on optimal 
incubation conditions and metabolism studies (Dogterom, 1993). Using tolbutamide and
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diazepam as test substances, a correlation was found between slice thickness (i.e. slice 
weight) and metabolite formation (amount formed / mg slice). It was demonstrated that 
variation in slice thickness does not alter the number of cells involved in drug metabolism 
(i.e. total amount of metabolite formed per shce does not alter). It has been suggested that 
this is probably because only the outer ceh layers contribute to metabohsm, as the parent 
compound is unable to diffuse into the inner part of the shce.
With the increase in the use of tissue shces in the last few years, a number of incubation 
systems have been developed (Table 1.3) which are ihustrated in Figures 1.3 and 1.4).
Incubation systems Type of system References
The roller system 
(dynamic organ culture)
Surface Culture Smith g/ a/., 1985
The rocker platform
(the hver shce is lying on a polyester 
mesh insert in a 6-well culture plate and 
rocked on a platform)
Surface Culture Leeman e/a/., 1995
The 12-well plate Submersion Culture Dogterom, 1993
The shaken flask
(the hver shce submerged in an 
Erlenmeyer in a shaking water bath)
Submersion Culture De Kanter and Koster, 
1995
The stirred well
(the hver shce is placed on a stainless- 
steel grid in a well of a 24-well culture 
plate equipped with a magnetic stirrer)
Submersion Culture Olingae/a/., 1993
The 6-well shaker
(the hver is submerged in a weh of a 6- 
well culture plate, placed in a box and 
shaken in a water bath
Submersion Culture Goethals et al., 1990
Table 1.3: The incubation systems Currently in use fo r  precision-cut liver slices.
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Only a couple of studies have actually compared these systems with respect to preservation 
of liver slice function. A direct comparison has been made between the dynamic organ 
culture system and the multiwell plate culture system (Fisher et al., 1995a). The dynamic 
organ culture system is thought to maintain rat liver slices at higher level of viability than 
the multiwell plate culture system suggesting that the dynamic organ culture is superior to 
the multiwell plate culture system. In contrast recent studies by Olinga et al. (1997b) show
SURFACE CULTURE SYSTEM
(a) Dynamic Organ Culture System (DOCS) 
Tissue Slice
(b) Rocker Platform
Roller
Insert
i
Incubation Via!
i
6-Well Culture 
Plate
Tissue Slice
Netwell Insert
Roller
Figure 1.3: Diagramatic representation o f surface cultures currently in use. (a) Dynamic 
organ culture system (DOCS) and (b) Rocker platform which involves the use o f  6-well plates 
with Netwell inserts on which the tissue slice is placed.
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SUBMERSION CULTURE SYSTEM
(a) Multiwell Plate System (b) Shaken Flask
Gas inlet
(i) 24-well plate
(ii) 6- and 12-well plates
24-well plates
Magnetic stirrer
Tissue slice on stainless steel grid
Magnetic flea
(ill) Stirred well
Figure 1.4: Different submerged culture systems currently in use, all incubated at
37 °C. (a) Multiwell plate system, (b) Shaken flask.
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that, after 24 hours, the shaken flask, the rocker platform, and the 6-well shaker incubation 
systems appear to be superior to the stirred well and the roller (dynamic organ culture) 
incubation systems.
1.4.4 Incubation Media
In vitro culture media are often modified in order to increase cell survival as well as specific 
activities such as growth (Mathis and Sirica, 1990; Schenider and Lavoix, 1990; Tennenbaum 
et al, 1990; Zhang and Armstrong 1990; Bisat et al, 1989; Viscardi et al, 1989; Fukuda and 
Iritani, 1987). It is well documented that nutrients affect the survival of cells exposed to 
oxidative stress (Marshal and Roberts 1990; Bucher and Roberts 1981; Roberts 1979; Kehrer 
and Autor 1978). Several studies have shown reduction of chemical toxicity by tissue culture 
components. For example, liver necrosis in rats receiving dimethylnitrosarnine, thioacetamide 
or bromobenzene was reduced using cysteine (De Ferreyra et al., 1979); moreover, carbon 
tetrachloride-induced liver necrosis can be prevented by a-tocopherol (Castro et al., 1968).
Studies with Precision-cut liver shces have used different culture media. However, it is thought 
that the composition of the incubation medium does influence the metabolism of xenobiotics by 
precision-cut hver shces. Altering the incubation media composition for in vitro rat hver shce 
cultures, alters the degree of the toxic responses produced by chlorobenzenes (Fisher et al.,
1993). Chlorobenzene toxicity was detected only at higher concentrations (2 mM) when the 
tissue culture medium was supplemented with foetal calf serum (Fisher et ah, 1990).
Beamand et al. (1993) used three standard hepatocyte culture media: RPMI 1640 medium, 
Wihiams’ medium E and Leibovitz's L-15 medium. It was demonstrated that rat hver shces
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could be maintained for up to 72 hours when cultured in RPMI 1640 or Williams’Medium E. 
In contrast, slices cultured in Leibovitz's L-15 medium could not be maintained for periods 
greater than 24 hours. Additional studies are required to establish the optimal tissue culture 
medium and additions for maintenance of viable rat hver slices.
1.4.5 Evaluation of Viability and Toxicity
Even though precision-cut liver culture systems are rather a new in vitro technique, an 
increasing number of different agents have been examined using slices (Table 1.1). In order to 
determine viability, a number of assays have been developed to measure membrane integrity, 
biochemical processes and energy status. To measure fimctional capacity of slices, enzymes 
that catalyses a wide spectrum of biochemical processes such as oxidative energy metabolism, 
amino acid catabolism, urea synthesis, lipogenesis and xenobiotic metabolism, have been used 
(Table 1.4).
L4,5.1 Ion homeostasis and energy status in slices
Changes in intracellular concentrations, is an indication of cellular injury/death and this is used 
as a general index of viability. The primary and most widely used measure of slice viabihty is 
intracellular leakage using flame photometry (DiRenzo et al, 1985). This assay is indicative 
of membrane and/or membrane-bound Na^/K^ dependent adenosine triphosphatase inhibition 
(DiRenzo et al, 1985; Stacey and Priestly, 1978). In comparison to other viability parameters, 
intracellular and Na"^  levels have been found to be one of the most sensitive indicators of 
cellular injury in isolated hepatocytes (Baur et al, 1975).
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ATP Amino acid catabolism
Intracellular Cytochrome P-450
Intracellular dà Ethoxycoumarin-O-deethylase
Protein synthesis Gluconeogenesis
Protein secretion Glutathione
LDH Hepatocellular glycogen content
MTT Lipogenesis
Mitochondrial fimction
Table 1.4: Indicators o f cell viability andfunction.
Following a recovery period after slicing procedures, content of slices remains relatively 
stable and constant in control slices for about 6-24 hr. In treated slices a decrease in cellular 
reflects a generalised cellular and membrane toxicity. Because of its reproducibility and its 
ability to monitor the overall condition of slices, this assay has been useful in studying the 
hepatotoxicity of all chemicals examined so far (Table 1.1).
Calcium ion has an essential role in cellular processes such as intracellular transport, secretion, 
cell contraction and motility (Orrenius et al., 1984). Loss of ion homeostasis, which occurs as 
a result of sudden loss of membrane permeability, results in Ca^  ^ influx into the cell. 
Chemicals which have been found to alter Ca^  ^homeostasis have also induced early changes in 
the plasma membrane producing "blebbing" that may occur as a result of the activation of 
calcium-dependent proteases or phospholipases, changing membrane-cytoskeleton interactions 
(Jewell et al., 1982; Nieminen et al., 1988). Calcium ion status has been examined in liver 
slices fi*om Sprague-Dawley rats exposed to cocaine (Connors et ah, 1990). Increase in
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intracellular calcium content was found to be concentration-, and time-dependent. Loss of 
intracellular levels also occurred in these studies.
Apart from ion homeostasis, other biochemical or fimctional parameters are used to determine 
the nature of cytotoxicity in tissue slices. From a fimctional point of view, examination of 
chemically-induced toxicity uses the in vitro system to its frill potential. Follovdng 
intoxication, loss of cellular fimction may explain the metabolic/biosynthetic status of the slice. 
For example, measurement of adenine nucleotides shows energy status and overall metabolic 
abihty of the slice subsequent to intoxication (Dickson and Pogson, 1977). ATP levels in slices 
are comparable to levels reported in freeze-clamped liver which have been maintained for 16- 
20 hours (Krebs et al, 1974; Smith et al, 1989).
L4.5.2 Protein synthesis and secretion
Protein synthesis is used as an indicator of macromolecular biosynthesis, whilst protein 
secretion is an energy dependent secretory process which responds readily to changes in the 
intra- or extra-cellular matrix (Ichihara et al, 1982). Retention or maintenance of both 
processes in slices subsequent to intoxication suggests that transport of amino acids, synthesis 
of protein from amino acids and secretion of synthesised protein remain intact and fimctional 
(Smith e /ûf/., 1986).
Changes in protein synthesis have been analysed using chlorobenzenes, valproic acid, allyl 
alcohol and halothane in slices (Ghantous et al, 1992c; Fisher et al, 1988,1990; 1991b; Smith 
et ah, 1987). These studies have shown that protein synthesis is a more sensitive indicator of 
toxicity relative to intracellular or lactate dehydrogenase leakage. Recent studies by
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Ghantous et ah (1992c) have shown a significant concentration-, time-dependent loss of both 
protein synthesis and protein secretion following exposure to halothane, enflurane and 
sevofiurane in comparison to control slices. This allowed the ranking of the anaesthetics 
according to their hepatotoxicity with halothane being the most toxic. In addition, this study 
also showed that synthesis of individual proteins such as albumin can also be monitored 
subsequent to intoxication.
1,4,53 Xenobiotic metabolism
Most studies have concentrated on the use of tissue slices for toxicological investigations and 
only a few publications have appeared dealing with metabolism studies. Many potentially 
toxic agents require bioactivation and consequently xenobiotic metabolism is an important 
parameter in in vitro studies. Since cytochrome P450 is located predominantly in the smooth 
endoplasmic reticulum of centrilobular hepatocytes, the presence of mixed-function oxidase 
activity may be used as a good indicator of both cellular viability and identity.
Cytochrome P450 levels and ethoxycoumarin-O-deethylase activity have been measured in rat 
liver slices. Barr et at. (1991a) have shown the oxidative 0-deethylation of the substrate 7- 
ethoxycoumarin in rat slices. It was demonstrated that the product of the cytochrome P450- 
catalysed 0-deethylation of 7-ethoxycoumarin (Phase I) was readily conjugated with sulphate 
or glucuronic acid (Phase II), illustrating Phase I and Phase II drug metabolising activities in 
liver slices. Such studies have also been carried out using human liver slices (Barr et ah, 
1991b).
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Cytochrome P450 and ethoxyconmarin-O-deethylase activity have been measured in untreated 
hver shces cultured for 8 hr and were reported to be relatively stable (Smith et al, 1989; 1987). 
However, under the same conditions. Lake et al (1993) reported a decrease in both cytochrome 
P450 content, and 7- ethoxycoumarin 0-deethylase activity in rat hver shces treated with 
phenobarbitone. Further studies have shown that cytochrome P450 levels decrease in untreated 
rat hver shces in culture, to a similar extent to that observed in cultured rat hepatocytes (Wright 
and Paine, 1992). Cytochrome P450 content was only 26% of the initial level after 24 hr of 
culture. It therefore, appears that, like primary rat hepatocyte cultures (Paine, 1990), 
cytochrome P450 and some mixed-function oxidase enzyme activities are not maintained in rat 
hver shces cultured in a standard medium. Additional studies are required to examine if 
manipulation of culture medium could improve the maintenance of cytochrome P450, as 
demonstrated for hepatocyte cultures (Paine, 1990). Using rat hver shces, Azri et a l (1990b) 
demonstrated that the degree of CCI4 toxicity might be easily manipulated through induction or 
inhibition of cytochrome P450 enzymes responsible for bioactivation of CCI4 . Further studies 
showed that total cytochrome P450 content in rat hver shces was only 41% and 53% of 
controls, 6 and 9 hours after the administration of 0.57 mM CCU (Azri et al, 1990c). Using 
this system manipulation o f specific isoenzymes o f cytochrome P450 is also possible. CYP2E, 
which is responsible for the bioactivation of CCU and can be induced by fasting Sprague- 
Dawley rats 48 hours prior to sacrifice (Johansson et al, 1988). Shces fi*om fasted animals 
displayed an increased loss of both cytochrome P450 and intracellular iC  following CCI4 
administration (Azri et al, 1990c).
Lake et a l  (1993) demonstrated that phenobarbitone (PB), p-napthoflavone (BNF) and Aroclor 
1254 (ARO) induce 7-ethoxycoumarin-O-deethylase, 7-benzoxyresomfin 0-debenzylase and
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7-ethoxyresomfin 0-deethylase activities. Using appropriate antibodies and Western 
immunoblotting this in vitro system has also been used to study the induction of cytochrome 
P450 isoenzymes immunologically. The polycyclic hydrocarbon-inducible cytochrome P450 
isoenzyme CYPlAl was not detectable in freshly cut liver slices (Murray and Reidy, 1990; 
Okey 1990; Nebert et al, 1991) but was present in rat liver shces cultured for with BNF 48 and 
72 hours (Lake et al, 1993) and 2, 3 ,1, 8-tetrachlorodibenzo-p-dioxin (TCDD) for 24 and 96 
hours (Drahushuk et al, 1999). Using the substrate 7-ethoxycoumarin, Cravedi and co­
workers (1998) have also demonstrated a 3-fold higher dééthylation rate of 7-ethoxycoumarin 
following incubation of trout hver shces with BNF for 24 hours. The effects of a wider range 
of cytochrome P450 inducers on mixed-function oxidase activities and specific cytochrome 
P450 isoenzymes in cultured hver shces requires further investigation.
Human hver shces in dynamic organ culture have been used for the determination of hepatic N- 
acetyltransferase (NAT) activity in humans (Gunawarhana et al, 1991). This study used para- 
aminobenzoic acid (PABA) and sulphamethazine (SMZ) and showed that these substrates are 
metabolised by N-acetylation for up to 16 hours in culture. The NAT activities were 
determined in the presence of other pathways of drug metabolism such as cytochrome P450- 
mediated 0-deethylation, glucuronidation and sulphation (Barr et al, 199la; 199lb). Recently, 
this has become quite significant as the genotoxicity of arylamine compounds has been found 
to be modified through different pathways of metabolism. Therefore, using this system, the 
metabolism of carcinogenic arylamine compounds by various species including humans can be 
studied.
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Precision-cut tissue slices have been used to predict biotransformation pathways and 
pharmacokinetic parameters (Vickers et al, 1993). This in vitro model has been used to study 
the contribution of different organs such as kidney, liver and intestine to metaboHsm of 
cylosporin A (Vickers et al, 1992). Whether this system can be used to predict the contribution 
of vital organs to the metabolism of other drugs requires further investigation. Precision-cut 
liver slices have also been used to study sex and species differences, allowing the ranking of the 
species in terms of the rate of metabolism or toxicity (Steensma et al, 1994; Dogterom and 
Rothuizen 1993; Fisher et al, 1991b). Clearly this in vitro system can be a useful tool in 
biotransformation studies.
1.4.6 Toxicity Studies
The screening of potential toxicants in vivo can be both time consuming and require large 
numbers of animals. Extrapolation from animal data is routinely carried out in order to study 
the effects of toxicants in human tissue. With the development of precision-cut liver slices, 
potential hepatotoxicants can be tested easily. From a liver many shces may be obtained (e.g. 
from a rat hver you can obtain about 50 shces), and therefore, this technique requires fewer 
animals and is less time consuming. Because human hver can be used in this system, clinically 
relevant species comparisons can be made.
For toxicological studies, careful selection of an animal model is essential. The selected 
model's response should closely resemble the manifestations of the toxicity observed in 
humans. The use of precision-cut hver shces has speeded up the process of selection of such a 
model, and the use of human tissue allows for immediate comparison of cellular responses. 
This was demonstrated by Fisher et a l (1990) where two strains of rats (Sprague-Dawley and
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Fisher 344) were chosen to investigate the hepatotoxicity of dichlorobenzene isomers in liver 
shces. 1,2-Dichlorobenzene (1,2 DCB) was found to be most hepatotoxic in shces from Fisher 
344 rats, fohowed by 1,3 DCB. In this strain 1,4 DCB was found to be the least toxic. In shces 
from Sprague-Dawley rats, the isomers were put in the foUowing rank order according to their 
toxicity: 1,3DCB >1,2 DCB >1,4 DCB. The same rank order of toxicity was also observed in 
human shces (Fisher et al, 1991a).
However, previous studies using shces to determine hepatotoxicity of bromobenzene and five 
o -substituted analogous produced the following rank order of toxicity: Br > H > CN > OCH3 
>CFs > CH3 (Fisher et al., 1988). The same rank order was found in hepatocytes in vitro, but 
the reverse order was obtained previously in in vivo studies. Therefore, although in vitro studies 
can be helpful in the evaluation of potential toxicants in a target organ, care must be taken 
when these studies are used as the sole criterion on which scientific conclusion is based.
Despite the progress made in investigating the hepatotoxicity of chemical agents in human 
hver, there are a number of problems associated with human tissue work. The tissue response 
to toxicants varies enormously, which may be due to age, sex, pathological changes, genetic 
and environmental factors, multiple drug therapy, and exposure to anaesthetics and surgical 
handling (Doherty, 1987). Before any conclusion can be made, adequate sample sizes are 
essential. However, the availabihty of human tissue can be unpredictable and so completion of 
studies may be delayed. To avoid this, cryopreservation of shces has been used. The 
cryopreservation of hver shces has been found to maintain approximately 75% of the viabihty 
and biotransformation abihty (Wishnies et al, 1991). The use of cryopreserved shces and the 
large numbers of samples which may be obtained from a sample of human hver tissue ahows a
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number of parameters and chemicals to be investigated simultaneously, providing extensive 
information.
The genotoxicity of a given xenobiotic can be determined in mammahan hepatocytes by the 
unscheduled DNA synsthesis (UDS) procedure (Butterworth et al, 1987,1984). Studies have 
demonstrated that precision-cut liver slices may be used for UDS studies (Beamand et al, 
1996, 1994; Lake et al, 1996b), emphasising on the wide application of precision-cut liver 
slices.
1.5 Objectives of the Current Study
The principal objectives of the present work are as follows:
1. To establish the metabolic viability of precision-cut rat and human liver slices in culture.
2. Compare the dynamic organ culture system with the 12-well plate system.
3. Evaluate the stability of human and rat hepatic cytochrome P450 proteins in precision-cut 
liver slices in culture.
4. Determine the stability of Phase II conjugation systems in human and rat precision-cut liver 
slices in culture.
5. Investigate the ability of precision-cut liver slices in the metabolism of the endogenous 
substrate melatonin.
CHAPTER 2
Materials and Methods
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2.1 MATERIALS
Alabama Research and 
Development Corp., Munsford, 
Al, USA.
Krumdieck tissue sheer
Aldrich Chemical Co Ltd., 
Poole, Dorset.
1,2-Dichloro-4-nitrobenzene.
Amersham International, 
Amersham.
14C-Lauric acid, ECL cytochrome P450 Western 
blotting kits (CYPlAl, 1A2, 2B, 2E, 3A and 4A), 
ECL nitrocellulose membrane, ECL molecular 
weight markers, horseradish peroxidase, "^^ C- 
debrisoquine (ethanol solution - 50 pCi), "^^ C- 
testosterone (toluene solution - 50 pCi), "^^ C- 
tolbutamide (ethanol solution -50 pCi).
BDH Chemicals, Poole, Dorset. Aniline, D-glucose, potassium cyanide, hydrochloric 
acid, sodium hydroxide, copper sulphate, potassium 
sodium tartrate, sodium carbonate, sodium hydrogen 
carbonate, sodium chloride, magnesium chloride, 
formaldehyde, glycerol, potassium dihydrogen 
orthophosphate, disodium hydrogen orthophosphate, 
potassium chloride, potassium hydroxide, 4- 
nitrocatechol, isoamyl alcohol, Fibrowax, xylene, 
toluene, ethanol, methanol, DPX, haematoxylin, 
eosin.
Fisher Scientific International 
Company, Loughborough, UK.
DMSO, Glycine, Perchloric acid (70%),
Gibco Life Sciences, Paisley, UK. Foetal calf serum, Earls’ balanced salt solution,
RPMI 1640, L-methionine.
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Hopkin and Williams, Essex. /?-Nitrophenol.
Mid-West Research Institute 
Kansas, USA.
Benzo(a)pyrene 4,5-dihydrodiol, benzo(a)pyrene 
4,5-oxide.
Molecular Probes, Eugene, OR, Resorufin, ethoxyresorufin, pentoxyresorufin,
USA. methoxyresorufin.
National Diagnostics, Aylesbury Acrylagel, bis-acrylagel.
Bucks.
Panvera Corporation, 
Madison, WI 53711 USA.
Anti-human cytochrome P450 2C10, 2D6,2E1, 
3A4.
Robens Institute of Health and 
Safety, Guildford, Surrey.UK.
Aroclor 1254.
Roche Diagnostic Systems, 
Basel, Switzerland.
Lactate dehydrogenase kit.
Sigma Co Ltd., Poole, Dorset. Cytochrome c, tris buffer, EDTA, dithiotheritol, 
bovine serum albumin (fraction V and free acid), 
ammonium persulphate, mercaptoethanol, glucose-6 - 
phosphate dehydrogenase, N,N,N’,N’ -
tetramethylethylenediamine, "peroxidase-labelled 
donkey anti-sheep, ‘peroxidase-labelled goat anti­
rabbit, "peroxidase-labelled goat anti-mouse, MOPS 
buffer, glutathione reductase, reduced glutathione, 
pyronin Y, 5,5’-dithiobis-(2-nitrobenzoic acid), 
lauric acid, Folin-Ciocalteau phenol reagent, 
dexamethasone, clofibric acid, isoniazid, 
gentamycin, insulin, hydrocortisone 2 1 - 
hemisuccinate, sulphatase (type H-1), P-
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glucuronidase (type B-1), l-chloro-2,4-
dinitrobenzene, tricine, Charcoal (activated,
untreated powder), dextran (molecular weight: 
65,000-85,000), sodium azide, gelatine, 2a-
hydroxytestosterone, 16a- hydroxytestosterone, 6 p- 
hydroxytestosterone, testosterone, androstenedione 
and hydroxytolbutamide.
Stockgrand LTD., School of Sheep anti-aMT6 S (6 -sulphatoxymelatonin)
Biological Sciences University antiserum.
of Surrey, Guildford.
TABB Laboratory, Reading, UK. TAAB 812 resin, DDSA EM grade, NNA EM grade,
DMP-30, propylene oxide, glutaraldehyde (24% 
solutution), osmium tetroxide (4%) and cacodylate.
Vitron, Inc. Tucson, AZ, USA. Titanium roller inserts and hand-held coring tool.
Western Laboratory Services 
Aldershot, UK.
Coming 12-well plates.
Dr Y Funae, Osaka University 
Medical School, Japan.
Antibodies to CYP2C11 ( a gift).
Dr U. Znger, Dr Margarete 
Fischer-Bosch-Institute fur 
Klinische Pharmakologie, 
Stuttgart, Germany.
Antibodies to CYP2D (a gift).
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2.2 METHODS
2.2.1 Animals
Male Wistar albino and Sprague-Dawley rats (200-250g) were obtained from B&K 
Universal Ltd. (Hull, East Yorkshire, UK) and allowed free access to appropriate 
laboratory animal diet and water. The animals were housed in accommodation maintained 
at 22 ± 2°C, with relative humidity of 30-40% and an alternating 12-hour photo-period.
Animals were allowed to acclimatise to these conditions for at least 7 days before use.
2.2.2 Determination of Tissue Slice Thickness
Liver slices form Wistar rats were prepared using the Krumdieck tissue sheer and the 
recommended setting of 200 in order to achieve tissue slices o f 250 pm thickness. In 
order to determine tissue thickness, a number of slices were prepared and were then fixed 
in 10% neutral phosphate buffered formalin (40% formaldehyde) overnight. The tissues 
were then processed for Hght microscopy.
2,2,2.1 Preparation o f Tissue Blocks
The tissues were embedded in paraffin wax (Fibrowax, with a melting point of 56°C) by 
the processes of dehydration, clearing and impregnation with wax, using the processing 
schedule outlined below:
Dehvdration:
70% ethanol 2 hours
85% ethanol 2 hours
95% ethanol 2 hours
1 0 0 % ethanol 2  hours
1 0 0 % ethanol 2  hours
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1 0 0 % ethanol 2  hours
Clearing:
Toluene 2 hours
Toluene 2 hours
Impregnation:
Paraffin wax at 60°C 2 hours
Paraffin wax at 60°C 2 hours
At the end of this process, liver slices were gently cut into two pieces and were then 
embedded upright in paraffin wax blocks. Sections of 5pm thickness were cut using a 
LKB Historange microtome, such that the liver slice was at right angles to the cutting edge 
of the microtome, in order to obtain a section across the thickness of the liver slice. The 
sections were floated on distilled water, at a temperature of 50°C and were then gently 
lifted onto glass slides. The slides were finally placed on a hot plate to dry overnight.
2,2.2,2 Staining fo r  Light Microcopy
The sections were stained with haematoxylin and eosin as follows:
1 . Dewax in xylene 3 minutes
2 . Transferred to 100% ethanol 1 minute
3. Rehydrated in 70% ethanol 1 minute
4. Rehydrated in 50% ethanol 1 minute
5. Rehydrated in distilled water 1 minute
6 . Stained in haematoxylin 15 minutes
7. Rinsed in tap water 1 minute
8 . Differentiated in acid alcohol 
(1% HCl in 70% ethanol)
5-10 seconds
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9. ‘Blue-ed’ in tap water
10. Examined under microscope to check staining
Nuclear staining
11. Counterstained in 1% aqueous eosin
12. Briefly rinsed in tap water
13. Dehydrated in 85% ethanol
14. Dehydrated in 100% ethanol
15. Dehydrated in 100% ethanol
16. Cleared in xylene
17. Cleared in xylene
1 0  minutes
2  minutes
30 seconds 
30 seconds 
30 seconds 
30 seconds 
30 seconds
The sections were finally mounted in D.P.X. (a mixture of distrene-a polystyrene-, a 
plasticiser-tricresyl phosphate- and xylene) by placing a drop o f the mountant on the 
section. A clean coverslip was gently placed over the section, exerting a slight pressure on 
the side of the coverslip to spread the mountant and to eliminate any existing air bubbles.
The thickness of liver shces was measured using a micrometer placed in the ocular of the 
microscope.
2.2.3 Preparation and Culture/Incubation of Liver slices
Rats with weight of about 250g were sacrificed by cervical dislocation. Livers were 
immediately excised and placed in cold EBSS containing 25 mM D-glucose, previously 
gassed with 95% O2 / 5% CO2 for 1 hour. The liver was cut into lobes, and then 
cylindrical cores of 8  mm in diameter were prepared using an 8  mm diameter hand-held 
coring tool (Vitron USA). The cores were then used to prepare liver slices o f 200-300 pm 
thickness in ice cold oxygenated EBSS (as above) using a Krumdieck tissue sheer
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(Alabama Research and Development Corporation, Munford, AL, USA) which was kept 
in the cold room overnight, prior to slicing.
2,23,1 Culture Medium
The culture medium utilised was essentially that described by Lake et al. (1993). The 
medium was RPMI 1640 containing 5% foetal calf serum, 0.5 mM L-methionine, 1 pM 
insulin, 0.1 mM hydrocortisone-21-hemisuccinate and 50 pg ml'  ^gentamycin.
2.2.3.2 Culture o f Liver Slices Using Dynamic Organ Culture Systems
Liver slices were floated onto titanium wire inserts (Vitron USA) (two slices per insert), 
and cultured in glass scintillation vials containing 3 ml culture medium. Small holes were 
made in the scintillation vial lids to facilitate gas exchange. Titanium wire inserts and 
glass vials were autoclaved prior to any culture procedure. The vials were placed on a 
roller system housed in a humidified incubator. They were incubated at 37°C in an 
atmosphere of 5% CO2 / 95% air and rotated at approximately 9 r.p.m. Slices were 
preincubated for 15-30 minutes prior to commencement of the experiments to allow 
equilibrium to take place and eliminate damaged cells from the cutting edges. Slices were 
then transferred to fresh media containing the required concentration of the test compound. 
The inserts were transferred to fresh media every 24 hours. Unless otherwise stated the 
test compounds were dissolved in dimethyl sulphoxide (DMSO) such that the final DMSO 
concentration was 0.5% (v/v) in all vials, including the control cultures.
2.2.3.3 Culture o f Liver Slices using the 12-Well Culture Plates
12-Well plastic tissue culture plates with an incubation volume of 1.5 ml were used 
containing 1 slice per well (unless otherwise stated). The plates were placed on a gyratory
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shaker (90 r.p.m.), such that slices floated and moved smoothly in the medium during 
rotation, housed in a humidified incubator at 37 °C in an atmosphere of 5% CO2 / 95% air.
At the end of each experimental time point, slices were briefly washed in 0.154 M KCl 
buffer containing 50 mM Tris HCl buffer, pH 7.4. Slices were subsequently homogenised 
(1 slice in 1 ml for the 12-well plates and 2 slices in 2 ml for DOCS) in this buffer by 
sonication. Whole homogenate and aliquots of the media were stored at -20 °C prior to 
analysis.
2.2.4 Metabolism of 7-Ethoxycoumarin
The metabolism of 7-ethoxycoumarin to 7-hydroxycoumarin and its subsequent 
conjugation with sulphate and glucuronide were monitored as described by Steensma et al. 
(1994). For the determination of conjugates, aliquots of the media were diluted with 0.5 
volume of 0.5 M sodium acetate buffer, pH 5.0, containing P-glucuronidase (5000 U/ml) 
or sulphatase (250 U/ml). These were then incubated at 37 °C for 16 hours.
Free 7-hydroxycoumarin was then determined as follows; aliquots of the media incubated 
with 50 pM 7-ethoxycoumarin were diluted to 1 ml with 0.154 M KCl buffer containing 
50 mM Tris-HCl, pH 7.4. Upon addition of 0.25 ml of 4 M HCl, the samples were 
extracted with 6  ml chloroform for 30 min. A 5 ml aliquot of the organic layer was then 
extracted with 3 ml 0.5 M glycine-NaOH, pH 10.5 for a further 30 min. The fluorescence 
of the aqueous layer was determined using an excitation wavelength of 380 nm and an 
emission wavelength of 452 nm. The levels of hydroxycoumarin were calculated in 
comparison with standards (0-2.5 pM) carried through the same procedure.
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2.2.5 Lactate Dehydrogenase Leakage
Liver slices were prepared and cultured as described in section 2.2.3, for various time
periods of up to 72 hours using the multiwell plate and the dynamic organ culture system
(DOCS). After each incubation time, slices were removed and the medium was stored at -
20°C in aliquots. The liver slices were briefly washed in 0.154 M KCl buffer containing
50 mM Tris-HCl, pH 7.4, and were then homogenisation (1 slice/ml), and stored at -20°C.
Both the medium and whole homegenates were analysed for LDH using the Ultimate 3
LDH SFBC, an in vitro diagnostic reagent system for use in the determination of the
catalytic activity of lactate dehydrogenase, and is based on the following equation:
LDH
Pyruvate + NADH + H^ ^  ^  L-lactate + NAD^
The rate of the NADH oxidation is directly related to the LDH activity.
The colorimetric analysis was carried out using an automated centrifugal analyser Cobas 
Bio® at 37°C for its reproducibility, ability to analysis large number of samples 
simultaneously, and minimum pipetting error. Quality controls were also employed in the 
assay.
2.2.6 Protein Determination
Microsomal and homogenate protein levels were determined essentially as described by 
Lowry et al (1951). Protein samples were diluted with 0.5 M sodium hydroxide (50-fold 
for whole homogenates and cytosolic protein, and 25-fold for microsomes). 5 ml Of 
freshly prepared 1% copper sulphate solution [2 % sodium potassium tartrate ( 2  ml), 2 % 
copper sulphate ( 2  ml) and 2 % sodium carbonate ( 2 0 0  ml)] was added to samples and 
standards. Tubes were then vortex-mixed and left to incubate at room temperature for 10
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minutes. 0.5 ml Folin-Ciocalteau phenol reagent (diluted 1:1 with distilled water) was 
added and the tubes were immediately vortex-mixed. These were incubated for a further 
30 minutes at room temperature and absorbance was read at 720 nm. Bovine serum 
albumin (500 pg/ml o f 0.5 M sodium hydroxide), in the range 0-150 pg was used as the 
protein standard.
2.2.7 Preparation of Subcellular Fractions
Liver slices (4-6) were homogenised in 2 ml of 0.154 M KCL buffer containing 50mMTris 
HCl pH 7.4, unless otherwise stated. Samples were then sonicated using an MSB soniprep 
(two 5 second burst with a 5 second interval). Samples were then centrifiiged at 9000 x g 
for 20 minutes to remove nuclei, mitochondria, and lysosomes etc. The resulting 
supernatant (S9) was then stored at -20°C prior to use. To obtain the cytosolic or 
microsomal fraction, the S9 fractions were thawed on ice, and were then centrifuged at 
105,000 X g for 45 minutes, the resulting supernatant (cytosol) being used for 
determination of Phase II enzyme activity. The microsomal pellet was resuspended in an 
equal volume of buffer and used for the determination of Phase I enzyme activities, or 
apoprotein levels.
2.2.8 Determination of Phase I Enzymes
2,2,8.1 Alkoxyresorufin O-dealkylase activity
The methods used were principally as described by Burke and Mayer (1974) and Lubet et 
al., (1985). Ethoxy-, methoxy-, and pentoxy-resorufin 0-dealkylase activities are used as 
markers for CYP 1 A l, 1A2 and 2B respectively (Namkung et al., 1988).
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The dealkylation of the three alkoxyresorufins, ethoxy-, methoxy-, and pentoxy- resorufin, 
was determined by following the production of resorufin using a Perkin Elmer LS5 
luminescence spectrofiuorimeter. The spectrofluorimeter was set at excitation and 
emission wavelengths of 510 nm and 586 nm respectively.
The following were added to 3 ml fluorimeter cuvettes:
Tris-HCl buffer (0.1 M pH 7.8 at 37 °C) 2 ml
Microsomal suspension 0.05 ml
* Ethoxyresorufin (0.53 mM) 0.01 ml
NADPH (50 mM in 1% NaHCOs) 0.01 ml
* Pentoxyresorufin (1 mM) or methoxyresorufin (1 mM)
Once the baseline was established, the reaction was initiated by the addition of NADPH. 
Increase in fluorescence was recorded and the initial rate of resorufin produced was 
calculated from the slope. CaHbration was achieved by the addition of 10 pi aliquots of 
resorufin (0.1 mM) to a cuvette containing Tris-HCl.
2,2.8,2 Aniline p-hydroxylase
^-Hydroxylation of aniline was determined according to Guarino et al. (1969). This assay
may be used as a selective probe for the detection of CYP2E. The following reaction
mixture was prepared in duplicate, and incubated at 37°C in a shaking water bath for 10 
minutes. Standards of 0-50 nmol/?-aminophenol were also incorporated into the assay.
Chapter 2: Materials and Methods 52
Test Sample Blank
Tris-HCl buffer (0.3 M, pH 7.6) 0 . 6  ml 0.9 ml
Aniline hydrochloride (40 mM, pH 7.6) 0.5 ml
Magnesium chloride (100 mM) 0 .1  ml 0 .1  ml
Glucose 6 -phosphate (100 mM) and 
NADP^(lOmM)
0 . 2  ml
Glucose 6 -phosphate dehydrogenase 
(10 U/ml buffer)
0 . 1  ml
Microsomes 0.5 ml 0.5 ml
Reaction was initiated by the addition of 0.5 ml aniline hydrochloride (40 mM, pH7.6). 
Tubes were then vortex-mixed and incubated for a further 30 minutes at 37°C in a shaking 
waterbath. To terminate the reaction, tubes were placed on ice and approximately 1 g of 
sodium chloride was added in order to precipitate out the protein. Samples were extracted 
for 30 minutes into 12 ml freshly prepared ether containing 1.5% (v/v) isoamyl alcohol. 
Aliquots (10ml) of the ether were added to 0.5 M tripotassium orthophosphate (4 ml) 
containing phenol (1%, v/v), added just prior to use. These were extracted for a further 30 
minutes on a rotatory shaker. Tubes were left at room temperature for one hour for layers 
to separate and for the colour to fully develop. Absorbance of the resulting blue aqueous 
solution was read at 620 nm. Enzyme activity was calculated with reference to standards 
(0-50 nmol p-aminophenol) and tissue blank.
2.2.83 p-Nitrophenol hydroxylase
The hydroxylation ofp-nitrophenol was determined essentially as described by Reinke and 
Moyer (1985). This assay is routinely used as a marker for the CYP2E subfamily. 
Standards of nitrocatechol (0-20 nmol) were also employed in the assay.
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The following were added into LP3 tubes in duphcates:
Blank Test samples
Phosphate buffer (0.2 M, pH 6 .8 ) 0.7 ml 0.4 ml
Ascorbate (1 mM) 0 .1  ml 0 .1  ml
/ 7-Nitrophenol (1 mM) 0 .1  ml 0 .1  ml
Microsomal suspension 0.3 ml
Tubes were incubated at 37 °C in a shaking water bath for 10 minutes to equilibrate. To 
initiate the reaction, 0.1 ml NADPH (10 mM) was added, vortex-mixed and incubated for 
a further 20 minutes. Tubes were transferred onto ice and the reaction was terminated by 
the addition of 0.5 ml ice-cold perchloric acid (0.6 M). Tubes were centrifuged for 10 
minutes at 3000 r.p.m. and the supernatant (1ml) was transferred to clean tubes. To one 
tube at a time 0.1 ml NaOH (10 M) was added, vortex-mixed and absorbance was read 
immediately at 536 nm. Activity was calculated with reference to the standards.
2.2.8.4 Lauric acid hydroxylase
This assay was essentially carried out as described by Parker and Orton (1980). Lauric 
acid hydroxylase determined by TLC measures the combined formation o f the 12(co)- and 
1 l(co-l)-hydroxylauric acid metabolites.
The following were added into test tubes:
Tris-HCl buffer (0.5 M, pH 7.4) 1.25 ml
Magnesium Chloride (150 mM) 0.10 ml
Lauric acid (1 mM) 0.20 ml
"^^ C Lauric acid (10 pCi/ml) 0.01 ml
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Microsomal suspension 0.10 ml
Test tubes containing the above reagents were preincubated for 10 minutes in a shaking 
waterbath at 37°C. The reaction was initiated by the addition of 50 pi NADPH (40 mM), 
tubes were then vortex-mixed and further incubated at 37°C for 20 minutes in a shaking 
waterbath. The reaction was terminated by the addition of ice cold 3 M HCl (0.2 ml). To 
each tube 1 0  ml diethylether was added, tubes were capped and placed on a rotary mixer 
for 1 hour to extract lauric acid and the hydroxylated products. Aliquots ( 8  ml) of the 
ether layer were then transferred into clean tubes and were evaporated to dryness under 
nitrogen. The residues were dissolved in 60 pi methanol, 25 pi of which were spotted onto 
a silica gel G TLC plate using a Hamilton syringe. The plates were then run in a solvent 
system consisting of hexane : diethylether : acetic acid (140 : 56 : 4). The radioactivity 
was then measured using a plate scanner (Berhold LB2842), each lane being scanned for 5 
minutes. Suitable blanks were carried out through the same procedure.
Although CYP4A1 is predominantly responsible for the 12-hydroxylase activity 
(Tamburini et. ah, 1984), CYP2C2 and CYP2E1 also hydroxylate lauric acid at the 11 
position (Fukuda et. al., 1994).
2.2.8.S NADPH-cytochrome c reductase
NADPH-cytochrome P450 reductase is localised in the microsomes and functions as 
component of the mixed-function oxidase system. The activity was measured, using 
cytochrome c as the electron acceptor, principally as described by Williams and Kamin 
(1962), at 37°C using an Uvikon 860 spectrophotometer.
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The following were added to two cuvettes:
Test Reference
Potassium phosphate buffer (50 mM, pH 7.6) 0.85 ml 0.90 ml
containing 10 mM potassium cyanide
Cytochrome c (0.1 mM) 0.50 ml 0.50 ml
Microsomal suspension 0 . 1 0  ml 0 . 1 0  ml
The reaction was initiated by the addition of 0.05 ml o f NADPH (30 mM in 1% w/v 
NaHCOs) to the test cuvette and mixed by inversion. The reaction was followed at 550nm 
and the initial velocity was taken as the measure of cytochrome c reduction. The 
concentration of the ferrous cytochrome c produced was calculated using a molar 
extinction coefficient of 18.5 mM'^ cm '\
2,2.8.6 Testosterone hydroxylase
Regio- and sterioselective hydroxylation of testosterone is often used as a measure of 
cytochrome P450 activities (Eugene et al, 1992; Donato et al, 1995). Several HPLC 
studies have been reported in which metabolites of testosterone were separated and 
determined (Eugene et al, 1992). However, the HPLC method described below is a 
modified method routinely used at Hoechst Marrion Roussel.
The substrate was prepared as follows: ^"^C-testosterone (50 pCi), (0.195 ml), was 
transferred to a vial containing 0.144 ml unlabelled testosterone (10 mg/ml in methanol). 
The solvents were evaporated under a stream of nitrogen and then resuspended in 
methanol (1 ml). For the assay, 0.02 ml of the substrate was used so that when added to 
0.4 ml a final concentration of 0.25 mM was achieved.
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To small plastic tubes, 0.02 ml of the substrate was added which was then evaporated 
under a stream of nitrogen. 0.1 M Phosphate buffer, pH 7.25 (0.18 ml) was added to each 
tube and left to preincubate with the substrate for 30 minutes in a shaking waterbath at 
37°C. Microsomal suspension was added (0.12 ml) and tubes were incubated for a further 
5 minutes. The reaction was initiated by the addition of 0.1 ml NADPH (0.8 mM). 
Microsomes prepared from freshly cut slices (zero-hours) and those cultured for 4 hours 
were incubated for 15 minutes, other slices cultured for up to 72 hours were incubated 
with the cofactor for 30 minutes. The reaction was terminated by the addition of 0.4 ml 
acetonitrile, tubes were capped, mixed well and placed on a blood roller for at least 1 0  
minutes. The tubes were then centrifuged at 3000 r.p.m. for 10 minutes to remove the 
protein. The supernatant was removed, transferred to clean tubes and evaporated under a 
stream of nitrogen and the residue was resuspended in 0.25 ml o f the HPLC mobile phase 
(90% water pH 2.5 : 10% acetonitrile), 0.1 ml o f which was finally loaded on to the HPLC 
in addition to internal standards (testosterone, 6|3- hydroxytestosterone, 16a- 
hydroxytestosterone, 2a-hydroxytestosterone and adrostendione). Appropriate blanks and 
positive control (microsomes prepared from 25% v/w rat liver) were also carried out 
through the above procedure.
HPLC Analysis
The conditions for HPLC analysis were as follows:
Mobile phase: A: Milli-Q water adjusted to pH 2.5 with HCl
B: Acetonitrile
Column: Jones Genesis C l8 , 4jn, 250 x 4.6 mm
Gradient: 10-90% B, 30 minutes
Retention times: Testosterone 22.3 minutes
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6 p-Hydroxytestosterone 
16a-Hydroxytestosterone 
2a-Hydroxytestosterone 
Androstenedione
15.1 minutes
15.3 minutes
18.1 minutes
23.4 minutes
Authentic metabolites were used to determine the retention times for the above metabohtes 
of testosterone as illustrated in the chromatogram below.
T e s t o s t e r o n e  s t a n d a r d s
6 0 0  J
Q .
TJ
j 4 0 0
S I
CO CL
CD
<  200 J
10 0
00 5 ' 00 10  ‘ 00 1 5  * 00  
TIME (MIN.)
20  ‘ 00 3 0  002 5  ‘ 00
Figure 2.1: A high performance liquid chromatogram o f testosterone and its 
metabolites, 6^ hydroxytestosterone, 16a-hydroxytestosterone, 2a-hydroxytestosterone, 
androstenedione and testosterone.
The conditions for detection were as follows:
Instrument: Hewlett Packard Series 1050 quaternary pump
Deterctors: Berthold LB506 C-1 radioactivity monitor with yttrium glass
Scintillant (400pl cell)
UV: Hewlett Packard Series 1050 variable wavelength (X = 240 nm)
The above conditions were also used for the assays in sections 2.2.S.7 and 2.2.8.S.
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2,2.8,7 Debrisoquine 4-hydroxylase
Debrisoquine was used as a substrate probe for rat CYP2D1 (Larrey et al, 1984) and 
human CYP2D6 (Gonzalez, 1996).
The substrate was prepared as follows: 50 pi of debrisoquine (120mM stock solution) was 
added to 100 pi ^"^C-debrisoquine (50 pCi) which was made up to 1 ml with ethanol 
(6 mM). Aliquot (0.02 ml) o f this solution was finally used in the assay such that when 
added to 0.4 ml a final concentration of 0.3 mM was achieved.
This assay was carried out as described above (section 2.2.8.6), using the same conditions 
for HPLC analysis, the only difference being that all samples were incubated with 
NADPH (0.8 mM) for 30 minutes in a shaking water bath at 37°C. Appropriate blanks 
and positive control (microsomes prepared from 25% v/w rat liver) were also carried out 
through the above procedure. Positive controls were incubated with the cofactor for 15 
minutes only. Figure 2.1 shows a high performance liquid chromatogram of debrisoquine 
and 4-hydroxydebrisoquine. Internal Standard (4-hydroxydebrisoquine) was also loaded 
onto the HPLC, to determine the retention times for the metabohte o f debrisoquine.
Retention times: debrisoquine 11.2 minutes
4-hydroxydebrisoquine 6 . 6  minutes
2,2.8.8 Tolbutamide 4-hydroxylase
Tolbutamide hydroxylase was used as a diagnostic probe substrate for human CYP2C9 
activity (Miners and Birkett, 1996). The substrate was prepared as follows: to tolbutamide 
(0.0054g ml'^), 40 pi "^^ C tolbutamide was added, which was then made up to 1 ml with
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ethanol. To achieve a final concentration o f 0.1 mM, 0.02 ml o f this was used per 0.4 ml 
incubation.
12 0
1 0 0  J
8 0  J
Ü
^  4 0  J
2 0  J
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Figure 2.2: A High performance liquid chromatogram o f debrisoquine (1) and its 
metabolite 4-hydroxydebrosoquine (2), following an incubation o f 15 minutes with rat 
liver microsomes.
To small plastic tubes 0.02 ml of the substrate was added which were then evaporated 
under a stream if nitrogen. 0.1 M Tris buffer pH 7.5 (0.18 ml) was added to each tube and 
left to preincubate with the substrate for 30 minutes in a shaking waterbath at 37°C. 
Microsomal suspension was added (0.12 ml), and tubes were incubated for a further 5
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minutes. The reaction was initiated by the addition of 0.1 ml NADPH ( 8  mM), tubes were 
mixed and incubated for 60 minutes in a shaking water bath at 37°C. The reaction was 
stopped by the addition o f 1 .2  ml diethyl ether, tubes were mixed capped and placed on a 
blood roller for at least 10 minutes. The ether layer was removed and blown to dryness 
under a stream of nitrogen. Residue was resuspended in the HPLC mobile phase (90% 
water pH 2.5 : 10% acetonitrile), 0.1 ml o f which was finally loaded on to the HPLC in 
addition to internal standards. Blanks were also carried out through the above procedure.
HPLC Analysis
The conditions for HPLC analysis were as follows:
Mobile phase: A: Milli-Q water adjusted to pH 2.5 with HCl
B: Acetonitrile
Column: Jones Genesis C l8 , 4p, 250 x 4.6 mm
Gradient: 10-90% B, 30 minutes
Retention times: Tolbutamide 21.4 minutes
Hydroxytolbutamide 15.2 minutes
Authentic hydroxytolbutamide, was used to determine the retention time.
2.2.9 Western Blotting of Proteins
This technique is also known as protein immunoblotting and was first described by 
Towbin et al. (1979). This procedure was essentially carried out as described by Burnette 
(1981), and involves the separation of polypeptides in gels followed by the electrophoretic 
transfer of the separated polypeptides to an immobilising nitrocellulose membrane. The 
“replica” profile of the polypeptide separation fi*om the gel electrophoresis step, created on
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the membrane, is probed with antisera to identify specific polypeptide(s). Therefore, 
Western blotting is a powerful method for identifying specific proteins in a complex 
mixture.
2.2.9.1 Solubilisation o f microsomal preparations
Microsomal proteins were solubilised by the addition of 10 pi of solubilisation buffer (0.1 
M potassium phosphate buffer pH 7.4, containing 10% w/v sodium cholate and 2% w/v 
Emulgen 911) for every mg of microsomal protein. Samples were mixed for 45 minutes at 
4°C. Preparations were then diluted to 1 mg/ml of protein with phosphate buffer, pH 7.5 
(PBS) and then aliquoted and stored at -20°C prior to analysis.
2.2.9.2 Gel electerophoresis
The following solutions were prepared using milli-Q water:
Upper gel buffer: Tris-HCl (0.5 M, pH 6 .8 ) containing 0.4% (w/v)
sodium dodecyl sulphate (SDS)
Lower gel buffer: Tris-HCl (1.5 M, pH 8 .8 ) containing 0.4% (w/v) SDS
Electrode buffer: Tris-HCl (25 mM, pH 8.3) containing 192 mM
glycine and 0.1% (w/v) SDS
Acrylagel (30%): Commercially available
Bis-Acrylagel (2%): Commercially available
Loading buffer: Milli-Q water 4.0 ml
(store in dark at Tris-HCl (0.5 M, pH 6 .8 ) 1 .0  ml
room temperature Glycerol 0 . 8  ml
for a maximum of SDS (10 %) 1 . 6  ml
2  weeks) 2 -mercaptoethanol 0 . 8  ml
Pyronin Y (0.05% w/v) 0.5 ml
Transfer Buffer: Tris (20 mM), glycine (150 mM) and 15 % (v/v)
methanol
Chapter 2: Materials and Methods 62
The mini-electrophoresis system was used for ah Western blots. Glass plates, spacers and 
comb were cleaned with acetone. Spacers (0.75mm) were placed between glass plates and 
gently slotted into the plate holder. Screws were firmly tightened and plates were then 
checked for leakage.
The lower running gel (10%) was prepared as foUows and was sufficient for two gels:
Acrylagel 8.11ml
Bis-Acrylagel 3.38 ml
Lower gel buffer 6.25 ml
Milli-Q water 7.14 ml
Ammonium persulphate ( 10% w/v) 0.125 ml
N,N,N’N ’-tetramethylethylenediamine (TEMED) (20 pi) was then added to initiate 
polymerisation of the gel. The solution was quickly mixed and poured between the glass 
plates using a pasteur pipette, leaving enough space for the upper gel. A small amount of 
milli-Q water was added on to the top of the gel solution to ensure a flat surface between 
the lower and upper gels. The plates containing the gels were then left at 4°C for a 
minimum of 2  hours to ensure complete polymerisation of the gels, after which the thin 
layer of water was gently removed using filter paper. Clean combs (10 line) were inserted 
between the glass plates and the stacking gel (3%) was prepared as follows:
Acrylagel 1.0 ml
Bis-Acrylagel 0.4 ml
Upper gel buffer 2.5 ml
Milli-Q water 6.0 ml
Ammonium persulphate 0.1 ml
( 1 0 % w/v)
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Polymerisation was once again initiated by the addition of TEMED (20 pi). The solution 
was mixed and gently poured into a small gap between the spacers and comb, ensuring no 
air bubbles were present between the sample wells. This was left for 30 minutes to 
polymerise. The plates were then removed and clipped into place into the stand with 
electrodes, which was placed into the tank that was then filled with electrode buffer. The 
comb was gently removed and the sample wells were filled with the buffer to maintain 
their integrity. Equal volumes o f loading buffer were added to the diluted, solubilised 
microsomes which were then heated for 3 minutes at 95-100°C. Samples were allowed to 
cool prior to centrifugation at 13000 r.p.m. for 3 minutes using a microcentrifuge; 10 pi of 
this sample (final protein concentration of 0.5 mg/ml of protein) was loaded into the 
sample wells unless otherwise stated. Molecular weight markers (10 pi) were run 
alongside the microsome samples and they were as follows:
Biotinvlated protein Approximate molecular weisht (Dalton)
Phosphorylase b (rabbit muscle) 97400
Catalase (bovine liver) 58100
Alcohol Dehydrogenase (horse liver) 39800
Carbonic anhydrase (bovine erythrocytes) 29000
Trypsin inhibitor (soybean) 20100
Lysozyme (chicken egg white) 14300
Electrophoresis was carried out immediately at a constant current of 40 mA and a voltage 
of 120 V. When the loaded pink band had migrated to the lower rim of the lower gel, the 
current was switched off.
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2.2.93 Transfer o f proteins onto nitrocellulose membrane
Four blotting papers and one nitrocellulose membrane per gel were cut to size. Two 
scotchbrite pads and the blotting papers were left to soak in the transfer buffer for 5-10 
minutes. The nitrocellulose membrane was soaked in distilled water, prior to soaking in 
transfer buffer in order for the membrane to equilibrate. The plates were removed from 
the electrophoresis tank and the glass plates separated. The upper gel was cut off using the 
spacer, prior to the transfer of protein onto the nitrocellulose membrane for 
immunoblotting.
The transfer cassette was placed in a tray containing transfer buffer (black side down). 
The membrane was sandwiched by using 1 scotchbride pad followed by 2 of the filter 
papers prepared earlier, the gel was then gently placed on top of the filter paper and was 
then covered by the nitrocellulose membrane. This membrane was then covered by a 
further 2  of the cut to size filter papers and was finally sandwiched by the addition of 
another scotchbride pad. Any existing air bubbles were removed between steps. The 
cassette was closed and placed in the transfer tank containing transfer buffer. Transfer was 
carried out overnight at a constant current of 100 mA and voltage of 120 V.
2.2.9.4 Immunodetection
The following reagents were prepared using milli-Q water:
Tris buffered saline (TBS), pH 7.6: 12.1 g Tris-base and 40.0g sodium chloride
dissolved in 5 litres of water 
TBS-Tween: 0.1% Tween-20 in TBS
The following were prepared fresh and are sufficient for the immunodetection of one blot:
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Membrane blocking reagent:
Diluent:
TBS containing 5% (w/v) milk powder 
(Marvel 0.5 g marvel in 10 ml TBS
TBS containing 1% (w/v) milk powder 
0.4 g Marvel in 40 ml TBS
The nitrocellulose membrane was gently rolled and placed in a 40 ml sterilin tube and was 
treated as follows using a total volume of 10 ml:
1. Block membrane
2. Wash
Membrane was incubated in 
the blocking reagent.
Membrane was washed with 
TBS-Tween 3 times.
1 hour
1 X 10 min 
2 x 5  min
3. Anti-cytochrome 
P450 antibody
Membrane was incubated with 
primary antibody diluted in diluent.
1 hour
4. Wash
5. Secondary antibody
Membrane was washed with 1 x 1 0  min
TBS-Tween 3 times. 2 x 5  min
Membrane was incubated with 1 hour
secondary antibody diluted in diluent.
6. Wash Membrane was washed with 
TBS-Tween 3 times.
1 X 10 min
2 X 5 min
7. Streptavidin Membrane was incubated with the 
complex diluted in diluent.
20 min
8. Wash Membrane was washed with 
TBS-Tween 3 times.
1 X 10 min 
2 x 5  min
9. Detection 3 ml ECL detection reagent 1 was 
mixed with reagent 2. Membrane was 
removed from the sterilin tube and 
excess buffer was drained of. The 
membrane was placed on a glass plate 
and was gently covered with the
1 min
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membrane detection reagent.
10. Exposure Excess detection reagent was drained Until
off. The membrane was placed on bands
Saran Wrap membrane face down develop
and was exposed to positive/negative 
Polaroid film in a mini camera.
At the end of the development time (30 seconds), the print was peeled away fi'om the 
negative with a swift, unhesitant motion. Care was taken not to touch or scratch the image 
surface of the negative or the print. The print was immediately coated using the print 
coater provided in order to prevent scratching and fading. The negative was immersed in 
18% sodium sulphite solution and gently agitated for 30-60 seconds. Tabs and back-coat 
material were removed. Once the negative was cleared of residual developer and opaque 
back-coat, the negative was then washed in running water for 5 minutes. Using clips the 
negatives were then hung up and left to dry. The bands on the negative were quantified 
using a densitophotometer (Shimadzu CS-9000-Wavelength Flying Spot Scanner).
2.2.10 Determination of Phase II Enzymes
2.2.10,1 Total Glutathione
Using an adaptation of the method by Akerboom and Sies (1981), the sum of the reduced 
GSH and oxidised (GSSG) forms of glutathione in the cytosolic fi*actions were 
determined.
To LP3 tubes containing 0.5 ml of cytosolic fi'action (diluted 1:5), 0.5 ml perchloric acid 
(2 M containing 4 mM EDTA) was added. To adjust pH to 7.0, 0.5 ml KOH (2 M 
containing 0.3 M MOPS) was added and tubes were vortex-mixed. Aliquots were
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centriftiged for 10 minutes at 2000 r.p.m. to remove precipitate, and the supernatant (0.1 
ml) was used in the assay. Standards (0-0.05 mM of GSSG) were carried out through the 
same procedure as the sample.
To a cuvette the following were added:
Potassium phosphate buffer (0.1 M, pH 7.0 1 ml
containing 2.5 mM EDTA) at 25°C
NADPH (4 mg/ml in 1 % (w/v) NaHCOs) 0.05 ml
Glutathione reductase (6 U/ml buffer) 0.02 ml
Standard / sample 0.1 ml
The reaction was initiated by the addition of 0.1 ml 5, 5’-dithiobis (2-nitrobenzoic acid) 
(CTNB) (1.5 mg/ml in 1% w/v NaiHCOg). The rate of formation of 5-thio-2- 
nitrobenzoate (TNB) was followed at 412 nm.
2,2.10.2 Glutathione reductase
The assay procedure was essentially that of Carlberg and Mannervik (1975). Cytosol was 
prepared from 4 liver slices per time point. Each sample was diluted with sodium 
phosphate buffer (0.1 M, pH 7.5 containing 0.1% (w/v) EDTA) as follows: cytosol from 0, 
4, 8 and 12 hours samples were diluted 1 : 25 and those from 24, 48 and 72 hours were 
diluted 1 :10.
The following reagents were placed in a 1.5 ml cuvette maintained at 37°C:
Sample Reference
Oxidised glutathione (17.5 mM) 0.1 ml 0.1 ml
FAD (0.3 mM) 0.05 ml 0.05 ml
Diluted cytosol 1.5 ml ___
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Sodium phosphate buffer (0.1 M,   1.5 ml
pH 7.5 containing 0.1% (w/v) EDTA)
The reaction was initiated by the addition of 0.1 ml NADPH (2 mM in 1% w/v NaHCOs). 
The reaction was then monitored at 334 nm, and glutathione reductase activity was 
calculated using the extinction coefficient of 4.3 mM"  ^ cm '\
2.2.10.3 Glutathione S-transferases
Glutathione S-transferase activity was determined by an adaptation of the method devised 
by Habig et al. (1974). The assay was carried out using the substrates 1, 2-dichloro-4- 
nitrobenzene (DCNB) and l-chloro-2, 4-dinitrobenzene (CDNB). CDNB is a good 
substrate for many of the glutathione S-transferase isoforms, forming S- (2, 4- 
dinitrophenyly) glutathione following conjugation.
The following were added to cuvettes:
Sample Reference
Sodium phosphate buffer 0.9 ml 0.95 ml
(0.1 M, pH 7.5)
DCNB or CDNB (25 mM in 0.05 ml 0.05 ml
absolute ethanol)
Reduced glutathione (25 mM) 0.25 ml 0.25 ml
The reaction was initiated by the addition of undiluted cytosol (0.05 ml) to the sample 
cuvette. Sample was mixed by inversion and the change in absorbance was measured at 
340 nm. Glutathione S-transferase activity was calculated from initial rate of reaction, 
assuming a molar extinction coefficeint of 8.5 mM* cm * for DCNB and 9.6 mM* cm * for 
CDNB.
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2.2.10.4 Sulphotransferases
This assay was carried out as described by Sekura et al. (1981). Using the probe substrate 
2-naphthol, the cytosolic sulphotransferase activity was determined colourimetrically. The 
principle of the method is based on the conjugation of 2-naphthol to form the 
corresponding ^-naphthol sulphate, in the presence of the sulphate donor molecule 3’- 
phosphoadenosine 5’-phoshosulphate (PAPS). For this assay 6 liver slices were used per 
time point and pooled for preparation of the cytosol.
The following incubation mixtures were prepared in plastic tubes:
Sodium phosphate buffer (0.1 M; pH 7.4) 0.06 ml
*2-Naphthol ( 1 mM in 5 % v/v acetone) 0.10 ml
2-Mercapthoethanol 0.02 ml
PAPS (1 mM in 0.1 M sodium phosphate 0.08 ml
Buffer pH 7.4)
* 2-naphthol was dissolved in absolute acetone first and then diluted, as dissolving in 5% 
(v/v) acetone proved to he difficult.
Tubes were pre-incubated at 37°C in a shaking waterbath for 10 minutes. The reaction 
was initiated by the addition of 0.1 ml cytosol and tubes were then incubated for a fiirther 
30 minutes. The reaction was stopped by the addition of 0.5 ml methylene blue (250 mg 
in 1 L distilled water containing 50 g anhydrous sodium sulphate and 10 ml concentrated 
sulphuric acid) and 2 ml chloroform. Tubes were capped and mixed on a rotary mixer for 
about 10 minutes and centrifuged at 2000 g for 10 minutes using a Beckman J-6 
centrifuge. The chloroform layer was then transferred to fresh glass test tubes containing 
50-100 mg anhydrous sodium sulphate and absorbance was then measured at 651 nm 
using a Kontron 860 spectrophotometer using a quartz cuvette. Suitable blanks were also
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carried out through the same procedure. Based on the assumption that 1 pmol o fZ - 
naphthol sulphate would yield an absorbance unit of 30, the enzyme activity was 
calculated
2.2.10.5 UDP-Glucuronosyl transferases
The glucuronosyl transferase protein is responsible for the glucuronidation of 1-naphthol 
and can be measured by incubating the microsomal fraction in a suitable buffer system in 
the presence o f the substrate and UDP-glucuronic acid (UDP glucUA). The unused 
substrate is extracted from the incubation mixture and the product 1-naphthyl glucuronide 
is measured by its fluorescence at alkaline pH.
The following were added to plastic tubes:
Blank Samples
Potassium phosphate buffer
(50 mM; pH 7.25 containing 5 mM EDTA)
0.80 ml 0.70 ml
Magnesium chloride (100 mM) 0.05 ml 0.05 ml
1-Naphthol (0.5 mM) 0.10 ml 0.10 ml
* Microsomal suspension 0.10 ml
* Prepared from four liver slices.
The tubes were preincubated for 5 minutes at 37°C in a shaking waterbath. The reaction 
was initiated by the addition o f 0.05 ml UDP-glucuronic acid (20 mM) maintained at 
37°C. The tubes were mixed and incubated for a further 10 minutes. The reaction was 
terminated by the addition of 1 ml of 0.4 M TCA/0.6M glycine, pH 2.2. Tubes were then 
vortex mixed and left to stand on ice for 5 minutes. Chloroform (10 ml) was added, tubes 
were capped and mixed on a rotary mixer for 10 minutes, pressure was released and
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samples were centrifuged for 5 minutes at 3000 r.p.m. using a Beckman TJ6. The aqueous 
phase (1 ml) was added to 2 ml of NaOH (0.45 M) in a fluorimeter cuvette. Samples were 
mixed by inversion and fluorescence was read at 293 nm excitation and 335 nm emission 
with the excitation and emission slit set at 10 and 2.5 respectively. For the standards, 1 ml 
of a range of standards (0-20 nmoFml) was added to 2 ml NaOH (0.45 M) in a fluorimeter 
cuvette and the fluorescence was measured as above.
2.2.10.6 Epoxide Hydrolase
This fluorimetric assay was carried out as described by Dansette et al. (1979). 
Benzopyrene 4,5-epoxide is hydrolysed by the microsomal epoxide hydrolase to the 
corresponding dihydrodiol. Prior to the start o f the assay, the fluorimeter was calibrated 
using 1 pi aliquots of benzo(a)pyrene-4,5-/rûr«5'-dihydrodiol (2 mM in acetonitrile).
In a quartz cuvette the following were added at 37°C:
Tris-HCl buffer (0.015 M; pH 8.7 at 37°C) 2.00 ml
*Microsomal suspension 0.05 ml
Benzo(a)pyrene 4,5-epoxide (2 mM in acetonitrile) 0.01 ml
* 6 slices per time point were used, pooled and homogenised in 2 ml KCl buffer. The 
microsomal pellet was resuspended in 0.5 ml KCl buffer and was then used fo r  the assay.
Contents were mixed by inversion and the increase in fluorescence with time was recorded 
using a Perkin-Elmer LS-5 lumiuescence spectrofluorimeter set at excitation and emission 
wavelength of 310 and 385 nm respectively, with excitation and emission slit width of 2.5 
cm and 5 cm respectively.
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2.2.11 RIA of 6-Sulphatoxymelatonin (aMT6s)
2.2.11.1 Principles o f Radioimmunoassay
aMT6s is measured by a competitive immunoassay procedure, whereby different amounts 
of unlabelled (cold) antigen in the sample is incubated with known amounts of 
radiolabelled antigen and antibody specific for the antigen being measured. The cold and 
labelled antigen compete for a restricted number of antibody binding sites and the amount 
of labelled antigen bound to the antibody is inversely proportional to the amount of 
antigen present in the sample. The reaction is continued until equilibrium is reached, after 
which the free antigen (unbound to the antibody) is separated using dextran-coated 
charcoal.
Known concentrations of antigen are used to prepare a standard curve, which is 
subsequently used to determine the concentration of antigen present in the sample by 
comparing the amount of radioactivity present in the sample to that the standards. The 
concentration of antigen contained in the samples is then calculated by interpolation using 
the RIAcalc program (EH & G Wallac, Wallac oy, P.O. Box 10, FIN-20101, Turku, 
Finland). This program automatically calculates the percentage of total counts in either 
the bound or free fraction. The values obtained are then plotted as a ftmction of the known 
concentration of standards. Based on the smoothing spline calculation method (EG & G 
Wallac, Wallac oy, P.O. Box 10, FIN-20101, Turju, Finland), a curve is fitted through 
each pair of the standard points. This curve is finally used to determine the concentration 
of the antigen in the sample.
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For each assay, separate standard curves are used, in addition to a minimum of 3 quality 
control samples of known concentration, giving 20%, 50% and 80% of maximum binding, 
to ensure assay performance and to permit calculation of the inter-assay variation.
2.2.11.2 RIA o f aMT6s in culture medium
Levels of 6-sulphatoxymelatonin were measured using the RIA as described by Arendt et 
al. (1985), modified by Aldhous and Arendt (1988), designed to determine levels of 
aMT6s in urine. However, this method was further modified to enable analysis of levels 
of aMT6s in culture medium (for details refer to section 8.3.1.1).
2.2.11.2.1 Reagents:
(a) Buffer: Unless otherwise stated, all dilutions were made in tricine buffer (0.1 M, pH 
5.5) containing 0.9% NaCl, 0.1% gelatin and 0.01% sodium azide made up in double­
glass-distilled water (DGDW); to dissolve the gelatin this was heated to 50°C.
(ff) Antiserum: The antiserum which was supplied as a fi*eeze-dried ahquot was 
reconstituted to 2ml with DGDW. Aliquots (50 pi) of this intermediate dilution of 
1:50 were then stored at -20°C. For the assay, each aliquot was made up to 20 ml with 
assay buffer to give the working dilution of 1:20000.
(c) Radiolabel: *^^I-aMT6s was diluted in the assay buffer to give 8000-10000 cpm/100 
pi.
(d) aMT6s Standards: Standard was supplied as a ready diluted standard of 200 pg/ml. A 
standard curve was constructed with a range of 0 to 50 ng/ml, diluting the top standard 
in tricine buffer. In addition, 100 pi of culture medium (diluted according to the
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dilution used for the assay) was also incorporated into the standards as shown in Table 
2 .1.
(e) Dextran-coated charcoal (DCC): Activated charcoal (2%) was suspended in tricine 
buffer for 5 minutes, centrifuged at lOOOg at 4°C, for 15 minutes; the supernatant was 
then discarded. The charcoal was resuspended in the original volume of tricine buffer 
containing 0.02% dextran T70. Using a magnetic stirrer in a cold room, this solution 
was stirred for at least 1 hour at 4°C, the suspension being then stored at 4°C.
Tricine buffer 
(pl)
aMT6S 
standard 
200pg/mi (pi)
R P M I1640 
(diluted) 
(pl)
aMT6S
(ng/ml)
aMT6S
(pg/tube)
490 0 100 0 0
485 5 100 0.5 1
480 10 100 1.0 2
470 20 100 2.0 4
450 40 100 4.0 8
420 70 100 7.0 14
390 100 100 10.0 20
290 200 100 20.0 40
0 500 100 50.0 100
Table 2.1: Dilutions used fo r  aMT6s standard curve.
(f) Quality controls: Quality controls were diluted 1:250 in the assay buffer using a 
Hamilton MicroLabM automatic diluter (Hamilton G.B. Ltd., Camforth, Lancashire).
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2.2.11.2.2 Method:
Total tubes (containing *^^I-aMt6s only), non-specific binding (NSB), standards, quality 
controls (QC) and samples were all run in duplicate. To all tubes, except total and non­
specific binding tubes, 200 pl of diluted antiserum was added, as outlined in the flow chart 
on page 76. Tubes were covered with saran wrap, vortex mixed and left to incubate at 
room temperature for 30 minutes. *^^I-aMt6s (100 pl) was added to all tubes, mixed, then 
covered with aluminium foil and incubated overnight at 4°C. To separate antibody-bound 
aMT6s from the free fraction, dextran-coated charcoal was mixed thoroughly and whilst 
still mixing 100 pl charcoal was added to all tubes except total count tubes. This was done 
quickly and accurately to reduce intra-assay variation. Tubes were vortex-mixed and 
incubated for 15 minutes exactly at 4°C, and then centrifuged at 3500 r.p.m. for a further 
15 minutes. Immediately after centrifugation, the supernatant was gently discarded and 
the edges of the tubes were blotted dry. The non-antibody-bound fraction in the charcoal 
pellet was counted for 60 seconds using a Wallac gamma-radiation counter. 
Concentrations of the aMT6S in the samples were automatically calculated from the dose- 
response curve.
Inter-assay variation was determined by calculating the coefficient of variation for the 
three quality control samples measured in each assay. Ideally it should not be greater than 
10%. The limit of detection is defined as the concentration of antigen measured by the 
c.p.m. at two standard deviations of the mean zero binding tubes. The analytical limit of 
detection of the assay is 0.25 ng/ml and the functional limit of detection is 0.43 ng/ml 
(Stockgrand Ltd.),
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Tubes
Total (pl) NSB (pl) Standard
(pl)
QC(pl) Sample
(pl)
Buffer 690 490
*RPMI 1640 10 10
Standard 490
QC 500
Sample *10
Antiserum 200 200 200
Incubate tubes for 30 minutes at room temperature
Radiolabel 100 100 100 100 100
Incubate tubes overnight at 4°C
I
DCC 100 100 100 100
Incubate tubes for 15 minutes at 4°C 
Centrifuge for 15 minutes at 3500 r.p.m.
Decant supernatant and count pellet
* The culture medium used for liver slices incubated with melatonin (50 pM) was diluted 1:1000 and 
that incubated with 6-hydroxymelatonin (50 pM) was diluted 1:500 of which 10 pl was used for the 
assay. To maintain consistency, the same dilutions were used in the standard and NSB tubes.
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2.2.12 Preparation of Samples for Light and Electron Microscopy
Liver slices were prepared and cultured as previously described 2.2.3. Slices were then 
removed from culture medium at various time points, briefly washed in 0.154 M KCl 
buffer (containing 50mM Tris-HCl pH 7.4) and were processed as follows.
2.2.12.1 Fixation and Dehydration
Slices were transferred to glass vials containing glutaradehyde (4 % in 0.1 M cacodylate 
pH 7.4) for at least 4 hours to fix. Samples were then transferred to vials containing 
storage buffer in which tissue may be maintained indefinitely.
Storage buffer consisted of:
Sodium cacodylate (0.2 M, pH 7.4) 50 ml
Distilled water 35 ml
Formaldehyde (40 % w/v) 10 ml
Glutaraldehyde (25 % w/v) 4 ml
At the end of the fixation time, tissues were cut into small pieces and washed thoroughly 
by decanting and resuspending a number of times (3-4 times) in cacodylate buffer (0.1 M 
pH 7.4) over a period of 1 hour. Tissues were then counterfixed in 2% buffered osmic 
acid/0.1 M cacodylate pH 7.4 (equal volumes of osmic acid and 0.2 M cacodylate buffer to 
give a final concentration of 0.1 M) for 1 hour.
Dehydration process was then carried out as follows:
Ethanol (25 % v/v) 10 minutes x 2 changes
Ethanol (50 % v/v) 10 minutes x 2 changes
Ethanol (75 % v/v) 10 minutes x 2 changes
Ethanol (90 % v/v) 10 minutes x 2 changes
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Ethanol (Absolute) 10 minutes x 2 changes
Propylene oxide/Absolute ethanol 10 minutes x 2 changes
(1:1)
Propylene oxide 10 minutes x 2 changes
2.2.12.2 Embedding
Tissues were finally covered with propylene oxide/epon 812 resin (1:1) for 1 hour. 
Capsules were gently filled with epon 812 resin.
Resin was prepared as follows:
TAAB 812 resin 50 ml
DDSA EM grade 45 ml
MNA EM grade 5 ml
DMP-30 2 ml
A small piece of tissue was transferred to the resin-filled capsule such that the tissue 
thickness would be at right angles to the cutting edge of the knife. Samples were left in 
resin at room temperature for 4 hours and then were left in a 60 °C oven for 12 hours to 
polymerise.
2.2.12.3 Section Cutting and Counterstaining
This procedure was kindly provided as a service, by the University of Surrey, Structural 
Studies Unit. The Epon blocks were trimmed to expose the tissue sample and sections 
(700A for electron microscopy and 1.5 pm for toluidine blue) were cut using the Reichert 
OMU-3 ultramicrotome (Reichert-Jung Ltd., Slough). For electron microscopy the 
sections were counter-stained in 2% uranyl acetate and 4% lead citrate for 20 minutes in
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each at 60°C. For the light microscopy of resin-embedded liver, thick sections were 
stained in toluidine blue (Richardson et al, 1960).
2.2.12.4 T.E.M. Examination and Photography
The sections were examined using a Phillips 400T electron microscope (Phillips UK Ltd., 
London). Photomicrographs were taken with the automatic camera of the microscope, on 
Kodak “Electron Image Film”. The micrographs were printed on grade 2 Ilford, Ilfospeed 
2.1M paper. This service was provided by the University of Surrey, Structural Studies 
Unit.
CHAPTER 3
Structural and Functional Integrity of 
Precision-cut Rat Hepatic Slices
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3.1 INTRODUCTION
During the last few years precision-cut tissue slices have attracted many scientists for 
their use in the study of metabolic pathways and toxicity o f chemicals. This is mainly 
due to the development of an automatic tissue slicer, capable of producing viable slices 
o f uniform shape and thickness (Parrish et aL, 1995; Bach et al., 1996). Slices have been 
successfiilly generated from a number of tissues such as liver, kidney (Phelps et a l, 
1987), lung (Fisher et ah, 1994), heart (Parrish et a l, 1992), and brain (Richards and 
Tegy, 1977; Richards and Sercombe, 1968, 1970) from different animal species 
including human. Tissue slices have been used to study metabolic pathways of 
xenobiotics (Ekins, 1996; Harris et ah, 1994; Barr et al, 1991a, 1991b), mechanisms of 
toxicity following in vivo administration of the toxin (Beales and McLean, 1995) and in 
vitro toxicity in various tissues (Fisher et a l, 1994; Miller et a l, 1993).
With increasing interest in the application of precision-cut tissue slices during the last 
few years, many incubation/culture systems have been developed. Viability o f tissue 
slices in long-term culture is of major concern, especially when investigating the 
metabolism of poorly metabolised chemicals. Currently many different types of 
incubation systems are being used for the culture of precision-cut tissue slices (Figure 
3.1). For more details refer to section 1.4.3.
The most commonly used incubation systems are the dynamic organ culture and the 
multiwell plates particularly the 12-well plate. The former involves rotating tissue slices 
adhering onto a wire mesh through the incubation medium and the atmosphere o f the vial 
in cycles, hence the name surface culture. The latter is also referred to as submersion
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culture, because tissue slices are submerged in culture-wells and are in continuous 
contact with the incubation medium, being gently agitated on a gyratory shaker.
PERCISION-CUT TISSUE SLICES
SURFACE CULTURE SUBMERSION CULTURE
The dynamic organ I The rocker I The multiwell plate i
system (the roller system) I _____ platform | system |
The shaken 
flask
\
The stirred well6- well plates |  24- well plates12- well plates
Figure 3.1: Schematic representation of the incubation systems currently in use for the 
culture of precision cut tissue slices.
Fisher et al. (1995a) compared the two procedures 
employing a number of viability parameters such as enzyme leakage (lactate 
dehydrogenase, LDH), ATP content, retention, protein content and the metabolism of 
7-ethoxycoumarin, and concluded that the dynamic organ culture is superior to the 
multiwell plate system for maintaining precision-cut slices in culture. More recent 
studies have compared five incubation systems for rat liver slices: the shaken flask (an 
Erlenmyer in a shaking water bath), the stirred-we 11 (24-well culture plate equipped with 
grids and magnetic stirrers), rocker platform (6-well culture plate with Netwell insert 
rocked on a platform), the dynamic organ culture system (roller system) and the 6-well 
shaker (6-well culture plate in a shaking water bath) (Olinga et al., 1997b). Viability of
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slices was evaluated by: content, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide) assay, histomorphology and LDH leakage. Determination 
of the metabolism o f lidocaine, testosterone and antipyrine was used to assess metabolic 
function of the liver slices. But results from their histomorphology studies were not 
presented. The authors concluded from these studies that after 24 hours incubation, the 
shaken flask, the rocker platform and the 6-well shaker incubation systems were superior 
to the stirred well and the dynamic organ culture system.
In the present study, the viability of rat liver slices in two culture systems, namely the 
dynamic organ culture system (DOCS) and the 12-wellplate system, was compared 
morphologically using light and transmission electron microscopy and correlated to the 
ability of the slices to metabolise 7-ethoxycoumarin. 7-Ethoxycoumarin has been widely 
used as a probe substrate for oxidative and conjugative metabolism in studies 
investigating the drug metabolic viability o f liver slices from several different species 
(Steensma et ah, 1994; Worboys et ah, 1995; Barr et ah, 1991a and b). It allows the 
simultaneous determination of Phase I and Phase II pathways.
In addition, a study was carried out to investigate whether an increase in the number of 
slices per incubation would lead to a proportional rise in metabolic activity, enabling 
such an approach to be used with poorly-metabolised substrates to generate sufficient 
amounts of metabolites for structural identification.
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3.1.1 Objectives of the Study
The principal objectives of this study were:
1. To carry out a comprehensive comparison of the dynamic organ culture and the 
multiwell plate system, with emphasis on their ability to support xenobiotic 
metabolism.
2. To correlate metabolic capacity with morphology evaluated by light and transmission 
electron microscopy.
3. Establish whether increasing the number of liver slices per incubation results in a 
proportional increase in metabolic activity.
3.2 METHODS
For the following methods refer to the corresponding section as outlined below:
(a) Culture conditions -  section 2.2.3
(b) Metabolism of 7-ethoxycoumarin -  section 2.2.4
(c) Determination of lactate dehydrogenase leakage (LDH) -  section 2.2.5
(d) Protein determination -  section 2.2.6
(e) Preparation of samples for light and electron microscopy -  section 2.2.12
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3.3 RESULTS
3.3.1 Determination of Tissue Slice Thickness
As the optimal thickness for liver slices was reported to be 200-250 pm (Parrish et ah, 
1995), the setting of 200 on the Krumdieck tissue slicer was initially used. To determine 
tissue thickness, slices were prepared which were then carried out through a dehydration 
procedure and were finally embedded in wax and stained according to section 2.2.2. 
Tissue thickness was then measured using a graticule in the eye-piece of a light 
microscope.
Setting on the Krumdieck tissue slicer Tissue thickness (pm)
400 862 ± 63
200 484 ± 50
100 380 ±48
0 266 ± 54
Table 3.1: Liver slice thickness from  different settings on the Krumdieck tissue slicer.
Results are presented as Mean ± SEM for 8 determinations.
However, the setting of 200 on the Krumdieck tissue slicer produced an average slice 
thickness of 484 ± 50 pm (Table 3.1). This clearly suggested that the Krumdieck tissue 
slicer needed to be calibrated prior to use for culturing. To achieve this slices were 
prepared using different settings on the slicer and tissue thickness was then determined 
as before. Table 3.1 shows that in fact the zero setting produced slices of thickness 266 
± 54 pm. In addition it was also noted that the number of weight plungers used in the 
slicer also affects tissue thickness (data not shown), and preliminary studies revealed that
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four weight plungers on the tissue cores, produced slices more uniform in thickness. 
Therefore, all studies were carried out using the zero setting on the Krumdieck tissue 
slicer, and 4 weight plungers.
3.3.2 Cumulative Metabolism of 7-EC by Rat Hepatic Slices Cultured in 12-Well 
Plate and the DOCS
Incubation of liver slices from Wistar rats with 7-j ethoxycoumarin (50 pM) resulted in a 
time-dependent metabolism in both the DOCS and the 12-well plate procedure. 
Metabolites measured were the sulphate and glucuronide conjugates of 7- 
hydroxycoumarin in addition to low levels of unconjugated 7-hydroxycoumarin (free). 
In both culture systems, sulphate conjugate was the predominant metabolite at all time
y
points. Although only low levels of free 7-l^roxycoumarin were measurable, the levels 
of this metabolite also increased steadily over time (Figures 3.2a and b).
No major difference could be seen between the two culturing procedures during the first 
6 hours. However, when the multiwell plate procedure was used, metabolism increased 
linearly for at least 10 hours, whilst it tended to plateau after 6 hours in the DOCS 
(Figure 3.2a and b).
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Figure 3.2: Cumulative metabolism of 7-ethoxycoumarin (50 fiM) to free J-HC, 7-HC 
glucuronide and 7-HC sulphate conjugate by rat liver slices cultured in the 12-well 
plate (a) and the DOCS (b). Results are presented as Mean ±  SEM for 3 animals. Each 
time point was carried out in duplicate, and analysis o f the metabolites for each 
incubation was similarly carried out in duplicate.
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3.3.3 Metabolic Viability of Rat Hepatic Slices Cultured in the 12-Well plate and the 
DOCS
In order to assess metabolic viability, liver slices were preincubated at 37°C for various 
periods of time up to 72 hours, prior to the addition of the substrate 7-ethoxycoumarin. 
At the specified time points, 7-ethoxycoumrarin (50 pM) was added and slices were 
incubated for a further 2 hours. Slices were incubated for 2 hours in the presence of the 
substrate because the liver slices formed substantial levels of metabolites after just 2 
hours to enable quantification. In addition, 2 hours was a convenient time point for 
assessing metabolic viability especially when the tissue slices were being preincubated 
over long time periods of, for example, 10 hours. After incubation with the substrate the 
media was removed and stored at -20°C prior to analysis. Liver slices were briefly 
washed in KCl buffer (0.154M containing 50 mM Tris-HCl, pH 7.4 and were 
homogenised in this buffer (1 slice/ml) for protein determination.
In both culture systems, at all time points studied, 7-ethoxycoumarin was metabolised to 
7-hydroxycoumarin sulphate and glucuronide conjugates, the former being the major 
metabolite, with only low levels o f fi'ee 7-hydroxycoumarin. Viability, as exemplified 
by the total metabolism of 7-ethoxycoumarin, was not substantially impaired for up to 10 
hours (Figure 3.3a). After 24 hours, about 60% of the original metabolic activity was 
still retained in the multiwell culture system falling to about 15% after 48 hours. Very 
low levels of metabolic activity towards ethoxycoumarin were still measurable following 
72 hour preincubation (Figure 3.3a). In the dynamic organ culture procedure, 45% of the 
initial metabolic activity was retained after a preincubation of 24 hours; virtually no 
metabolic activity was observed following 48 and 72 hours preincubation (Figure 3.3a).
Chapter 3: Structural and Functional Integrity o f Precision-cut Rat Hepatic Slices___________________  89
No marked differences in the free 7-hydroxycoumarin levels were noted for the first 24 
hours in both culture systems (Figure 3.3b). Figure 3.3b shows that about 17% of the 
initial activity still remains following 48 hours culture in the multiwell plate and DOCS 
and also 17% activity at 72 hour using the multiwell plate system with no measurable 
levels in the DOCS. However, it is important to note that variability is large at these 
time periods, and levels were just above the limits of detection.
The formation of 7-hydroxycoumarin glucuronide conjugate with time appears to be very 
similar to that of the sulphate conjugate (Figures 3.3c and d). No marked change in the 
rate of formation of glucuronide conjugates occurred for up to 10 hours (Figure 3.3c). 
After 24 hours, about 60% and 45% of initial activity still remains in the multiwell plate 
system and DOCS respectively. Approximately 10% of the activity remained after 48 
hours in the multiwell plate system and very low, but measurable, levels in the DOCS. 
Although small amounts were still measurable following 72 hours in the multiwell 
system, none were detectable in the DOCS (Figure 3.3c).
The formation of the sulphate conjugate does not appear to be affected by the type of 
culture system used. During the first 10 hours, levels o f sulphate conjugates formed 
were similar in the DOCS and the multiwell system (Figure 3.3d). The slices were 
capable of forming 60% of the original sulphate conjugates at 24 hours in the multiwell 
system and approximately 45% of the original level in the DOCS (Figure3.3d). 
However, after 48 hours a decline of approximately 80% in activity can be noted in the 
multiwell system with very little activity from slices cultured in the DOCS. Although at 
72 hours no sulphate conjugates were measurable in the DOCS, but very low levels were 
still detectable using the multiwell system (Figure 3.3d).
Chapter 3: Structural and Functional Integrity o f Precision-cut Rat Hepatic Slices 90
(a) M 12-well plate 
□  DOCS
^  O J D
« e 0.8
4 8 10 24 48
Preincubation time (h)
72
(b) 0.12 □  12-well plates
□  DOCS
E .5 0.08 s
P  M  0.06
8 10 24 48
Preincubation time (h)
72
Chapter 3: Structural and Functional Integrity o f Precision-cut Rat Hepatic Slices 91
■  12-well plates 
□  DOCS
0.6
0.5
bc e
0.2
0.1
240 4 8 10 48 72
Preincubation time (h)
■  12-well plates 
□  DOCS
S) •§ 
•11
M 0.6
0.4
0.2
720 4 8 10 24 48
P reincubation tim e (h)
Figure 3.3: Metabolism of 7-ethoxycoumarin (50 fjM) by liver slices from Wistar rats 
cultured in the 12-well plate and the DOCS. Liver slices were incubated fo r  various time 
periods up to 72 hours. After specified time periods liver slices were incubated with the 
model substrate for a further 2 hours (a) total metabolites, (b) free 7-hydroxycoumarin,
(c) glucuronide conjugate and (d) sulphate conjugate. Results are presented as Mean ± 
SEM for 3 animals. Each time point was carried out in duplicate, and analysis o f  the 
metabolites for each incubation was similarly carried out in duplicate.
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Homogenate protein content of rat liver slices incubated in the dynamic organ culture 
and the multiwell plate system following various preincubation times was measured. 
During the first 24 hours of incubation, a gradual decline in protein levels was noted in 
liver slices using both culture systems (Figure 3.4). However, following this time point, 
there was a rapid decline in protein levels of slices incubated in the dynamic organ 
culture system (DOCS) to about 50% its original level after 72 hours, whilst protein 
levels remained stable for up to 72 hours in the multiwell plate system (Figure 3.4).
12-w ell plate 
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Figure 3.4: Homogenate protein content of rat liver slices cultured in the multiwell 
plate (12-well) arid the DOCS following various preincubation times. Results are 
presented as ±  SEM for 3 animals. Each time point was carried out in duplicate.
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3.3.4 Lactate Dehydrogenase (LDH) Leakage
A time-dependent leakage of lactate dehydrogenase, indicating progressive cellular 
damage, was seen with both culture procedures; no difference in the extent of leakage 
between the two procedures was evident (Figure 3.5).
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Figure 3.5; Lactic acid dehydrogenase in rat liver slices incubated using the dynamic 
organ culture system (DOCS) and the multiwell plate (12-well) culture system. Liver 
slices from Wistar rat were incubated for up to 72 hours using the dynamic organ and the 
multiwell plate culture systems. Activity o f lactic dehydrogenase in the media was 
measured in duplicate and expressed as % o f total activity.
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3.3.5 Morphological analysis of rat liver slices incubated in the multiwell plate and 
the DOCS
3.3.5.1 Light Microscopy (LM)
Liver slices from Wistar rats were cultured for various time periods of up to 72 hours 
using the multiwell plate system and the dynamic organ culture system. Following each 
incubation time point, liver slices were briefly washed in KCl buffer and were then 
processed for light and electron microscopy according to section 2.2.12. Under the light 
microscope the even uptake of toluidine blue in all the cells across the tissue thickness of 
the slice indicates that with freshly cut slices all the cells, except those damaged by the 
actual slicing procedure at the cutting edge, are viable (Figure 3.6).
V -.: .S .
Figure 3.6: Light photomicrograph of a section across the thickness of freshly 
prepared precision-cut liver slices from Wistar rats. Note the even staining across the 
tissue, except for the faint hand at the cutting edges on both sides o f the tissue, 
illustrating damaged cells. Red Blood Cells (RBC).
Toluidine blue: magnification X  972.
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Irrespective of the type of incubation system used, compared to fresh liver slices (0- 
time), a dramatic change in the appearance of the cells after just 4 hours in culture was 
observed, (Figures 3.7a and b). However, judged by the intensity o f toluidine staining, in 
both culture systems, there was some loss of viability particularly in the centre of the 
tissue (indicated by faint toluidine blue staining). But, this necrotic region appears 
somewhat wider in slices incubated in the DOCS (Figure 3.7b). In contrast to the 
multiwell system, hepatocytes below the cutting edge of the slices cultured in the 
dynamic organ system for 4 hours, appear similar to those in the fresh slices (Figure 3.6). 
This suggests that the hepatocytes are probably better maintained using this incubation 
system. Although, after 8 hours of culture, the difference between the two incubation 
systems is more pronounced. Slices cultured in the multiwell system appear to be better 
maintained than those in the DOCS, although some contain vacuoles (Figure 3.8). A 
distinctly necrotic central band can be noted in the latter system, whereas the hepatocytes 
in the centre of the slices are better maintained in the multiwell system. It is also evident 
that in the dynamic organ system the viable cell band on one side of the cut surface is 
substantially thicker than the other side, presumably reflecting the contact with the wire 
mesh (Figure 3.8b). This picture remains the same following 10 hours of incubation 
(Figure 3.9b). The only change that can be noted at this time point is the presence of 
vacuoles in the hepatocytes, just below the cutting edges in both the culture procedures 
used (Figure 3.9a and b). At 24 hours, a distinct band of central necrosis is evident in 
both systems, but the degree of necrosis is somewhat less in the slices cultured in the 
multiwll plate system (Figure 3.10). The layers of viable cells at the cutting edges (darker 
stained cells), also appear better preserved in the multiwell system containing less 
vacuoles (Figure 3.10a). No viable cells were observed in slices incubated for 48 
(Figures 3.11), and 72 hours (data not shown) using either culture system.
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Figure 3.7: Light photomicrograph of cells across the thickness of precision-cut liver 
slices from Wistar rats cultured for 4 hours in the (a) 12-well plate system, and (b) 
DOCS. Note the predominantly fainter stained necrotic region in the centre o f (h) and 
also note how the cells just below the cutting edges (arrows) closely resemble those of 
the freshly cut slices. V=vacuoles.
Toluidine blue: magnification X  972.
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Figure 3.8: Light photomicrograph of cells across the thickness of precision-cut liver 
slices from Wistar rats cultured for 8 hours in the (a) 12-well plate system, and (b) 
DOCS. Note the necrotic region (N) in the centre o f (h) and also note how the number of 
viable cells (indicated by the darker staining) just below the cutting edge on one side oj 
the tissue (arrow) is significantly lower than on the other side. V = vacuoles 
Toluidine blue: magnification X  972.
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Figure 3.9: Light photomicrograph of cells across the thickness of precision-cut liver 
slices from Wistar rats cultured for 10 hours in the (a) 12-well plate system, and (b) 
DOCS. Note the necrotic region (N) in the centre o f (h) and also note how the number o f 
viable cells (indicated by the darker staining) just below the cutting edge on one side o f 
the tissue (arrow) is significantly lower than on the other side. V = vacuoles.
Toluidine blue: magnification X  972.
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Figure 3.10: Light photomicrograph of cells across the thickness of precision-cut liver 
slices from Wistar rats cultured for 24 hours in the (a) 12-well plate system, and (b) 
DOCS. Note the necrotic region (N) in the centre o f the tissue. V = vacuoles.
Toluidine blue: magnification X  972.
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Figure 3.11: Light photomicrograph of cells across the thickness of precision-cut liver 
slices from Wistar rats cultured for 48 hours in the (a) l2-well plate system, and (b) 
DOCS. The even faint staining o f cells show necrosis throughout the thickness o f the 
tissue..
Toluidine blue: magnification X  972.
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3,3.5.2 Transmission Electron Microscopy (TEM)
Morphological examination of the regions of viable cells with electron microscopy 
showed good preservation of hepatocytes and sinusoidal cells. Following a 4 hour 
culture of the liver slices, in both systems, intact bile canaliculi, hepatocytes with well 
preserved endoplasmic reticulm, mitochondria and other cytoplasmic structures are 
clearly evident (Figure 3.12 a and b). After an 8 hour incubation, good preservation of 
intracellular and extracellular components, with both culturing systems is observed, 
although cytoplasmic degeneration in the form of vacuoles close to bile canaliculi is 
evident in the dynamic organ system (Figure 3.13 a and b). At 24 hours of incubation in 
the multiwell system, hepatocytes with stacked rough endoplasmic reticulum, distended 
bile canaliculi, large intracellular vacuoles, some containing lipid material, and necrosed 
sinusoidal cells are evident (Figure 3.14a); in the dynamic organ system a more 
pronounced cellular disruption was noted (Figure 3.14b). Slices incubated for 24 hours 
or longer periods contain numerous electron dense vacuoles in both systems, but 
especially in the dynamic organ system, which appear to be lipid droplets. Incidence and 
intensity of staining in these droplets increases with the length of incubation (Figure 
3.14b). X-ray microprobe analysis revealed the presence of osmium in these droplets 
indicating that they contain unsaturated fat.
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Figure 3.12: Electron photomicrograph of precision-cut rat liver slices cultured for 4 
hours in the (a) 12-well plate system, and (b) DOCS. Liver slices from Wistar rat were 
cultured for various time periods o f up to 72 hours. Slices were fixed in glularcddehyde, 
embedded in resin and stained with uranyl lead citrate. N, nucleus; ER, endoplasmic 
reticulum; BC, bile canaliculi; LD, lipid droplets; V, Vacuoles; NC, Necrosed cell. 
Magnification: X  5OK.
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Figure 3.13: Electron photomicrograph of precision-cut rat liver slices cultured for 8 
hours in the (a) DOCS, and (b) 12-well Plate system. Liver slices from Wistar rat were 
cultured for various time periods o f up to 72 hours. Slices were fixed in glut ar aldehyde, 
embedded in resin and stained with uranyl lead citrate. N, nucleus; ER, endoplasmic 
reticulum; M, mitochondria ; LD, lipid droplets; V; Vacuoles.
Magnification: X  5OK.
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Figure 3.14: Electron photomicrograph of precision-cut rat liver slices cultured for 24 
hours in the (a) 12-well plate system, and (b) DOCS. Liver slices from Wistar rat were 
cultured for various time periods o f up to 72 hours. Slices were fixed in glutar aldehyde, 
embedded in resin and stained with uranyl lead citrate. N, nucleus; ER, endoplasmic 
reticulum; BC, bile canaliculi; LD, lipid droplets; V, Vacuoles; NC, Necrosed cell. 
Magnification: X  5OK.
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3.3.6 The Effect of the Number of Hepatic Slices per Incubation on Metabolic 
Activity and Viability
Liver slices from Sprague-Dawley rats were incubated for various time periods up to 72 
hours using the multiwell plate culture system. At the end of each time point, slices were 
incubated for a further 2 hours in the presence of the model substrate 7-ethoxycoumarin 
(50 pM). This was carried out using one and two liver slices per culture well. At the 
specified time points, the media were removed and stored at -20 °C prior to analysis. 
Liver slices were briefly washed in KCl buffer and were homogenised in this buffer (1 
slice/ml) for protein determination.
From Figure 3.15 it is evident that the homogenate protein content of two slices is double 
that of one liver slice. However, the protein content decreases with incubation time 
when two slices are used, whilst protein levels present in one liver slice per culture-well 
appears to be fairly stable over the entire 72 hour incubation period.
Total metabolism of ethoxycoumarin, expressed as nmoFincubation, was modestly 
higher during the first 10 hours of preincubation when two slices were utilised per 
incubation compared to one (Figure 3.16a). A similar pattern was observed when the 
amounts of the sulphate conjugate of 7-hydroxycoumarin, the principal metabolite, were 
determined (Figure 3.16d). As far as the glucuronide conjugate is concerned, one and 
two slices produced similar amounts for the first 10 hours of preincubation, but at 
subsequent times more was recovered from the media containing a single slice (Figure 
3.16c). Low levels of free 7-hydroxycoumarin were also detectable, more being 
produced by the incubations containing two slices (Figure 3.16b).
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However, a different picture emerged when 7-ethoxycoumarin metabolism was 
expressed in terms of mg of homogenate protein to account for the different amounts of 
protein, i.e. the number of liver slices and the slight variation in tissue thickness, in the 
incubations (Figure 3.17). Total ethoxycoumarin metabolism, as well as, the generation 
of individual metabolites were almost twice as high with a single slice compared to two 
slices per incubation (Figure 3.17a).
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Figure 3.15: Protein content of 1 and 2 liver slices per incubation. Liver slices from  
male Sprague-Dawley rats were preincubated in 12-well plates (I slice per well and 2 
slices per well) for various time periods. At specific time points, the liver slices were 
incubated for a further 2 hours in the presence o f 7-ethoxycoumarin (50pM) after which 
slices were briefly washed in KCl buffer and homogenised in KCL buffer (1 slice/culture- 
well). Results are presented as Mean ±  SEM for 3 animals. Each time point was carried 
out in duplicate, and analysis o f the metabolites for each incubation was similarly carried 
out in duplicate.
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As in the case of the Wistar rat, the principal metabolite was the sulphate conjugate of 7- 
hdyroxycoumarin, with substantial amounts of the glucuronide but very low levels of the 
unconjugated metabolite being formed. However, the rate of metabolism of 
ethoxycoumarin, i.e. the sum of the sulphate, glucuronide and free 7-hydroxycoumarin, 
by Sprague-Dawley rat, expressed as nmol/mg of protein (Figure 3.17a), was twice that 
of the Wistar strain (Figure 3.3a). Moreover, in the Sprague-Dawley rat significant 
ethoxycoumarin metabolism was still measurable following a 72-hour preincubation.
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Figure 3.16: The effect of the number of liver slices per incubation on metabolic 
viability (expressed per incubation). Liver slices from Sprague Dawley rats were 
incubated for various time periods for up to 12 hours using the multiwell plate culture 
system. At the end o f each preincubation time, slices were incubated for a further 2 
hours in the presence o f the substrate 7-ethoxycoumarin (50 pM). Results are 
expressed as nmol per incubation and are presented as Mean ±  SEM for 3 animals. 
Each time point was carried out in duplicate, and analysis o f  the metabolites for each 
incubation was similarly carried out in duplicate, (a) Total metabolites, (b) free 7- 
hydroxycoumarin, (c) glucuronide conjugate o f 7-hydroxycoumarin and (d) sulphate 
conjugate o f 7-hydroxycoumarin.
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Figure 3.17: The effect of the number of liver slices per incubation on metabolic 
viability (expressed per mg protein). Liver slices from Sprague Dawley rats were 
incubated for various time periods for up to 72 hours using the multiwell plate culture 
system. At the end o f each preincubation time, slices were incubated fo r  a further 2 
hours in the presence o f the substrate 7-ethoxycoumarin (50 pM). Results are 
expressed as nmol per mg homogenate protein and are presented as Mean ±  SEM fo r  3 
animals. Each time point was carried out in duplicate, and analysis o f the metabolites 
for each incubation was similarly carried out in duplicate, (a) Total metabolism, (b) 
free 7-hydroxycoumarin, (c) glucuronide conjugate o f 7-hydroxycoumarin and (d) 
sulphate conjugate o f 7-ethoxycoumarin.
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3.4 DISCUSSION
The principal objective of the present study was to compare two incubation systems for 
liver slices, the dynamic organ culture, a surface incubation system, and the multiwell 
(12-well) plate, a submersion incubation system. The two procedures were evaluated in 
their ability to metabolise a xenobiotic, namely 7-ethoxycoumain, and morphologically 
using light and electron microscopy.
3.4.1 Comparison of the Multiwell Plate and the DOCS
7-Ethoxycoumarin was chosen as a substrate probe because its principal metabolite 7- 
hydroxycoumarin is formed as a result of cytochrome P450-mediated oxidative 
dealkylation, and readily conjugates with sulphate and glucuronide, thus allowing the 
simultaneous monitoring of oxidation and conjugation pathways (Steensma et ah, 1994). 
Sulphation and glucuronidation are assessed indirectly by deconjugation of 7- 
hydroxycoumarin with sulphatase and p-glucuronidase, the resulting 7-hydroxycoumarin 
can then be readily determined fluorimetrically, allowing the rapid processing of a large 
number of samples. However, in recent studies, other unidentified metabohtes have also 
been detected following HPLC analysis coupled to a radiochemical detector, the majority 
of which are thought to be sulphate conjugates (Ball et ah, 1996). It was originally 
believed that liver slices do not retain metabolites of 7-ethoxycoumarin (Barr et al., 
1991a). Although in more recent studies reported after the completion of the current 
experiments, high levels of the fi’ee 7-hydroxycoumarin were reported to remain attached 
to the slice, thus underestimating the levels in the culture medium (Ball et al., 1996). In 
the present study, 7-ethoxycoumarin was used to assess the metabolic viability o f liver 
slices over a long culture period of 72 hours. The metabolites formed were purely used 
for assessing Phase I and Phase II enzyme activities in the liver slices during culture. For
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a more accurate measure of metabolites, liver slices should be homogenised and 
sonicated for a 6 w  seconds in the culture medium in order to disrupt the cell membranes 
so that any metabolites retained in the tissue w^ould be released into the medium and thus 
would be accounted for.
7-Ethoxycoumarin was readily metabolised in a time-dependent fashion, at least up to 10 
hours, in both incubation systems. In agreement with previous studies (Steensma et ah, 
1994; Ball et ah, 1996), the major metabolite was the sulphate conjugate of 7- 
hydroxycoumarin with significant amounts of the glucuronide conjugate being formed 
and very little unconjugated 7-hydroxycoumarin, indicating integrated Phase I and Phase 
II enzyme activities. Total metabolism o f 7-ethoxycoumarin as well as the formation of 
individual metabolites increased linearly with time for at least 10 hours (the last 
sampling time) when liver slices were cultured in the mulitwell plate system. However, 
in the dynamic organ culture system, following 6 hours incubation total metabolism and 
levels o f the conjugates started to plateau. The reason for this is not known, although it 
is unlikely to be due to depletion of either substrate or cofactors since in both systems the 
rate of metabolism of 7-ethoxycoumarin up to 6 hours was the same.
In order to evaluate metabolic viability of slices in both incubation systems, liver slices 
were preincubated for various time periods of up to 72 hours. After each time point 
slices were incubated for a fiirther 2 hours in the presence of 7-ethoxycoumarin. Two 
hours incubation with the model substrate was chosen because following this time point, 
sufficient levels of metabolites were formed to enable detection. In addition this 2 hours 
was practically convenient, especially when liver slices were preincubated for long time 
periods such as 10 hours.
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One of the advantages of the multiwell plate system was reported to be the constant 
contact of the tissue with the substrate (Dogterom 1993). But Worboys et al. (1995) later 
showed that ethoxycoumarin metabolism is higher when using the dynamic organ culture 
system than the multiwell plate system (12- or 24-well plates) and suggested that for 
maximum rates, continued exposure of slice to medium and substrate is not critical. 
However, such differences were not observed in the present study, which tends to imply 
that during short culture periods, the type of incubation system used does not make a 
marked difference on the rate of metabolism of 7-EC.
Slices were viable in both incubation systems for the first 8 hours, but at 10 hours 
metabolic activity towards 7-EC started to decline. At this time point, total rate of 
metabolism of 7-EC was similar in both incubation systems. At subsequent time points 
the rate of metabolism declined in both systems but the rate of loss of metabolic capacity 
was more rapid in the dynamic organ culture compared with the multiwell plate system. 
Even after 72 hours of incubation, low levels o f metabolism were still evident in the 
multiwell system whereas no metabolic activity was detectable in the slices cultured in 
the dynamic organ system. It should be noted that the ratio of sulphate to glucuronide 
conjugation remained relatively constant at all time points of incubation, indicating that 
the viability of these enzyme systems under these conditions did not differ.
In the past maintenance of liver slices in culture for more than several hours, proved to 
be a difficult task due to the high metabolic requirement of this tissue. One critical factor 
in viability is tissue slice thickness. It has been suggested that 250 pm is the optimum 
thickness (Smith et ah, 1985) in order to allow maximal gas and nutrient exchange on 
both the gas-tissue and media-tissue interfaces. Thinner slices would be inappropriate
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because the ratio o f damaged cells to undamaged cells is greater as a result o f the tissue 
slicing procedure and therefore, the greater loss in protein content with culture time. But 
recent studies have shown that the optimal slice thickness is actually 175 pm (Price et 
al, 1998a). This conclusion was based on the metabolic turnover of 7-ethoycoumarin 
following incubation of slices with the substrate for short culture periods of up to 120 
minutes only, which may be long enough for the metabolism of some compounds. 
However, whether 175 pm thickness, would be the optimal thickness for long-term 
culture remains to be established.
It is important to point out that tissue thickness was determined using light microscopy. 
This method is time consuming and allows the determination of tissue thickness of 
randomly selected slices, but does not give any indication of the thickness of the slice 
being used in the experiment, as a result a lot o f variation in tissue thickness was noted. 
The average thickness of slices employed in the present study was approximately 250 
pm, and following histological examination, a band of central necrosis was observed in 
the tissue slices. However, this was apparent at earlier time points in the dynamic organ 
cultures compared with the multiwell plate system implying better oxygenation in the 
latter system. As a result, lactate dehydrogenase leakage by slices in the dynamic organ 
culture was anticipated to be greater, yet lactate dehydrogenase leakage was surprisingly 
similar in the slices from both systems, implying that histologically apparent differences 
are marginal. This clearly suggests that viability is dependent on the parameter used. 
Electron microscopy revealed that cytoplasmic damage in the form of vacuoles was 
evident earlier in the slices incubated utilising the dynamic organ culture system. 
Therefore, morphological evaluation of the slices incubated using the two systems is in 
good agreement with the metabolic findings.
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It should be noted that in the current study all tissue cultures were carried out under an 
atmosphere of 95% air / 5% CO2. Since the completion of the present study a number of 
reports have shown that tissue slices are better maintained using 95% O2 / 5% CO2 
(Fisher et al., 1995a) which may prevent the central necrotic region observed following 
histological examination. Although using the rate of metabolism of 7-ethoxycoumarin as 
a measure of viability, it was recently reported that the gas phase does not effect the rate 
of 7-ethoxycoumarin metabolism (Price et ah, 1998a). But whether the use of 95% 
oxygen can improve cell viability morpohologically, remains to be elucidated.
Overall, the present studies indicate that hepatic slices incubated using the multiwell 
system remain viable for longer periods of time when compared with the dynamic organ 
culture system. The dynamic organ culture system is laborious, occasionally slices float 
off the wire mesh, become submerged in the medium, and are not rotating in and out of 
the culture medium as intended. In such cases, the slices are subjected to physical 
damage as the glass vial turns and the titanium inserts roll onto the slices. Even if 
titanium inserts are not used and just simply wire meshes are employed, slices would still 
be submerged if they float off. Moreover, slices occasionally fold on themselves, 
rendering oxygenation and diffusion of nutrients difficult. After long culturing periods, 
tissue slices have the tendency to attach themselves to the wire mesh and fungal 
contamination occurred, about 75 % of the time using the dynamic organ culture system. 
Such technical problems were also noted and reported by Olinga et al. (1997b). It must 
be emphasised that slices under any one of these conditions were eliminated from the 
present study. No contamination was noted in the multiwell system. Although anti- 
fungal agents such as fungizone may be used to prevent fungal growth, anti-fungals were 
not used in the present study in order to eliminate any possible interference with the
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cytochrome P450 enzyme system and thus the metabolic capacity of the liver slices. It 
may be concluded that the multiwell plate is a more appropriate system to use in 
metabolic studies than the dynamic organ culture system. It is noteworthy to point out 
that each incubation system has its own specific advantage i.e. for metabolism studies a 
small amount of medium could be advantageous and for kinetic studies, quick sampling 
may be essential, therefore, the multiwell plate would be an appropriate culture system to 
use. The dynamic organ culture system does not allow rapid sampling, but is very useful 
for testing volatile substrates simply because the liver slices are cultured in a closed 
environment (glass vial) with the test substance, therefore preventing the evaporation of 
volatile substrates.
Following evaluation of these two incubation procedures using exclusively biochemical 
markers such as intracellular K^, protein synthesis, alanine aminotransferase (ALT) and 
lactate dehydrogenase (LDH), ATP content, MTT reduction and 7-ethoxycoumarin 
metabolism, Fisher et al. (1995b) concluded that the dynamic organ system was superior 
to the multiwell plate system. However, no zero time values were provided in this study 
and it is therefore, difficult to assess the degree of damage compared to a freshly cut liver 
slice. The morphological observations presented in the current study indicate that no 
viable cells remain in the tissue slices beyond 24 hours, therefore, the value of 
biochemical markers of intracellular integrity (e.g. ATP, K^) at these time points is of 
limited use. The same authors (Fisher et al., 1995a) also evaluated 7-ethoxycoumarin 
metabolism at 4 time points, expressing activities per slice rather than per mg protein, 
and observed higher rates of sulphate and glucuronide conjugation, at all time points, in 
the slices cultured using the dynamic organ culture system compared with the multiwell 
system, in contrast to the findings of the present study. Although these differences
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cannot be explained, it should be noted that in the present study RMPI 1640 culture 
medium containing 5% foetal calf serum was used whereas in their studies they utilised 
Waymouth’s culture medium containing 10% foetal calf serum.
3.4.2 Effect of Number of Slices per Incubation on Metabolic Activity and Viability
Whilst conducting other metabolism studies using a novel chemical developed at 
Hoechst Marion Roussel, it was noted that it was poorly metabolised and the generation 
of metabolites was too low to permit quantification and identification. This problem in 
addition to the rapid decline in the capacity of liver slices in culture following 10 hours 
incubation, prompted me to investigate whether doubling the number of slices per 
incubation could lead to a proportional increase in metabolite formation. 7- 
Ethoxycoumarin was used as the model xenobiotic and liver slices from Sprague-Dawley 
rats were used instead of Wistar albino because this strain was previously used for in 
vivo metabolic studies of the Hoescht Marion Roussel compound so that the same strain 
had to be used for in vitro studies for direct comparison. However, this was also a good 
opportunity to compare the metabolism of 7-ethoxycoumarin by rat liver slices from the 
two different strains.
When the rate of metabolism is expressed in terms of total metabolites produced per 
incubation, total metabolism of 7-ethoxycoumarin, and the formation of the free and 
sulphate conjugated 7-hydroxycoumarin, were higher when 2 slices were present in each 
incubation, but the differences tended to become less pronounced as incubation time 
increased. The formation of the glucuronide conjugate of 7-hydroxycoumarin, however, 
did not differ between the one- and two- slice incubations, except at the longer 
incubation time points where surprisingly more was generated by the one slice
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incubation. If, however, metabolism is expressed as specific activity in terms of 
homogenate protein, it is clear that the rate of metabolism of 7-ethoxycoumarin, as well 
as generation of individual metabolites, were substantially higher in the one-slice 
incubation system. These findings demonstrate that increasing the number of sHces from 
one to two in the incubation system, does not proportionally increase metabolic activity 
and, consequently, it is not a suitable approach for scaling up the system. In agreement 
with the present study, Sidlemann et al. (1996) using the substrate metronidazole, 
reported a linear relation between amount of metabolite formed and the number of slices 
incubated although increase in metabolite formation was not proportional to increase in 
the number of slices. However, the present study compared one- and two- liver slices, 
whilst Sidlemann et al. (1996) employed up to six slices per culture well.
When two slices are incubated together, they come into physical contact as they are 
shaking in the incubator. This contact could lead to structural damage to the cells and 
possible loss of cells from the edges of the tissue slice. Although morphology of 2 slices 
per well was not studied, it is reasonable to expect that if slices keep coming in contact 
with each other, and at times adhere to each other, this would seriously impair their 
metabolic capacity on account of behaving like a single slice of double thickness. It has 
already been reported how critical tissue thickness can be (Sidelmann et al, 1996; Price 
et al, 1998a). The clear appearance of the viable bands immediately beneath the 
damaged cut surface cells, divided by a middle necrotic layer confirms the argument for 
an optimal slice thickness. It is important to note that homogenate protein levels of 2 
slices per well declined rapidly during the first 48 hours in culture, whilst protein levels 
of 1 slice per well remained relatively constant during the 72 hour culture. This is a 
possible indication of loss of cells from the tissue due to physical contact of the two liver
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slices together. Sidlemann et al. (1996) showed a linear increase in metabolite formation 
with increase in the number of liver slices, up to 6 slices per well. In their study they 
used a culture medium volume of 3 ml in 12-well plates whilst in the present study a 
volume of 1.5 ml was used. An increase in the culture medium volume per well (i.e. 
volume of 3 ml) may maintain the tissue slices, better when 2 slices are used. However, 
it is difficult to envisage how increase in the number of tissue slices to 6 would not affect 
tissue viability. 6-Well plates maybe a more appropriate system for the incubation of 
more than 1 slice per well. This is because the surface of a single well in 6-well plates is 
approximately 2.4 times greater than in the 12-well plates, which is an advantage for gas 
exchange with the medium, but this needs to be established experimentally.
3.4.3 Strain Difference in the Metabolism of 7-EC by Rat Liver Slices
A strain difference was noted in the rate of 7-ethoxycoumarin metabolism. The rate of 
metabolism of 7-ethoxycoumarin by Sprague-Dawley rats was double that observed in 
Wistar rats incubated under the same conditions. Nothing has been reported on such a 
strain difference in the last decade.
3.4.4 Conclusion
In conclusion, this study has shown that precision-cut liver slices are better maintained in 
the multiwell plate incubation system than the dynamic organ culture system; 
fiirthermore, the latter is less laborious and more suitable for xenobiotic metabolism 
studies where long periods of incubation may be required. The multiwell plate syst^n 
also allows the manipulation of a larger number of slices, as extra slices are not requirecf 
in case of contamination over long culture periods, or if slices float off the wire mesh as 
with the dynamic organ culture system. Therefore, the multiwell plate culture system is
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the system of preference in studies of xenobiotic metabolism and all subsequent studies 
were carried using this incubation system.
CHAPTER 4
Stability of Cytochrome P450 Isoforms 
In Precision-cut Rat Hepatic Slices
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4.1 INTRODUCTION
Mammalian hepatic cytochromes P450 constitute the major enzyme system involved in 
the metabolism o f foreign compounds and comprise a number of isoforms, each 
characterised with its own substrate selectivity. The cytochromes P450 are believed to 
be responsible for the metabolism o f over 200,000 drugs and other xenobiotics, 
catalysed mainly by the families CYPl, CYP2 and CYP3. Only a small number of 
foreign compounds are metabolised by the CYP4 family as this family is mainly 
involved in the metabolism of endogenous long-chain fatty acids. As a result, there is 
considerable scientific interest in the function of the cytochrome P450 superfamily 
(Nelson et al., 1996; 1993), particularly in the field of drug metabolism (Spatzenegger 
and Jaeger, 1995; Korzekwa and Jones, 1993). It is well established that despite the fact 
that Phase I enzymes fonction primarily to detoxify xenobiotics by oxygenation, 
cytochrome P450 proteins, particularly those belonging to the CYPl family and CYP2E 
subfamily, may oxygenate molecules to form reactive intermediates, which are difficult 
to detoxicate through conjugation, and may bind covalently to cellular components 
provoking many forms of toxicity, including carcinogenicity.
With the growing use of precision-cut liver slices, slices have been cultured for up to 72 
hours and even 96 hours (Lake et al, 1998,1997,1996a and 1993; Gokhale et al, 1995, 
1997; Vandenbranden et al, 1998). However, such long-term studies assume that 
cytochromes P450 are maintained folly active for such periods of time, and if loss of 
activity occurs, the activity o f all isoforms is impaired in the same time-dependent way, 
so that the cytochrome P450 composition remains fairly constant. It is conceivable that 
if some isoforms of P450 are more stable than others, then the ratio of the metabolites of 
a given xenobiotic may not reflect the in vivo situation.
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The principal objective of the present study was to determine the stability of the 
xenobiotic-metabolising cytochromes P450 in rat liver slices in long-term culture. 
Cytochromes P450 were monitored using appropriate selective probes and 
immunologically employing quantitative Western blotting.
4.2 METHODS
In order to investigate the stability of the cytochrome P450 isoforms in precision-cut rat 
liver slices, male Wistar albino rats (200-250 g) were treated in vivo with established 
inducers of cytochrome P450 (Table 4.1). However, for determination of NADPH 
cytochrome c reductase, CYP2C, CYP2D activity and appoprotein levels, control 
animals (non-induced) were used.
Inducer Principal cytochromes P450 induced Dose
Aroclor 1254 CYP1A/2B 500 mg/kg in com oil
Isoniazid CYP2E 100 mg/kg in water
Dexamethasone CYP3A 30 mg/kg in com oil
Clofibrate CYP4A 80 mg/kg in water
Table 4.1: Treatment of Wistar rats with known P450 inducers. Animals were given 
single daily intraperitoneal injections for three consecutive days, and were killed on the 
fourth day, with the exception for Aroclor 1254, which was given as a single 
intraperitoneal dose and animals were killed on the fifth day.
Animals were sacrificed by cervical dislocation, the livers were removed and slices were 
prepared according to section 2.2.3. Liver slices were then cultured for various time 
periods up to 72 hours. After specific time points, liver slices were briefly washed in 
0.154 M KCl buffer (containing 50 mM Tris-HCl, pH 7.4) and, depending on the
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enzyme assay, 4-6 slices were homogenised in 2 ml KCl buffer (using a Potter Elvehjem 
homogeniser) which were then sonicated (MSE soniprep) for 10 seconds ( 2 x 5  second 
bursts). It was observed that homogenisation alone was not enough to obtain sufficient 
amounts of microsomes from the liver slices, and homogenisation followed by sonication 
of samples proved to be a very important addition to the method. Microsomes were 
isolated as described in section 2.2.7. Initial studies were undertaken to ascertain the 
number of slices required for the determination of each cytochrome P450 activity (Table 
4.2).
The following enzyme activities were measured as described in section 2.2.8:
Cytochromes P450 The number of 
liver slices used
Activity measured
CYPlAl 4 Ethoxyresorufin 0-deethylase
CYP1A2 4 Methoxyresorufin 0-demethylase
CYP2B 4 Pentoxyresorufin 0-depenthylase
CYP2C11 '6 Testosterone 2a- hydroxylase
CYP2D '6 Debrisoquine hydroxylase
CYP2E 6 Aniline ^ -hydroxylase
CYP3A *6 Testosterone 6p- hydroxylase
CYP4A 4 Laurie acid co-hydroxylase
Table 4.2: The number o f liver slices used to determine activities o f the cytochrome 
P450 isoforms. * Homogenised in 1 ml o f buffer only.
to
Western blotting was carried out according^section 2.2.9.
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4.3 RESULTS
4.3.1 Stability of Cytochrome P450 Isoforms in Cultured Precision-cut Rat Hepatic 
slices
4.3.L1 CYPIA Family
Ethoxyresorufm and methoxyresorufin 0-dealkylase activity were used as markers for 
CYPlAl and CYP1A2 activity respectively. Figure 4.1a and b, shows a rapid loss of 
approximately 55 % of the CYPlAl and 50% in CYP1A2 activity after only 4 hours, 
when activity is expressed as per mg of microsomal protein. A similar picture is 
obtained when activity is expressed per liver slice. Irrespective of how the activities are 
expressed, the pattern of decline is similar between the two proteins. It can be noted 
from Figure 4.1 that activity of both enzymes then decreases gradually to non-detectable 
levels after 48 hours of culture.
Immunoblot analysis utilising antibodies specific to CYPlAl showed a gradual decline 
in the intensity of the bands with culture time (Figure 4.2a). Figure 4.2b shows CYPlAl 
apoprotein levels decreased by just 10% during the first 12 hours of culture, and a fiirther 
30% by 24 hours, with approximately 25% of the initial level still remaining after 72 
hours. CYP1A2 immunoblots show apoprotein levels remained virtually unchanged 
during the first 24 hours and then declined to very low levels following 72 hours 
incubation (Figure 4.3a). However, quantification of bands revealed CYP1A2 
apoprotein levels were fairly stable during the first 12 hours and levels gradually 
declined to approximately 45% following 72 hours incubation (Figure 4.3b).
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Figure 4.1: Stability o f CYPlAl and CYP1A2 activity with culture time, (a)
Ethoxyresorufin O-deethylase (EROD) activity; 100% activity was 3.5 ±0.3 nmol m in ' 
per mg microsomal protein and 2.6 ±  0.4 nmol m in ' per liver slice. (b) 
Methoxyresorufin O-demethylase (MROD) activity; 100% activity was 914 ±178 pmol 
min^ per mg microsomal protein and 676 ±  152 pmol m in’ per liver slice. All values 
are expressed as a percentage o f  the zero time. Results are presented as mean ±  SEM 
for 3 animals; each analysis was performed in duplicate.
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Figure 4.2: Immunoblot analysis with anti-CYPlAl of solubilised hepatic microsomes 
derived from precision-cut rat liver slices. Solubilised microsomal proteins were 
resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to nitrocellulose. 
The immunoblot was carried out with anti-rat CYPlAl (diluted 1:200) followed by 
peroxidase-labelled anti-rabbit IgO (diluted 1:2000). All lanes were loaded with 5pg 
protein, (a) Immunoblot o f CYPIA, letters A to G represents culture time periods i.e. 0, 
4, 8, 12, 24, 48 and 72 hours. Lane H represents the positive control (microsomes 
derived from Aroclor 1254-treated rat liver). The first lane from the left illustrates the 
molecular weight markers, (b) Quantification of apoprotein levels using a densitometer.
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Figure 4.3: Immunoblot analysis with anti-CYPIA2 of solubilised hepatic microsomal 
proteins derived from precision-cut rat liver slices. Solubilised microsomal proteins 
were resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-rat CYPlAl (diluted 1:200) 
followed by peroxidase-labelled anti-rabbit IgG (diluted 1:2000). All lanes were loaded 
with 5pg protein, (a) Immunoblot o f CYPlAl, letters A to G represents culture time 
periods i.e. 0, 4, 8, 12, 24, 48 and 72 hours. Lane LI repre.sents the positive control 
(microsomes derived from Aroclor 1254-treated rat liver). The first lane from the left 
illustrates the molecular weight markers, (b) Quantification o f apoprotein levels using a 
densitometer.
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4.3,L2 CYP2 Family
There was a rapid loss of CYP2B activity during the first 24 hours of culture as assessed 
by pentoxyresorufin 0-depentylase. When expressed as per mg of microsomal protein 
there is about 70, 55 and 30% activity still remaining following 4, 8 and 12 hours culture 
respectively. On the other hand if activity is expressed per liver slice then there is about 
50, 38 and 29% activity still remaining at the same time points (Figure 4.4a). Activity 
continued to decline to non-detectable levels after 48 hours. An unexpected observation 
was a rise in the CYP2B apoprotein levels (Figure 4.5a) with an increase of about 45% 
above the fi*esh slices after just 4 hours in culture (Figure 4.5b). CYP2B apoprotein 
levels remained stable for 24 hours followed by a decline of 25% and 80% after 48 and 
72 hours, respectively (Figure 4.5b). The microsomal preparation used for CYP2B was 
the same as that used for CYPlAl and CYP1A2. In addition. Western blots for these 
three isoforms were carried out at the same time; however, a different pattern was 
observed for CYPlAl and 1A2, with no rise in levels at 4 hours. Furthermore, the 
CYP2B immunoblot was carried out on three separate occasions using different 
microsomal preparations from the same sample, and the same pattern was observed in all 
cases.
CYP2C11 activity was determined by measuring 2a-hydroxytestosterone levels. A very 
rapid loss of activity occurred during the first 8 hours of culture whether activity is 
expressed per mg of microsomal protein or per liver slice (Figure 4.4b), with only about 
40 and 15% activity still remaining after 4 and 8 hours culture respectively. No activity 
was detectable after 24 hours of culture. Immunoblot analysis using antibodies specific 
to CYP2C11 showed a steady decrease in apoprotein levels with culture time (Figure 
4.6a).
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Figure 4.4: Stability of CYP2B and CYP2C activity with culture time. (a)
Pentoxyresorufin O-depentylase (PROD) activity; 100% activity was 87.5 ±  11.4 pmol 
min^ per mg microsomal protein and 62.9 ± 7 .9  pmol min^ per liver slice, (b) 
Testosterone 2a-hydroxylase activity; 100% activity was 7.8 ± 0 .7  nmol min^ per mg 
microsomal protein and 3.4 ±0.2 nmol min^ per liver slice. All values are expressed as 
a percentage o f the zero time. Results are presented as mean ±  SEM for 3 animals; 
each analysis was performed in duplicate.
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Figure 4.5: Immiinoblot analysis with anit-CYP2B of solubilised hepatic microsmes 
derived from precision-cut rat liver slices. Solubilised microsomal proteins were resolved 
by 10% (w/v) SDS PAGE and transferred electrophoretically to nitrocellulose. The 
immiinoblot was carried out with anti-rat CYP2B (diluted 1:200) followed by peroxidase- 
labelled anti-rabbit IgG (diluted 1:2000). All lanes were loaded with 5pg protein, (a) 
Immiinoblot ofCYP2B, letters A to G represents culture time periods i.e. 0, 4, 8, 12, 24, 48 
and 72 hours. Lane H represents the positive control (microsomes derived from Aroclor 
1254-treated rat liver). The first lane from the left illustrates the molecular weight 
markers, (b) Quantification ofCYP2B apoprotein levels using a densitometer.
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Figure 4.6: Immunoblot analysis with anti-CYP2CII from solubilised hepatic 
microsomes derived form precision-cut rat liver slices. Solubilised microsomal proteins 
were resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-rat CYP2C11 (diluted 1:1000) 
followed by peroxidase-labelled anti-rabbit IgG (diluted 1:2000). All lanes were loaded 
with 5pg protein, (a) Immunoblot o f CYP2C11, letters A to G represents culture time 
period i.e. 0, 4, 8, 12, 24, 48, and 72 hours. The first lane from the right illustrates the 
molecular weight markers, (b) Quantification o f CYP2C11 apoprotein levels using a 
densitometer.
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Debrisoquine hydroxylase activity was used as a marker for CYP2D. The loss of activity 
after the first 4 hours of culture was very similar to that observed for CYP2C in that, 
when expressed as per mg of microsomal protein, only about 38% activity still remained 
(Figure 4.7a). However, levels remained unchanged for the next 4 hours of culture, but 
then declined rapidly after 12 hours with only about 4% activity still remaining. Loss of 
activity appears to be more rapid when expressed as per liver slice, with only 22 and 
18% still remaining after 4 and 8 hours of culture respectively. No activity was 
detectable after 24 hours culture. Changes in CYP2D apoprotein levels were very similar 
to those of the CYP2C subfamily during the first 12 hours in culture. Apoprotein levels, 
declined rapidly, with a loss of 80% after 8 hours of culture (Figure 4.8). A very faint 
band was visible following 24 hours with no band being visible after this time point.
In relation to other cytochrome P450 isoforms, CYP2E activity as assessed by aniline p- 
hydroxylase, showed a very different pattern with culture time. Like most other 
isoforms, there was a loss of about 60% activity after the first 4 hours of culture, but 
levels remained stable for up to 24 hours when expressed as per mg of microsomal 
protein. Activity then declined gradually with approximately 28 and 4% activity still 
remaining after 48 and 72 hours respectively (Figure 4.7b). A somewhat different 
picture emerged when activity was expressed per liver slice; although loss in activity 
during the first 4 hours was very similar (Figure 4.7b), decline in CYP2E activity was 
more rapid following this time point with only 10% still remaining following 24 hours of 
culture. The apoprotein levels of the CYP2E subfamily were fairly stable during the 72 
hours incubation (Figure 4.9a and b). No major change occurred during the first 4 hours 
but there was a decline of about 35% after 8 hours culture; levels remained relatively 
stable after this time point (Figure 4.9b).
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Figure 4.7: Stability of CYP2D and CYP2E with culture time, (a) Debrisoquine 
hydroxylase activity; 100% activity was 4.2 ±0.3 nmol min  ^per mg microsomal protein 
and 2,43 ±  0.05 nmol min  ^per liver slice, (b) Aniline hydroxylase activity; 100% 
activity was 372 ±39 pmol min‘ per mg microsomal protein and 15.1 ±0.9 pmol min  ^
per liver slice. All values are expressed as a percentage of the zero time. Results are 
presented as mean ±SEMfor 3 animals; each analysis was performed in duplicate.
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Figure 4.8: Immunoblot analysis with anti-CYP2D from solubilised hepatic 
microsomes derived from precision-cut rat liver slices. Soluhilised microsomal proteins 
were resolved by 10% (w’/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-rat CYP2D (diluted T.IOOO) 
followed by peroxidase-labelled anti-mouse IgG (diluted 1:1000). All lanes were loaded 
with 5pg protein, (a) Immunoblot o f GYP 2D, letters A to G represents the culture time 
periods i.e. 0, 4, 8, 12, 24, 48 and 72 hours. The first lane from the right illustrates the 
molecular weight markers, (b) Quantification o f CYP2D apoprotein levels using a 
densitometer.
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Figure 4.9: Immunoblot analysis with anti-CYP2E from soluhilised hepatic 
microsomes derived from precision-cut rat liver slices. Soluhilised microsomal 
proteins were resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-rat CYP2E (diluted 1:200) 
followed by peroxidase-labelled anti-rabbit IgG (diluted 1:2000). All lanes were 
loaded with 5/ug protein, (a) Immunoblot o f CYP2E, letters A to G represents the 
culture time periods i.e. 0, 4, 8, 12, 24, 48 and 72 hours. Lane H represents the positive 
control (microsomes derived from isoniazid-treated rats, (h) Quantification o f GYP 2 E 
anonrotein levels usimr a densitometer.
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4,3.L3 CYP3A Family
Attempts were made to measure CYP3A activity initially using erythromycin N- 
demethylase as a diagnostic probe. This spectophotometric assay was not sensitive 
enough to measure CYP3A in precision-cut rat liver slices. As a result another activity, 
namely testosterone 6p-hydroxylase, was used utilising an HPLC method for analysis of 
metabolites. It has been established that 6p-hydroxytestosterone is formed primarily by 
the CYP3A in rat (Gokhale et al, 1997). However, 6p-hydroxytestosterone peak co­
eluted with 16p-hydroxytestosterone, making quantification difficult; due to lack of time 
it was not possible to address this problem, or develop a method to separate these two 
peaks.
Immunoblot analysis of CYP3A showed a gradual decline in apoprotein levels. No 
bands were visible beyond 12 hours of culture (Figure 4.10a). Quantification o f the 
bands showed a rapid decline o f approximately 45% in CYP3A apoprotein levels after 
just 4 hours in culture, levels then continued to decline to an undetectable level after 24 
hours (Figure 4.10b).
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Figure 4.10: Immunoblot analysis with anti-CYP3A from soluhilised hepatic 
microsomes derived from precision-cut rat liver slices. Solubilised microsomal proteins 
were resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with rabbit anti-CYP3A (diluted 1:200) 
followed by peroxidase-labelled anti-rabbit IgG (diluted 1:2000). All lanes were loaded 
with 5pg protein, (a) Immunoblot o f GYP3A, letters A to G represents the culture time 
periods i.e. 0, 4, 8, 12, 24, 48 and 72 hours. The first lane from the left illustrates the 
molecular weight markers, (b) Quantification o f GYP3A apoprotein levels using a 
densitometer.
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4.3.1.4 CYP4A Family
+(co-1 )
CYP4A activity was monitored using lauric acid co-hydroxylation as a diagnostic probe.A
There was about 55% loss of activity following 4 hours of culture, which then decreased 
gradually with about 35 and 20% remaining following 8 and 12 hours respectively. Loss 
of activity reached non-detectable levels after 48 hours (Figure 4.11). Both the CYP4A 
immunoblot and the graph illustrating the percentage in CYP4A apoprotein levels show 
a steady decrease in CYP4A apoprotein levels during the first 12 hours of culture, with a 
decline of about 60 and 70% following 12 and 24 hours respectively (Figures 4.12a and 
b). Apoprotein levels were detectable even after 72 hours with about 15% still 
remaining.
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Figure 4.11: Stability of CYP4A activity with culture time. Changes in lauric acid 
hydroxylase activity; 100% activity was 2.0 ±  0.8 nmol min^ per mg microsomal 
protein and 2.4 ± 0 .7  nmol min^ per liver slice. All values are expressed as a 
percentage o f the zero time. Results are expressed as Mean ±  SEM for 3 animals; 
each analysis was performed in duplicate.
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Figure 4.12: Immunoblot analysis with anti-CYP4A from soluhilised hepatic 
microsomes derived from precision-cut rat liver slices. Soluhilised microsomal proteins 
were resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-rat CYP4A (diluted 1:200) 
folloM’ed by peroxidase-labelled anti-sheep IgG (diluted 1:2000). All lanes were loaded 
with 5/jg protein, (a) Immunoblot o f CYP4A, letters A to G represents the culture time 
periods i.e. 0, 4, 8, 12, 24, 48 and 72 hours. The first lane from the left illustrates the 
molecular weight markers, (b) Quantification o f CYP4A apoprotein levels using a 
densitometer.
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4.3.1.5 NADPH-cytochrome P450 reductase
The flavoprotein, NADPH-cytochrome P450 reductase is a necessary component of the 
cytochrome P450-dependent drug oxidation system and its activity was therefore 
measured in precision-cut rat liver slices. To determine activity 4 liver slices were used 
and when activity was expressed in terms of mg microsomal protein, a decline of 
approximately 45% was observed after 8 hours culture. Loss of activity was gradual and 
slow after 12 hours with about 45% still remaining following 72 hours incubation 
(Figure 4.13). If expressed per liver slice, the decline in activity follows a similar pattern 
but the degree of change is more pronounced.
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Figure 4.13: Stability o f  NADPH cytochrome P450 reductase activity in culture. 100% 
Activity was 44.8 ±4.1 nmol m in‘ per mg microsomal protein and 35.7 ±5 .8  nmol min^ 
per liver slice. All values are expressed as a percentage o f the zero time. Results are 
presented as mean ±  SEM for 3 animals; each analysis was performed in duplicate.
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4.3.2 Microsomal Protein Levels in Cultured Rat Hepatic Slices
In all studies, it was readily visible that the size of microsomal pellets decreased with 
culture time. Following microsomal protein determination using bovine serum albumin 
as standard (Lowry et al, 1951), it was noted that microsomal protein concentration 
from liver slices from control, Aroclor 1254 and isoniazid-treated animals, decreased 
with culture to approximately half their initial value by 24 hours (Figure 4.14). After this 
time point, protein levels declined gradually, with about 25% of the initial level 
remaining by 72 hours. Microsomal protein concentration from animals treated with 
clofibrate was highest during the first 12 hours of culture, but levels rapidly declined 
after 24 hours. At this time point and onwards, protein concentrations from induced and 
non-induced were similar.
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Figure 4.14: Microsomal protein content o f rat liver slices from  induced and non­
induced animals following long-term culture. Results presented as mean ±  SEM for 3
animals; each analysis was performed in duplicate.
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4.4 DISCUSSION
During the last few years there has been an increase in the number of publications 
concerned with the advantages of precision-cut liver slices over other in vitro models for 
studying the metabolism and toxicity of xenobiotics (Steensma et ah, 1994; Azri et al, 
1990a; Brendel et al, 1987). However, the value o f such an important tool is largely 
dependent on maintenance of metabolic activity over sufficient period of time to permit 
analysis of metabolites or toxicological effects to occur. Because the most important 
enzyme system catalysing Phase I metabolic reaction is the cytochrome P450 system, it 
was considered essential to investigate the stability of cytochrome P450 isoforms in 
precision-cut rat liver slices, in long-term culture, employing specific substrate models 
and immunologically utilising antibodies specific to cytochrome P450 isoforms.
Primary hepatocyte cultures and precision-cut liver slices have been used widely for 
studies o f microsomal enzyme activities (Bars et a l, 1989; Paine, 1990; Wortelboer et 
al, 1991; Lake et al., 1993). It has been shown that levels of total cytochrome P450 
decline in cultured rat hepatocytes (Bars et al., 1989; Paine, 1990; Wortelboer et al., 
1991) and in precision-cut liver slices (Wright and Paine, 1992; Lake et ah, 1993).
Recently a number of studies have reported the induction of several cytochrome P450 
isoenzymes in precision-cut liver slices namely CYP1A1/1A2 (Drahushuk et al., 1996, 
Lake et al., 1996a, Muller et al., 1996), CYP2A, 2B, 2C (Gokhale et al., 1997) and 
CYP3A (Gokhale et al., 1997; Lake et a l, 1997). Induction studies by Lake et al. (1996) 
showed EROD activity o f slices cultured for 72 hours (with DMSO only) was 2.4 ± 0.3 
pmol/min per mg whole homogenate protein. However, no EROD activity was detected 
following 72 hours of culture in the present study, even though the livers used were from
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Aroclor 1254 induced rats. The reason for this discrepancy is not known, but, it is 
important to note, that Lake and colleagues (1996a) utilised liver slices from male 
Sprague-Dawley rats, whilst male Wistar rats were used in present study. Earlier studies 
showed that liver slices from Sprague-Dawley rats produced almost double the amounts 
of 7-ethoxycoumarin metabolites as compared to slices from Wistar rats (Sections 3.3.3 
and 3.3.6). Furthermore, very little metabolism was observed following 72 hour 
preincubation, using slices from Wistar rats, but substantial levels of metabolites were 
still measurable even after 72 hour of preincubation time, using the Sprague-Dawleys. 
Therefore, Sprague-Dawley rats may contain higher basal drug metabolising enzyme 
activities, and thus may provide a better model for biotransformation studies. In 
addition. Lake et al. (1996a) utilised a dynamic organ culture system and the liver slices 
were incubated in the presence of DMSO which is believed to help maintain liver 
specific function possibly due to its ability to scavenge hydroxyl radicals (Villa et ah, 
1991).
Gokhale et al., (1997) utilised the metabolism of 17|3-testosterone at various positions on 
the molecule as an indicator for the presence of various P450 isoforms. Testosterone 
was added to the cultures at zero and 72 hours and the metabolites were measured at 24
t
and 96 hours respectively by HPLC analysis. Interestingly, it was noted that following 
24 hours incubation of liver slices with testosterone the only metabolites identified were 
2a  OH-T and androstenedione. Surprisingly however, after 72 hours preincubation the 
following metabolites were detected, 6p, la , 16a, 16p, and 2a-hydroxytestosterone, and 
androstenedione. Even if the liver slices were maintained viable in culture, one would 
expect the activities to decline gradually with culture time. Contrary to this assumption, 
after 72 hours preincubation time, more metabolites was identified suggesting the
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presence of different P450 isoforms, which were not present/active following 24 hours 
culture. Moreover, after 72 hours preincubation the level of androstenedione was 3 times 
greater compared with slices cultured for only 24 hours. The authors did not explain 
these unexpected findings and implied that liver slices are metabolically viable for 4 days 
and that cytochromes P450 activity is maintained. It is important to note that the 
medium used in their study was Chee’s essential medium, supplemented with DMSO 
and dexamethasone. The possible effect of DMSO in the culture medium has already 
been discussed above; more importantly dexamethasone can act as cytochrome P450 
inducer in culture (Edwards et al, 1984), which may explain to some extent the greater 
number of metabohtes formed following 72 hours preincubation.
In the present study the rate of loss of enzyme activity during the 72 hours culture 
between CYPIA and CYP4A family was very similar, some activity still remaining 
following 24 hours and then declining to non-detectable levels after 48 hours. It is 
important to note that for the determination of CYP4A activity, a method was used that 
measures combined ©- and m-1 hydroxylation. However, liver slices fi'om clofibrate- 
pretreated animals were used which means that co-hydroxylation was the predominant 
form.
Interestingly the CYP2 subfamilies studied behaved differently to each other in culture in 
terms of enzyme activity. After the first 4 hours in culture there was a decline of 
approximately 60% of initial activity in CYP2C, 2D and 2E subfamilies but only a loss 
of 30% in CYP2B activity. A loss of 60% in CYP2B activity was only observed after 12 
hours in culture but then this declined rapidly to non-detectable levels after 48 hours. 
CYP2C behaved very much like the CYPIA and 4A families with the exception that no
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activity could be measured after 24 hours. After an initial loss of about 60% activity of 
the CYP2D subfamily following 4 hours culture, levels remained unchanged for up to 8 
hours and then declined rapidly with only about 3-4% activity remaining after just 12 
hours of culture. Although there was also a loss of 60% activity in the CYP2E after 4 
hours, activity then declined very gradually with about 30% still remaining following 24 
hours of culture. Activity continued to decline but was still measurable even after 72 
hours suggesting that the CYP2E subfamily is one of the, best conserved isoforms in 
culture.
In conclusion important differences in the rates of loss of individual rat cytochromes 
P450 enzyme activities were observed with culture time, which appear to be biphasic in 
nature. The stability of the P450 isoforms can therefore, be compared in two ways, (a) 
short term culture (0-12 hours) and (b) long term culture (24-72 hours) (Table 4.3). This 
is because some P450s may decline rapidly during the first 12 hours of culture, but then 
activity may decline more gradually following this time to even measurable levels after 
72 hours, for example CYP2E. Alternatively, drop in activity may be gradual during the 
first few hours in culture, but then decline more rapidly to levels just above limits of 
detection after 24 hours, for example CYP2B. This loss maybe due to inactivation of 
cytochrome and/or loss of enzyme protein. There may be a loss/change in haem 
prosthetic group with culture time, a change which maybe cytochrome P450 isoform 
specific, hence the differences in activities between the cytochrome P450 isoforms.
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Stability Grade
Cytochrome P450 Short term culture Long term culture
lA l 3 3
1A2 3 3
2B 1 2
2C11 4 5
2D 4 5
2E 2 1
4A 3 4
Table 4.3; Stability o f cytochrome P450 isoforms in rat liver slices in both short and 
long-term culture. Cytochrome P450 activities graded according to their stability in 
culture, 1 being the most stable and 5 the least.
The flavoprotein, NADPH-cytochrome P450 reductase is a necessary component of the 
cytochrome P450-dependent drug oxidation system. This flavoprotein has flavin adenine 
dinucleotide (FAD) and flavin mononucleotide (FMN) as its prosthetic groups. It is 
believed that FAD acts as the acceptor flavin from NADPH + H^ and FMN as the 
donating flavin to cytochrome P450 in the electron transfer chain (Gibson and Skett, 
1986). Consequently, the activity o f this flavoprotein was also measured in precision-cut 
rat liver slices. Although there was loss of activity with culture time, a substantial 
amount (50%) was still measurable even after 72 hours. Interestingly, cytochrome c- 
reductase activity is also maintained in rat hepatocyte monolayers at greater than 50% of 
initial activity after 24 hours culture (Guzelian et al, 1977). Therefore, this enzyme is 
unlikely to be the limiting factor responsible for the loss of P450 activity in culture. It is 
important to note that in these studies NADPH was added exogenously and it assumes 
that in the intact liver slices NADPH is not limiting.
Chapter 4: Stability o f Cytochrome P450 Isoforms in Cultured Precision-cut Rat hepatic Slices 148
Immunoblot analysis generally revealed a decline in P450 apoprotein levels with culture 
time, although the rate of change differed markedly amongst the different families and 
subfamilies. In contrast to the cytochrome P450 activities, apoprotein levels were still 
detectable even after 72 hours in all subfamilies studied, with the exception of CYP2C, 
2D and CYP3A. This may be because the loss of cytochromes P450 is associated with a 
lack of haem prosthetic group incorporation into the apo-cytochrome.
There was a gradual decline in apoprotein levels of CYPlAl and 1A2 with substantial 
amounts still remaining following 72 hours incubation. An unexpected observation was 
the change in CYP2B apoprotein levels with culture time. Levels were higher after 4, 8, 
12 and even 24 hours compared with the fi’esh liver slices. Furthermore, compared to the 
other cytochrome P450s studied, after 4 hours culture CYP2B expressed the highest 
activity. Immunoblot analysis of CYP2C (Figure 4.6) and CYP2D clearly indicates a 
decrease with culture time whilst CYP2C apoprotein levels were detectable even after 48 
hours, CYP2D apoproteins were not detected beyond 24 hours of culture. Apoprotein 
levels of the CYP2E subfamily were very stable during the 72 hours culture and 
interestingly this was the only isoenzyme whose activity was still detectable after 72 
hours. Rate of loss of CYP3 A apoprotein levels was greatest amongst the cytochrome 
P450s studied with only about 10% remaining following 12 hours. CYP4A declined 
gradually with time by about 90% after 72 hours.
The cytochrome P450 apoprotein levels in culture can be graded according to their 
stability as follows: CYP 2E>2B> 1 A2> 1A 1 >4A>2D>2C>3A. Therefore, CYP2E 
apoprotein levels were the most stable in culture, as was the activity, and CYP3A was 
the least stable, although CYP3 A enzyme activity was not measured in the present study.
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The stability of the P450 proteins can also, be compared in two ways, (a) short term 
culture (0-12 hours) and (b) long term culture (24-72 hours) (Table 4.4).
Stability Grade
Cytochrome P450 Short term culture Long term culture
lA l 1 3
1A2 2 2
2B 1 3
2C11 4 4
2D 5 5
2E 1 1
3 A 4 5
4A 3 3
Table 4.4; Stability o f cytochromes P450 isoforms in precision-cut rat liver slices in 
both short and long-term culture. Cytochrome P450 apoprotein levels is graded 
according to their stability in culture, 1 being the most stable and 5 the least.
Studies using primary hepatocytes, have shown that total cytochrome P450, measured 
spectrally as CO-binding haem.-oprotein, declined 68% during the first 72 hours in 
culture. However, the cytochromes P450 apoprotein levels declined only 24% (Steward 
et al, 1985). The present study also demonstrates that cytochrome P450 apoprotein 
levels differ from activities in precision-cut rat liver slices in long-term culture. This 
may be because immunoblotting is a very sensitive method of detection and that even if 
changes have occurred in the protein, which resulted in loss of activity, the changes may 
be so small that the protein is still identified by the antibodies even following 72 hours of 
culture. A more rapid decline in cytochromes P450 activity, maybe due to the loss of its 
haem moiety as opposed to loss in protein. Therefore, it is concluded that like the 
cultured hepatocytes, loss of cytochrome P450 in precision-cut rat liver slices involves
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loss of the haem moiety in addition to changes in the concentrations of the individual 
isoforms.
4.4.1 Conclusion
In conclusion, cytochrome P450 activities decline rapidly in culture employing the 
multiwell plate system, but loss in activity appears to be isoform specific. The rate of 
loss in cytochrome P450 apoprotein levels was also isoform specific, but unlike the 
activities, they were still detectable in the majority of isoforms even after 72 hours of 
culture. The most stable cytochrome P450 in culture was the CYP2E and 2B and the 
least stable were the CYP2C, 2D and 4A. Because the loss of activity of all the isoforms 
is not impaired in the same time-dependent manner, the ratio of metabolites of a given 
xenobiotic may be different to that of an in vivo system. Therefore, the use o f precision- 
cut rat liver slices in long term culture for drug metabolism studies may not reflect 
qualitatively the in vivo situation.
CHAPTER 5
Stability of Phase II Drug Metabolising 
Enzymes in Precision-cut Rat Hepatic Slices
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5.1 INTRODUCTION
The metabolism o f foreign compounds can be divided into two phases (Williams, 1959): 
Phase I metabolism which involves functionalisation reactions such as oxidation, 
reductions and hydrolysis, and prepares compounds for Phase II metabolism. Phase II 
metabolism or conjugation involves a diverse group of enzymes, localised in the 
microsomes and cytosol, generating products which are more water-soluble. Phase II 
reactions include, glucuronide, sulphate, glutathione, amino acid conjugation and 
acétylation. For a long time, Phase II metabolism was considered to be a detoxification 
reaction that terminates the biological or pharmacological activity of xenobiotics and 
endobiotics. However, this view is no longer tenable, as studies have shown that 
sulphate and glucuronide conjugate formation is a bioactivation reaction for N-hydroxy 
2-acetylaminofluorene (Hanna and Banks, 1985). Another example is the 
glucuronidation of morphine which leads to pharmacologically very active conjugates: 
the glucuronide conjugate formed at the 6-position of morphine is a much more potent 
agonist than is morphine itself, whereas the glucuronide at the 3-position is an extremely 
potent antagonist (Smith et ah, 1990; Paul et al, 1989). Other studies have shown that 
glutathione conjugate formation is the initial step in the bioactivation o f several groups 
of xenobiotics to metabolites that are toxic, mutagenic, and carcinogenic (Dekant et al, 
1988; Anders, 1988; Anders et al, 1988).
Currently over 200 laboratories are using the in vitro technique of precision-cut tissue 
slices for metabolism and toxicity studies (Gandolfi et al, 1995). Despite this no studies 
have been reported on the maintenance o f Phase II enzymes in long-term culture. The 
one published study is that of Ekins et al (1996) who investigated the stability o f Phase 
II enzymes in precision-cut liver slices over a 4 hour time period using only the substrate
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7-ethoxycoumarin. However, the limitation of their study is that the conjugation is 
dependent on the P450 mediated formation of the 7-hydroxycoumarin. In addition only 
a short culture time point was used.
Because of the important role o f the Phase II drug metabolising enzymes in both 
detoxification and bioactivation of xenobiotics, it was considered essential to study their 
stability in precision-cut rat liver slices in long term culture.
5.2 METHODS
For protein determination and total glutathione refer to sections 2.2.6 and 2.2.10.1 
respectively. Activities were measured according to section 2.2.10. Initial studies were 
undertaken to ascertain the number of slices required for the determination of individual 
enzyme activities (Table 5.1).
The following enzyme activities were measured as describe in section 2.2.10.
The number of liver slices used Activity measured
6 Epoxide hydrolase
4 UDP-Glucuronosyl transferase
4 Glutathione S-transferase
4 Glutathione reductase
6 Sulphotrasferase
Table 5.1: The number o f liver slices used and the activities measured to determine the 
Phase I I  enzyme activities.
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5.3 RESULTS
5.3.1 Comparison of Cytosolic and Microsomal Protein Content with Culture Time
Liver slice protein content, both microsomal and cytosolic, decreased with time but the 
extent of decrease and rate of decline were more pronounced in the case of microsomal 
protein (Figure 5.1). During the first 12 hours in culture, very little change in cytosolic 
protein content was observed but, there was about 50% loss in microsomal protein 
content (Figure 5.1a and b). About 45% of the original fi*esh shce cytosolic protein 
content remained after 72 hours culture whereas the equivalent level in the microsomes 
was only about 15% (Figure 5.1b).
5.3.2. Changes in Phase II Microsomal Activities
Epoxide hydrolase activity, determined using benzo[a]pyrene-4,5-oxide as substrate, 
when expressed per slice, showed a marked drop of about 40% of the initial activity 
during the first 8 hours, and then continued to diminish more slowly; activity was still 
measurable albeit at low levels, even following 72 hours of culturing (Figure 5.2a). 
When activity was expressed in terms of microsomal protein, epoxide hydrolase activity 
appeared to be better maintained, with over half of the initial activity still remaining in 
the 72 hour cultured slices.
Microsomal glucuronosyl transferase was monitored using 2-aminophenol as a probe 
substrate and, when expressed per slice, activity declined with time, but some 40% of the 
initial ftresh slice activity was still present following 24 hours of culturing and was still 
measurable at 72 hours (Figure 5.2b). When specific activity was calculated, activity did 
not change significantly for the first 24 hours and only a modest loss o f activity was 
evident even after 72 hours of culture.
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Figure: 5.1 Protein content during the culturing o f precision-cut rat liver slices, (a)
Cyotsolic protein; (b) microsomal protein. Results are presented as Mean ±  SEM for 3 
animals; each analysis was performed in duplicate.
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Figure 5.2: Maintenance o f the microsomal phase II  enzymes in precision-cut rat liver 
slices, (a) Epoxide hydrolase; 100% activity was 2.9 ±  0.8 nmol min‘ per mg 
microsomal protein and 1.9 ± 0.5 nmol min‘ per liver slice. (b) Glucurosonyl 
transferase; 100% activity was 5.5 ±0.7 nmol min' per mg microsomal protein and 7.1±
1.3 nmol min  ^per liver slice. Results are presented as Mean ±  SEM for 3 animals. 
Each analysis was performed in duplicate.
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5.3.3. Changes in Phase II Cytosolic Activities
Cytosolic glutathione S-transferase activity was monitored using two substrates, namely 
CDNB and DCNB. When the former served as the substrate and activity expressed per 
sUce, there was a gradual decline in activity, some 50% of the initial activity being 
present after culturing the liver slices for 24 hours, with 25% of the activity being 
retained at 72 hours (Figure 5.3a); a similar picture is observed when the activity is 
expressed per mg of cytosolic protein. When DCNB was used as the glutathione- 
accepting substrate, a very marked drop of 80% in activity per sHce was evident after 24 
hours, with less than 10% of the activity being retained in the slices cultured for 72 hours 
(Figure 5.3b); a comparable picture emerges when the specific activity is calculated.
Glutathione reductase appears to be a robust enzyme with about 50% of the activity per 
slice retained even after 72-hour culture of slices; no significant change in the specific 
activity was seen throughout the culture period (Figure 5.4a). Total glutathione levels 
dropped gradually but about 50% of the original concentration were still present at the 
end of the 72-hour culture period (Figure 5.4b).
Finally, cytosolic sulphotransferase activity per hver slice, measured using 2-naphthol as 
a substrate, was stable for the first 8 hours of culture but then declined rapidly, being 
only just detectable after 72 hours (Figure 5.5). When specific activity was monitored, 
no significant loss in activity was observed for the first 24 hours, but then activity 
dropped to very low levels at 72 hours.
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Figure 5.3: Maintenance o f cytosolic glutathione S-transferase activity during the 
culture o f precision-cut rat liver slices, (a) Glutathione S-transferase activity using the 
substrate CDNB; 100% activity was 2.2 ±0.4 jumol min' per mg cytosolic protein and 
4.8 ±  1.0 fjmol min^per liver slice, (b) Glutathione S-transferase activity using the 
substrate DCNB; 100% activity was 70 ±3.4 nmol min  ^per mg cytosolic protein and 
149.5 ±6.9 nmol min^per liver slice. Results are present as Mean ±  SEM for 3 animals; 
each analysis was carried out in duplicate.
Chapter 5: Stability of Phase II Drug Metabolising Enzymes in Rat Hepatic Slices 159
(a)
(b)
140 nmol/min per mg cytosolic protein 
nmol/min per liver slice
«R
OiI
I
I
■ses
16 24 32 40 48
Culture time (h)
56 64 72
60
im«a
Ee
I
£
Ss
I
50
40
30
20
I
16 24 32 40 48 56 64 72
Culture time (h)
Figure 5.4: Stability o f cytosolic glutathione reductase activity and glutathione 
concentration during the culture o f precision-cut rat liver slices, (a) Glutathione 
reductase activity; 100% activity was 138.9 ±0.9  nmol min  ^per mg cytosolic protein 
and 296.8 ± 19.7 nmol min  ^per liver slice, (b) Total glutathione at zero time point was
48.3 ±4.1 nmol per liver slice. Results are present as Mean ±  SEM of 3 animals; 
each analysis was performed in duplicate.
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Figure 5.5; Maintenance of the cytosolic Sulphotransferase activity in precision-cut 
rat liver slices. 100% activity was 0.3 ±  0.03 nmol min  ^per mg cytosolic protein and 
0.97 ± 0.09 nmol min  ^ per liver slice. Results are presented as Mean ±  SEM for 3 
animals; each analysis was performed in duplicate.
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5.4 DISCUSSION
The advantages of precision-cut liver slices over other comparable in vitro techniques 
have frequently been stated, and include the conservation of tissue architecture and 
maintenance of cell to cell communication. However, its value as a tool for studying the 
metabolism and toxicity of xenobiotics is largely dependent on the maintenance of 
metabolic activity for sufficient time to allow meaningfiil results to be obtained. Ekins, 
(1996) reported the maintenance of 7-hydroxycoumarin glucuronide and sulphate 
conjugation over a short-term culture period of 4 hours.
As part of a comprehensive study evaluating the stability of the xenobiotic-metabolising 
enzyme systems in precision-cut liver slices, the present study aimed to determine the 
activity of the Phase II systems over a culture period of 3 days (72 hours). The activity of 
a specific enzyme at a given time following culturing of the liver slices, assuming the 
availability of cosubstrates, will depend on the amount and fimctional integrity o f the 
enzyme. Protein levels per slice declined with time in both the cytosol and microsomes, 
but the rate of protein loss was clearly more pronounced in the latter implying that the 
soluble, cytosolic enzymes are generally more robust than the membrane-bound 
microsomal enzymes. About 45 % of the original fresh slice cytosolic protein content 
remained after a 72-hour culture whereas the equivalent level in the microsomes was 
only about 15 %. As far as total homogenate is concerned, it has been reported that 50 % 
of the original slice protein content survives over 72 hours, in studies where the liver 
slices were cultured in RPMI 1640 medium, containing foetal calf serum, and using the 
dynamic organ culture system (Lake et al, 1993). Whether the loss of protein is due to 
decreased synthesis, accelerated breakdown or a combination of these processes remains 
to be established. It is pertinent to point out that liver slices retain their ability to respond
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to cytochrome P450-inducing agents, showing that enzyme synthesis is operative during 
the culturing process (Lake et ah, 1993 and 1996). Although studies carried out in 
section 4.3.1, showed a rapid decline in the cytochromes P450 activities.
All activities studied decreased with incubation time, but rate of loss differed 
substantially depending on the nature of the enzyme. In the current study, changes in 
activity are expressed per slice to show the overall change in enzyme activity, and also 
per mg of protein to show changes in specific activity. Epoxide hydrolase activity, as 
determined using benzo(a)pyrene-4,5-oxide as substrate, declined in a biphasic manner; 
an initial rapid drop in activity during the first eight hours of culture was followed by a 
more gradual loss. As far as the specific activity is concerned, following an initial rapid 
loss of activity for the first four hours of incubation, activity was more or less constant 
throughout the 72-hour culture period. These observations would imply that the decrease 
in activity per slice is primarily due to lower enzyme levels. Microsomal glucuronosyl 
transferase activity, measured using 2-aminophenol as substrate, declined constantly on 
culturing, but low levels of activity were still present after 72 hours of culture. Specific 
activity remained constant for the first 24 hours and then dropped modestly, but most of 
the initial fresh slice activity was retained even in the 72-hour slices. It is once again 
implied that the loss of activity in the slices is largely a consequence of the lower 
enzyme levels. Recently Vandenbranden et al (1998) showed a doubling in 7- 
hydroxycoumarin glucuronosyl transferase activity after 8 hours culture in human liver 
slices, and the present study illustrates a 20% increase in glucuronsyl transferase activity 
following 24 hours of culture. Interestingly in hepatocytes cultured for 24 hours a slight 
increase in this enzyme has also been reported which were higher than the intact liver 
(Croci and Williams, 1985).
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The cytosolic glutathione-S-transferase activities were monitored using CDNB and 
DCNB, these being non-specific substrates (Awasthi et ah, 1994), thus allowing the 
evaluation of a large number of isoforms. The two substrates exhibited different 
kinetics, suggesting that the loss of activity during the culture of liver slices is likely to 
be isoform-specific. Glutathione-S-transferases exist as a superfamily of proteins, each 
protein comprising two subunits (DeLeve and Kaplowitz, 1991). When DCNB was 
employed as the substrate, activity per liver slice showed a rapid loss during the first 24 
hours of more than 80 % of the fresh slice activity, whereas when CDNB served as the 
substrate the loss during the same culture period was only 55 %. A similar picture 
emerges when specific activities are considered. As the principal function of glutathione 
S-transferases is to detoxicate electrophiles through conjugation with glutathione, 
availability of glutathione is essential for the system to operate.
The concentration of glutathione in the hepatic cytosol fell on culturing of the liver 
slices, but some 45 % of the original fresh slice concentration remained even following 
72 hours of culturing. However, only reduced glutathione can participate in Phase II 
conjugation, and the enzyme glutathione reductase effectively maintains the tripeptide in 
the reduced form. The activity of this enzyme also declined with time, but more than 
half o f the original activity remained following 24 hours of culturing. In contrast, no 
significant loss in specific activity during the entire 72-hour of culturing was evident, so 
that the loss of activity per slice can be attributed primarily to the lower levels of 
cytosolic protein.
The stability of sulphotransferases was monitored using 2-naphthol as a probe substrate. 
Activity per slice was maintained in the cytosol of the cultured slices for eight hours and
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then declined, but at 24 hours nearly half of the original activity was retained. A similar 
profile was obtained when specific activity was considered. At the end of the 72-hour 
culture period, only traces of activity were detectable expressed either per slice or per mg 
of cytosolic protein.
It is clear from the present studies that the activity o f the various Phase II enzymes 
declines during culture, the rate of loss depending on the enzyme system in question. In 
general terms, however, considerable activity is still present 24 hours after culture and, in 
some cases, it is maintained even up to 72 hours, thus allowing the use of liver slices in 
prolonged incubations for metabolic studies not only to identify pathways of metabolism, 
but also to generate sufficient levels of metabolites for ftirther processing. Two points 
must be emphasised; firstly Phase II enzymes exist as families o f proteins and it is likely 
that the isoform-specific changes occur during culture as already observed in the case of 
cytochrome P450 proteins (Chapter 4). Indeed, in the present studies the loss of 
glutathione S-transferase activity displayed dissimilar kinetics when two different 
substrates were employed. It is thus prudent to extend such studies to establish the 
stability of individual isoforms. Furthermore, the activity o f a Phase II enzyme in culture 
may be compromised by the unavailability of co-substrates such as UDP-glucuronic acid 
and adenosine 3 '-phosphate 5 '-phosphosulphate. It is, therefore, essential that the levels 
of these substrates are also determined following the culture of liver slices, so that a 
complete picture of the stability of Phase II enzymes can be achieved.
CHAPTER 6
Structural and Functional Integrity 
of Commercially Available Precision-Cut 
Human Hepatic Slices
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6.1 INTRODUCTION
Animal experiments are the main source of the current knowledge on the mechanisms of 
transport, metabolism and toxicity o f xenobiotics in the liver. Such studies in humans, in 
vivo are restricted due to ethical considerations. Therefore, the ability to study these 
liver functions in man using in vitro human liver preparations provides a valuable tool. 
Such data may enhance our understanding o f the functions of the human liver and 
ultimately would be valuable for drug development and toxicity studies.
Animal experiments are extensively used in drug development research. Due ito the 
large interspecies differences particularly in metabolism studies, the extrapolation of data 
to human is not always appropriate (Rueluis, 1987). The use of human in vitro 
preparations for drug research can lead to the reduction of the number o f animals and 
may even replace animal experimentation in the near future. It is important however, to 
assess the in vitro system of choice in terms o f the extent the in vitro data can be 
extrapolated to in vivo in man.
A drawback is that sufficient human liver material for research purposes is often scarce. 
In most countries, human liver tissue can only be used according to strict ethical 
guidelines, which must be approved by a local medical ethical committee. Human livers 
have been obtained form a different number of sources. Although human liver from 
autopsies has been used for xenobiotic metabolism studies, a marked decrease in hepatic 
xenobiotic metabolising activity has been reported (Powis et a l, 1988). Liver samples 
taken from needle biopsies are often small (20-100 mg) and quality o f the liver is 
dependent on the status of the liver from which the tissue was taken i.e. nature of
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disease; such small pieces of tissue may be used to isolate hepatocytes but may be 
difficult to prepare liver slices from. Human liver tissue from partial hepatectomy from 
patients with liver tumours has also been used (Olinga et aL, 1997a; Morel et al, 1990; 
Vons et a l, 1990; Ballet et a l, 1984). However, the amount of the healthy area that can 
be used for research depends on the locahsation and size of the tumour. In addition this 
procedure involves clamping of the afferent and efferent blood vessels which often result 
in warm ischaemia.
Establishments have now been set up largely in the United States, whereby human tissue 
slices are provided for research studies. Slices are prepared from liver organs that can 
not be used for transplantation, and the slices are then distributed to researchers 
throughout the world. Depending on the location of the recipient, it may take many 
hours or even days before slices can be received; it normally takes 24-48 hours to obtain 
slices from such organisation in the United Kingdom. The present study therefore, aims 
to assess the viability of such liver slices in long-term culture for drug metabolism and 
toxicity studies.
6.1.1 Principal Objectives of the Study
The principal objectives of the present study were:
1. To assess the cumulative metabolism of the substrate 7-ethoxycoumarin by 
commercially available human hepatic slices.
2. To assess metabolic viability of commercially available human hepatic slices using 
the substrate 7-ethoxycoumarin.
3. To evaluate morphological changes across tissue thickness in long-term culture.
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6.2 METHODS
Human liver slices were purchased from the International Institute for the Advancement 
of Medicine (HAM) (15 E. Uwchlan Avenue, Suite 406, Exton, PA 19341) and the 
Human Cell Culture Centre (HCCC) (PO Box 5437, Laurel MD, 20726) -  (USA). 
Hepatic slices were received 24-48 hours after the liver was removed from the donor. 
Liver slices were transported in Belzers solution on ice. It is important to note that slices 
may be delivered at inconvenient hours; however, every attempt was made to use slices 
immediately upon receipt. Slices were transferred into a sterile container and the Beltzers 
solution was decanted very careftilly and slices then were washed 3 to 4 times (by 
decanting) with culture medium. Slices were preincubated for 30 minutes prior to the 
start of any experiment, to allow equilibrium to take place and ensure complete removal 
of the transport buffer (Belzers solution).
Five donors (for details see Table 6.1) were used for this study and the same donors 
were used for both cumulative metabolism of 7-ethoxycoumarin (50 pM), where slices 
were cultured in the presence of the above substrate for up to 10 hours, and for metabolic 
viability, whereby slices were preincubated for various time points and then were further 
incubated for 2 hours in the presence of the substrate 7-ethoxycoumarin (50 pM). Slices 
were cultured in 12-well plates housed in a humidified incubator at 37 °C with 95% air / 
5% CO2 supply. For more details on culture conditions and analysis of media for 
metabolites please refer to sections 2.2.3.3 and 2.2.4 respectively. Following analysis of 
the media, donors 4 and 5 were eliminated from the study because o f lack of initial 
activity. For light and electron transmission microscopy, human liver slices from donor 
2 were used and were processed according to section 2.2.12.
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To evaluate morphological changes across tissue thickness, liver slices, from donor 1 
was used. For details of the donor refer to Table 6.1.
6.3 RESULTS
6.3.1 Cumulative Metabolism of 7-EC by Human Hepatic Slices
Incubation of human liver slices from the three different donors with 7-ethoxycoumarin 
(50 pM) resulted in a large inter-individual variability in the cumulative metabolism of 
7-EC. 7-Ethoxycoumarin was metabolised to free 7-hydroxycumarin, 7- 
hydroxycoumarin glucuronide and sulphate conjugates, illustrating integrated Phase I 
and Phase II enzyme activities. Slices from donor 1 resulted in a linear increase in 7- 
ethoxycoumarin metabolites up to 4 hours incubation only, reaching a plateau after this 
time point (Figure 6.1a), whilst metabolism increased linearly for 6 hours by liver slices 
from donor 2, before it reached a plateau (Figure 6.1b). In contrast donor 3 showed a 
time-dependent metabolism for up to 8 hours before reaching a plateau (Figure 6.1c).
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Figure 6.1: Cumulative metabolism of 7-ethoxycoumarin (SOfjM) by human liver slices 
cultured in 12-well plates. Liver slices were incubated for various time periods of up to 10 
hours in the presence of 7-ethoxycoumarin (50pM). Results are presented as mean oj 
duplicate cultures from (a) donor 1, (b) donor 2 and (c) donor 3. Analysis of the 
metabolites for each incubation was carried out in duplicate.
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The major metabolites formed were the 7-OH glucuronide and 7-OH sulphate 
conjugates, the levels of which increased with incubation time. Equal amounts of the 
two conjugates were produced at all times in all 3 donors. Small levels o f free 7- 
hyroxycoumarin were also present.
An interesting finding was that at times, a marked difference in the metabolic turnover of 
7-EC was noted between duplicate cultures i.e. between liver slices from the same donor 
(Figure 6.2a and b). Note, that after 4 hours incubation total metabolites formed from 
one liver slice, is over 3 times greater than the slice incubated for 2 hours with 7-EC 
(Figure 6.2a); whilst there was only a slight increase in total metabolism after 4 hours of 
the duplicate culture in relation to the 2 hour time point (Figure 6.2b).
6.3.2 M etabolic V iability o f  H um an H epatic Slices
7-Ethoxycoumarin was metabolised to free 7-hydroxycoumarin, 7-hydroxycoumarin 
glucuronide and sulphate conjugates. Equal proportions of the main metabolites, the 7- 
hydroxycoumarin glucuronide and sulphate conjugates were formed at all time points. 
Total metabolites formed after zero-hour preincubation time was 6.5, 0.7 and 2.33 
nmoFmg protein by donors 1, 2, and 3 respectively illustrating marked inter-individual 
variability in the metabolic turnover of 7-ethoxycoumarin (Figures 6.3, 6.4 and 6.5).
Chapter 6: Structural and Functional Viability of Commercially Available Human Hepatic slices 173
(a)
□  Total metabolism
□  Sulphate conjugate
□  Glucuronide conjugate
□  Free 7-HC
14i
t 124a.
bc
1o
£
104
8-1
c
$
"S.aa
4i
I
« 24
o k
T l
esfczai
4 6
Incubation time (b)
10
(b)
12
•I 10
£O.w) 8E
o
S 6 s
4
□  Total metabolism
□  Sulphate conjugate
□  Glucuronide conjugate
□  Free 7-HC
4 6
Incubation time (h)
10
Figure 6.2: Cumulative metabolism o f 7-ethoxycoumarin (50pM) by human liver 
slices obtained from  donor 1 and cultured in 12-well plate. For each time point 2 liver 
slices were used, 1 in each culture-well (duplicate culture). This figure is illustrating the 
metabolism of 7-ethoxycoumarin by (a) slice 1 and (b) slice 2 -  duplicate cultures 
obtained from the same donor. Analysis of the metabolites for each incubation was 
carried out in duplicate.
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Donor 1 :
No change in the rate of metabolism of 7-ethoxycoumarin occurred after the first 4 hours 
of preincubation (Figure 6.3). There was, however, a loss of about 35 and 23% activity 
after 8 and 10 hours respectively with about 56% of original activity still remaining 
following 24 hours preincubation time. Metabolic activity was still measurable even 
after 72 hours with 18% still remaining (Figure 6.3).
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Figure 6.3: Metabolic viability o f precision-cut human liver slices from  donor 1. Liver 
slices were preincubated for various time points fo r  up to 72 hours. After specific time 
periods, liver slices were incubated for a further 2 hours in the presence o f the substrate 7- 
ethoxycoumarin (50pM). Results are presented as mean o f duplicate cultures. Analysis oj 
the metabolites for each incubation was similarly carried out in duplicate.
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Donor 2:
The metabolic capacity of the slices from donor 2 towards 7-ethoxycoumarin was 
markedly lower compared to donors 1 and 3. In addition, no change in the metabolic 
turnover of 7-ethoxycoumarin occurred during the first 24 hours culture (Figure 6.4). 
Very little activity (15%) was still measurable following 72 hours incubation.
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Figure 6.4: Metabolic viability o f precision-cut human liver slices from  donor 2. Liver 
slices were preincubated for various time points for up to 72 hours. After specific time 
periods, liver slices were incubated for a further 2 hours in the presence of the substrate 
7-ethoxycoumarin (50pM). Results are presented as mean of duplicate cultures. 
Analysis of the metabolites for each incubation was similarly carried out in duplicate.
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Donor 3:
No change in metabolic activity as assessed by total metabolism, was observed after 8
hours preincubation time (Figure 6.5). Following zero and 8 hours preincubation time, 
coumarin
the level of 7-bydrox)^sulpbate conjugate appeared to be slightly greater than the 
glucuronide conjugate. Only 10% of the initial activity was measurable after 10 hours of 
preincubation. Surprisingly, about 68% metabolic activity still remained after 24 hours 
preincubation time (Figure 6.5). This discrepancy indicates that the slices used for the 
10-hour preincubation were not metabolically viable. After 48 and 72 hours, there was 
18 and 27% of initial metabolic activity remaining respectively. But the major 
metabolite formed after these time points, was largely the free 7-hydroxycoumarin.
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Figure 6.5; Metabolic viability o f precision-cut human liver slices from  donor 3. Liver 
slices were preincubated for various time periods up to 72 hours. After specific time 
periods, liver slices were incubated with model substrate, 7-ethoxycoumarin (50pM) for  
a further 2 hours. Results are presented as mean o f duplicate cultures. Analysis o f  the 
metabolites for each incubation was similarly carried out in duplicate.
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6.3.3 Homogenate Protein Content
Following 4 hours of culture, a rapid decline in protein content of slices from donor 1 
was observed, after which levels remained relatively stable even after 72 hours (Figure
6.6). Very little change in protein content of slices from donor 2 was observed during 
the first 48 hours of culture, but protein content declined very gradually after this time 
point (Figure 6.6). No significant change in protein content was observed from donor 3 
during the first 24 hours of culture, but then levels gradually declined with about half the 
initial value remaining after 72 hours of culture (Figure 6.6).
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Figure 6.6: Homogenate protein content o f human liver slices following various 
culture time periods. Results are presented as mean o f duplicate cultures, each analysis 
being carried out in duplicate.
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6.3.4 Morphological Analysis of Human Hepatic Slices in Long-term Culture
6.3.4.1 Light Microscopy (LM)
Following histological examination, a large variation of approximately two-fold in slice 
thickness was noted. The cells from liver slices, at zero hours i.e. at the time of receipt, 
appear very well preserved (Figure 6.7). Virtually no damaged cells were apparent at the 
cutting edges of the tissue presumably because these damaged cells are lost during 
transportation in buffer. Incubation of slices for 4 hours, led to loss of viability in cells 
in the centre of the tissue, as indicated by slightly fainter toluidine blue staining (Figure 
6.8a). Apart from a small number of vacuoles, generally the cells below the cutting 
edges are still viable and no different to those at zero hours (Figures 6.7 and 6.8a). The 
slice used for determining the effect of 8 hours culture on the cells across the tissue 
thickness was much thicker than 250pm (Figure 6.8b). Only about 4 cells thick on either 
side of the tissue were still viable following 8 hours culture with a thick necrotic region 
in the centre of the tissue. In addition, some necrotic cells were also evident at the 
cutting edges, illustrated by a light, toluidine blue staining (Figure 6.8b). After 10 hours, 
there were no damaged cells at the cutting edges of the tissue (Figure 6.9a). The viable 
cells on either side o f the tissue were also divided by a lighter stained necrotic region 
(Figure 6.9a). The slice used for 24 hours culture was damaged probably at the time of 
slicing or during transport and therefore, was not of good quality. Thus, following 24 
hours of culture cells across the tissue thickness appear necrotic with virtually no intact 
nuclei present (Figure 6.9b). In contrast, viable cells on both sides of the tissue were still 
present even after 48 and 72 hours culture (Figures 6.10a and b). Although it is 
important to point out that the slice used for the 72 hour culture was much thicker, and 
thus, a thicker necrotic region in the centre of the tissue was evident. Following 48 hours
Chapter 6: Structural and Functional Viability o f  Commercially Available Human Hepatic slices 179
some darkly stained droplets were evident in the centre of the tissue which increased by 
72 hours (Figure 6.10).
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Figure 6.7: Light photomicrograph o f cells across the thickness o f precision-cut 
human liver slices at zero-hours (Le, the time the slices were received). Slices were 
fixed in glutaraldehyde, embedded in resin and stained with toluidine blue.
Magnification: X 1042
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Figure 6.8: Light photomicrograph o f cells across the thickness o f precision-cut 
human liver slices cultured for 4 and 8 hours, (a) 4-h culture; (b) 8-h culture; note the 
necrotic cells at the cutting edge o f tissue (light stained cells on the left). Slices were 
fixed in glutar aldehyde, embedded in resin and stained with toluidine blue. N, Necrotic 
region; V, vacuoles.
Magnification; X 1042
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Figure 6.9: Light photomicrograph of cells across the thickness of precision-cut 
human liver slices cultured for 10 and 24 hours, (a) 10-h culture; note the darkly 
stained viable cells on either side o f tissue separated by a necrotic centre (N); (b) 24-h 
culture; note no nuclei are present. Slices were fixed in glutaraldehyde, embedded in 
resin and stained with toluidine blue.
Magnification: X 1042
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Figure 6.10; Light photomicrograph of cells across the thickness of precision-cut 
human liver slices cultured for 48 and 72 hours, (a) 48-h culture; (b) 72-h culture, 
note the large necrotic area in the centre o f tissue. Slices were fixed in glutaraldehyde, 
embedded in resin and stained with toluidine. Note the difference in tissue slice 
thickness. D; darkely stained droplets; N, necrotic region.
Magnification: X 1042
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6.3.3.2 Transmission Electron Microscopy (TEM)
Morphological examination of the regions of viable cells with electron microscopy 
showed remarkably good preservation of cells. Figure 6.11 shows two hepatocytes, one 
necrotic with condensed nuclei material, and the adjacent cell containing very well 
preserved endoplasmic reticulum, mitochondria and other cytoplasmic structures. After 
8 and 10 hours of culture good preservation of intracellular and extracellular components 
is observed (Figure 6.12), although a large number of lipid droplets are evident after 10 
hours of culture (Figures 6.12b). Following 48 hours culture, interestingly some cells are 
still fairly well preserved, but these hepatocytes contain large vacuoles, some of which 
contain lipid droplets (Figure 6.13a). It is important to note that surrounding cells are 
clearly necrotic. Cells were largely necrotic after 72 hours (Figure 6.13b).
W i
w
ER
Figure 6.11: Electron photomicrograph of precision-cut human liver slices at zero 
hours (Le. the time the slices were received). Slices were fixed in glutaraldehyde, 
embedded in resin and stained with uranyl lead citrate. N, nucleus; ER, endoplasmic 
reticulum; M, mitochondria; LD, lipid droplets; NC necrosed cell. Note the cell on the 
right is necrotic, whilst the cell on the left is very well preserved.
Magnification: X  34K.
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Figure 6.12: Electron photomicrograph of precision-cut human liver slices cultured in 
the 12-well plate system for 8 and 10 hours, (a) 8-h culture; (b) 10-h culture. Slices 
were fixed in glutaraldehyde, embedded in resin and stained with uranyl lead citrate. N, 
nucleus; ER, endoplasmic reticulum; M, mitochondria; BC, bile canaliculi; LD, lipid 
droplets.
Magnification: X  34K.
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Figure 6.13: Electron photomicrograph of precision-cut human liver slices cultured in 
the 12-well plate system for 48 and 72 hours, (a) 48-h culture; note surrounding cells 
are necrotic; (b) 72-h culture. Slices w’ere fixed in glutaraldehyde, embedded in resin 
and stained with uranyl lead citrate. N, nucleus; ER, endoplasmic reticulum; M, 
mitochondria; LD, lipid droplets; NC necrosed cell.
Magnification: X  34K.
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6.4 DICUSSION
The availability of an in vitro system using human liver tissue is a valuable tool for 
identifying human-specific metabolites, characterising previously unidentified metabolic 
pathways and also for detecting drug interactions in man. As a result, there has been an 
increase in demand for human tissue. Human tissue can be obtained from organ donors, 
as biopsy material from surgical procedures, and as cadaver material. However, 
organisations such as the International Institute for Advancement of Medicine (HAM) 
and the Human Cell Culture Centre (HCCC) obtain non-transplantable human tissues, 
and actually produce slices for distribution to researchers throughout the world. The 
present study was undertaken to determine the viability of human liver slices obtained 
from such organisations using the substrate 7-ethoxycoumarin, and morphologically 
using light and electron microscopy.
6.4.1 Metabolic Viability
The substrate 7-ethoxycoumarin was used to determine the metabolic viability of the 
liver slices. The reasons for choosing 7-ethoxycoumarin as the substrate have aheady 
been discussed in Chapter 3. Total metabolism (free 7-HC, 7-OH glucuronide and 
sulphate conjugates) was used as an indicator of metabolic viability. Studies have shown 
that the major metabolite formed by human liver slices incubated with 7-ethoxycoumarin 
is the 7-OH glucuronide conjugate (Ekins et al, 1996; Walsh et al, 1995; Barr et al, 
1991b), but in the present study, equal levels o f 7-OH glucuronide and 7-OH sulphate 
conjugates were formed at all times. This may be in part due to the fact that D-saccharic 
acid 1,4 lactone was not incubated with the sulphatase in order to inhibit the 
contaminating p-glucuronidase activity present in the sulphatase as carried out by
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Steensma et al (1994), therefore, 7-OH sulphate conjugation in the present study may 
also include some glucuronide conjugate, and hence suggesting higher sulphate 
conjugation than expected.
To evaluate the ability of human hepatic slices to metabolise 7-ethoxycoumarin for up to 
72 hours, slices were preincubated for specified time periods, 7-ethoxycoumrarin was 
then added and a further 2-hour incubation was allowed for the metabolism of the 
substrate. Such an approach determines the metabolic viability o f the shces at a given 
time point. Large inter-individual variation was observed in the metabolic turn over of 
7-ethoxycoumarin. Very little change in the metabolic viability o f human slices occurred 
during the first 24 hours of culture. Significant levels of metabolites were still 
measurable by slices from donor 1, even after 48 and 72 hours preincubation time. In 
contrast, very low levels were measurable following these time points by slices from 
donors 2 and 3. It is important to note that the level o f metabolites from donor 1, was 
highest even at zero-time, which may be why they were still measurable even after 72 
hours culture.
Cumulative metabolism of 7-ethoxycoumarin (50 pM) for up to 10 hours revealed that in 
contrast to the rat hepatic slices, (section 3.3.2), commercially available human hepatic 
slices did not metabolise 7-ethoxycoumarin in a time-dependent fashion for up to 10 
hours. Total metabolism of 7-ethoxycoumarin as well as production of individual 
metabolites increased linearly for up to 4, 6 and 8 hours using hepatic slices from donors 
1, 2 and 3 respectively. An observation made was that slices from the same donor when
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used to carry out duplicate cultures metabolised 7-ethoxycoumarin in a different manner 
(Figure 6.3).
A marked difference was noted in the metabolic turnover of 7-ethoxycoumarhi among 
the different subjects even at zero time. This may be due to: (a) biter-individual 
variability, and/or (b) loss of metabolic viability, due to transport/shipping time taken 
(usually 24-48 hours) prior to receipt of the human liver slices (c) medical history i.e. 
drugs, alcohol, smoking etc. Furthermore, in some cases difference in the metabolic 
turnover of 7-ethoxycoumarin was also noted between liver slices from the same human 
subject. The reason for this maybe because (a) some slices loose their viability at a faster 
rate due to the time taken for transport because the slices might differ in their thickness, 
or (b) the human liver is a large organ and thousands of slices can be produced from it 
and slices may have been prepared from different lobes and may reflect inter-lobular 
expression of enzymes such as the cytochrome P450. Considering the zonal distribution 
of drug metabolising enzymes, some slices may express smaller levels o f cytochromes 
P450 and hence the lower levels of metabolism (Buhler et ah, 1992).
Another way of determining the metabolic viability o f liver slices, would be to use the 
same human liver slice and culture it for various time periods as carried out by Barr et 
al, (1991a). After specified time periods transfer slices to fresh medium containing the 
substrate, incubate further for metabolism to take place, then remove media for analysis 
of metabolites and replace with fresh media. Taking into account the cost of obtaining 
human liver slices, this system would be much more cost effective. However, the 
present study utilised different liver slices for various time points and has therefore.
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highlighted the fact that large variations can occur in the metabolic viability of human 
liver slices even from the same donor. Therefore, when using human liver slices 
obtained from commercial organisations duplicate cultures may not be sufficient for 
qualitative or quantitative studies.
The present study was carried out using the 12-well plate culture system housed in a
rat
humidified incubator gassed with 95% air / 5% CO2 . It has been shown tha^tissue slices 
are better maintained using 95% O2 / 5% CO2 (Fisher et ah, 1995a), but more recent 
studies revealed that the rate of 7-ethoxycoumarin metabolism in liver slices was not 
affected if air instead of O2 was used as the gas phase (Price et al, 1998a).
Light microscopy of sections across the tissue thickness showed a large variation (about 
2-fold) in thickness of commercially supplied slices. This also reflected in variation in 
homogenate protein content. The hepatic slices from donor 1 and 2 were obtained from 
HAM, but they were clearly different in terms of homogenate proteiu suggesting that 
slices may not be of uniform thickness. The homogenate protein content of hepatic 
slices from donors 2 and 3, were lower than that of donor 1, implying that the slices were 
thinner. Interestingly protein levels from donors 2 and 3 declined to approximately half 
their initial value, whilst very little changes were noted in slices from donor 1. This 
maybe because, following the tissue slicing procedure, cells at the cutting edges are 
damaged, but the ratio of damaged cells to undamaged cells is greater in thinner slices, 
and therefore, damaged cells may be lost into the culture medium, hence, the lower 
protein content in the tissue.
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6.4.2 M orphology o f  Cells across T issue Thickness
Considering the time taken for transport of human hepatic slices (24-48 hours), light 
microscopy showed that the cells across the tissue thickness were very well preserved, 
maintaining normal morphology with regard to cell architecture and nuclear integrity. 
Apart from the slices for one time point (8-hour), slices did not contain any damaged 
cells at the cutting edges as previously observed with rat liver slices (section 3.3.5.1). It 
is conceivable that the damaged cells at the cutting edges are lost in the buffer during 
transport. In addition, in comparison to the rat liver slices (section 3.3.5.1) very few 
vacuoles were noted in the human liver slices during long-term culture.
A large variation is tissue slice thickness was also observed morphologically, as a result 
o f which the thicker slices contained a larger degenerative area in the centre of the tissue. 
The need for an optimum slice thickness to maintain viability is well documented 
(Brendel et al, 1993; Smith et al, 1986). The optimal slice thickness, which is believed 
to be 200-250 pm for liver (Brendel et al, 1993), is a function o f the oxygen 
consumption rate of the tissue and varies according to the tissue. However, more recent 
studies have shown that the optimal slice thickness for liver is actually 175 pm, as 
opposed to the 250 pm thickness often used for studies of xenobiotic metabolism (Price 
et al, 1998a).
6.4.3 Conclusion
In conclusion, this study has shown that despite the fact that it can take 24-48 hours to 
receive commercially available human hepatic slices, they remain metabolically and 
morphologically viable for up to 24 hours in culture. It is important to note that a large
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variation in slice thickness was observed, suggesting inconsistencies between suppliers 
and within the same supplier which can affect the viability of tissue during transport and 
subsequently in culture. The utilisation o f human tissue in vitro, provides a bridge 
between extrapolation of data obtained in vitro and in vivo animal studies, to the human 
situation. As a result, there is a need in the application o f human liver slices for drug 
metabolism and toxicity studies, but because some slices may be more viable than others, 
duplicate cultures are not sufficient for the qualitative and quantitative metabolism 
studies and the use of more slices is recommended.
CHAPTER 7
Stability of Phase I  and Phase II 
Drug Metabolising Enzymes 
in Precision-cut Human Hepatic slices
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7.1 INTRODUCTION
Drugs are metabolised by a number of enzyme systems, which have the ability to interact 
with an endless number of organic chemicals. Animal studies have demonstrated sex, 
and strain differences in drug metabolism and pharmacokinetics, illustrating the ever- 
increasing awareness of the complexities of the cytochrome P450 enzymes, and other 
enzymes involved in hydrolysis, reduction and conjugation (Lu and West, 1980). Large 
species differences exist in biotransformation of drugs (Chenery et ah, 1987; LeBigot et 
al, 1987) making extrapolation of data from animal experiments to humans difficult or 
even hazardous.
Human in vitro preparations can be used to detect human-specific metabolites and to 
identify metabolic pathways in humans at a very early stage in drug development. The 
development of a tissue slicer capable of producing slices of uniform thickness 
(Krumdieck et al, 1980) and the setting up of organisations which can provide human 
liver slices, has led to an increase in the use of human liver slices for xenobiotic 
metabolism and toxicity studies, as an alternative to hepatocyte cultures. This in vitro 
system is used in more than 200 laboratories for metabolism and toxicity studies, and this 
number continues to increase (Gandolfi et al, 1995).
However, very little information is available on the maintenance of Phase I, and Phase II 
drug metabolising enzymes in precision-cut human liver slices in long-term culture. 
Studies have shown that CYP1A2, CYP3A and CYP4A activity declines over a 72 hours 
culture time period (Lake et al, 1996a, 1997), but in this work only one time point was 
used. In a recent study it was shown that the P450 activities decrease fairly rapidly
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during the first 24 hours culture and, in contrast, found the Phase II enzymes to be more 
stable (Vandenbranden et al, 1998). These studies were limited to monitoring the 
activities using selective substrates, but no immunological determination was carried out. 
Moreover, crude homogenates were used rather than isolated microsomes. Furthermore, 
the liver slices were prepared by the investigators and not purchased, so that the time 
between obtaining the samples and preparing slices was relatively short.
7.1.1 Principal Objectives of the Study
The principal objective of the present study were to determine:
1. The stability of the xenobiotic-metabolising cytochromes P450 in commercially 
available human liver slices in long-term culture, using appropriate selective probes 
and immunologically employing Western blotting.
2. The stability of Phase II conjugation systems in commercially available human liver 
slices in long-term culture, employing appropriate substrate models.
7.2 METHODS
Immediately upon receipt, the slices were briefly washed in tissue culture medium 
(RPMI 1640) in order to wash of the transport buffer. To determine the viability of the 
human liver slices, they were preincubated for various time periods up to 72 hours. After 
each time point, slices were incubated for a fiirther 2 hours in the presence of 7- 
ethoxycourmarin (50 pM). The metabolites, 7-hydroxycoumarin, and its glucuronide
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and sulphate conjugates were measured fluorimetrically (for more details and viability 
data refer to Chapter 6, section 6.3.2).
Human liver slices were purchased on four separate occasions i.e. from four different 
human subjects and were cultured for various time points of up to 72 hours. However, 
following studies to determine their viability it was noted that liver slices from 2 out of 
the four donors, were not viable upon receipt. Therefore, the present study was carried 
out using liver slices from only two human subjects, for details of donors, refer to 
Chapter 6, Table 6.1. Donor 2 was used to study CYPlAl, CYP1A2, CYP2E, CYP4A, 
NADPH cytochrome c-reductase and Phase II enzymes. Donor 3 was used to determine 
the stability of CYP2C, CYP3A and CYP2D as well as the cytochrome P450 apoprotein 
levels.
For the determination of Phase I and Phase II enzyme activities refer to Chapter 2, 
section 2.2.8, and 2.2.10, respectively. The activities measured and the number of slices 
used for individual assays are outlined in Table 7.1 and 7.2. At the end of each culture 
time point liver slices were briefly washed in 0.154 M KCl buffer containing 50 mM 
Tris-HCl and were homogenised, sonicated and centrifiiged as described in Chapter 4, 
section 4.2. Protein determination and Western blots were carried out according to 
sections 2.2.6, and 2.2.9 respectively.
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Cytochromes P450 The number of 
liver slices used
Activity measured
CYPlAl 6 Ethoxyresorufin 0-deethylase
CYP1A2 6 Methoxyresorufin 0-demethylase
CYP2B 6 Pentoxyresorufin 0-depentylase
CYP2C9 *12 Tolbutamide hydroxylase
CYP2D *12 Debrisoquine 4-hydroxylase
CYP2E 6 p-Nitrophenol hydroxylase
CYP3A *12 Testosterone 6p- hydroxylase
CYP4A 6 Laurie acid co-hydroxylase
Table 7.1: The number of liver slices used and the activities of the cytochrome P450 
isoforms measured. 12 Human liver slices were homogenised in 2 ml of the 
homogenisation buffer, the microsomal pellet was resuspended in 1 ml of the buffer.
The number of Activity measured
liver slices used
6 Glutathione reductase
6 Glutathione S-transferase
Table 7.2: The number of liver slices used and the Phase II enzyme activities 
measured.
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7.3 RESULTS
7.3.1 Stability of Cytochrome P450 Isoforms in Human Hepatic Slices 
7.3.L1 CYPIA Subfamily
CYPlAl activity, determined using ethoxyresorufin as the probe substrate, when 
expressed per slice showed a marked drop of about 74% during the first 8 hours in 
culture, and then continued to diminish more slowly to non-detectable levels at 48 hours 
(Figure 7.1a). When the results were expressed in terms of microsomal protein, activity 
appeared to be slightly better maintained. There was a drop of about 62% in activity 
after the first 8 hours of culture. Activity also declined to non-detectable levels after 48 
hours Figure 7.1a).
CYT1A2 activity was determined by the substrate methoxyresorufin. There was a 
marked decline of 35 and 75% after 4 and 12 hours culture respectively when expressed 
per shce (Figure 7.1b). Activity continued to fall gradually with about 10% remaining 
following 24 hours, after which levels remained relatively stable for up to 72 hours. 
When activity was expressed in terms of microsomal protein, methoxyresorufin-0- 
demethylase activity appeared to be better maintained. There was a loss of only 10 and 
58% activity following 4 and 12 hours respectively. Following this time point levels 
remained stable for up to 72 hours (Figure 7.1b).
Immunoblot analysis using antibodies specific to CYPlAl and CYP1A2 showed a single 
band, which gradually declined in intensity with culture time, with no band being 
detected after 72 hours incubation (Figure 7.2). This band is assumed to be that of the 
CYP1A2 because CYPlAl is largely an extrahepatic enzyme although it is readily 
inducible in the liver.
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Figure 7.1: Stability of CYPlAl and CYP1A2 activity in human liver slices with 
culture time, (a) Ethoxyresorufin 0-deethylase (EROD) activity; 100% activity was 8.7 
pmol min^ per mg microsomal protein and 4.9 pmol min^ per liver slice. (b) 
Methoxyresorufin O-demethylase (MROD) activity; 100% activity was 10.4 pmol min^ 
per mg microsomal protein and 5.5 pmol m in ' per liver slice. All values are expressed 
as a percentage o f the zero time, and results are presented as mean o f duplicates.
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Figure 7.2: Immunoblot analysis with anti-CYPlA of solubilised hepatic microsomes 
derived from precision-cut human liver slices. Solubilised microsomal proteins were 
resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to nitrocellulose. 
The immunoblot was carried out with anti-rat CYP1A1/1A2 (diluted 1:10,000) followed 
by peroxidase-labelled anti-sheep IgG (diluted 1:2000). Letters A to G represent culture 
time periods i.e 0, 4, 8, 12, 24, 48 and 72 hours. All lanes were loaded with 20pg  
protein except for control rat liver (5pg) (H) and Aroclor 1254-induced liver (3.5 pg) (I).
7.3.1.2 CYP2 Family
In order to determine CYP2B activity the substrate pentoxyresorufin was used. CYP2B 
activity was not measurable at any time point even in fresh human liver slices (zero-time 
point). Tolbutamide hydroxylation was used as a marker for CYP2C9, which was also 
not measurable even in fresh human liver slices (zero-time point).
Apoprotein levels of CYP2C family were determined using antibodies raised to 
CYP2C10 and CYP2C11. Immunoblots show that CYP2C10 apoprotein levels are more 
stable than those recognised by the antibody to the rat CYP2C11 (Figures 7.3 and 7.4). 
Very little change in CYP2C10 band intensity was observed during the first 8 hours of
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culture, after which they gradually declined, but the band was clearly detectable even 
after 48 hours (Figure 7.3). In contrast CYP2C11 detected apoprotein levels decreased 
slightly after the first 4 hours of culture, levels then remained relatively stable for up to 8 
hours, and decreased rapidly being just detectable by 24 hours (Figure 7.4).
Figure 7.3: Immunoblot analysis with anti-CYP2C10 of solubilised hepatic 
microsomes derived from precision-cut human liver slices. Solubilised microsomal 
proteins were resolved by lOYo (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-human CYP2CI0 (diluted 
1:1000) followed by peroxidase-labelled anti-rabbit IgG secondary antibody (diluted 
1:2000). Letters A to G represents culture time periods i.e. 0, 4, 8, 12, 24, 48 and 72 
hours, and lane H = control rat liver slices. All lanes were loaded with lOpgprotein.
Figure 7.4: Immunoblot analysis with anti-CYP2CII of solubilised hepatic 
microsomes derived from precision-cut human liver slices. Solubilised microsomal 
proteins were resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-, rat CYP2C11 (diluted 
1:1000) followed by peroxidase-labelled anti-mouse IgG secondary antibody (diluted 
1:2000). Letters A to G represents culture time periods i.e. 0, 4, 8, 12, 24, 48 and 72 
hours. All lanes were loaded with lOpg protein.
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Debrisoquine 4-hydroxylase activity was used as a diagnostic probe for CYP2D6, which 
was not measurable even in fresh human liver slices (zero-time point). It is important to 
note that rat liver microsomes were also employed as positive control. Immunoblot 
analysis using antibodies specific to CYP2D6 showed a very slight decrease in 
apoprotein levels during the first 12 hours of culture. Levels then declined rapidly, a 
very faint band being visible after 24 hours which was just detectable following 48 hours 
of culture (Figure 7.5).
Figure 7.5: Immunoblot analysis with anti-CYP2D6 of solubilised hepatic microsomes 
derived from precision-cut human liver slices. Solubilised microsomal proteins were 
resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to nitrocellulose. 
The immunoblot was carried out with anti-human CYP2D6 (diluted 1:500) followed by 
peroxidase-labelled anti-rabbit IgG secondary antibody (diluted 1:2000). Letters A to G 
represents culture time periods i.e. 0, 4, 8, 12, 24, 48 and 72 hours. All lanes were 
loaded with lOpg protein, except for control rat microsomes derived from liver slices, 
where only 5pg were loaded (H).
p-Nitrophenol hydroxylase activity was used as a marker for CYP2E. When activity was 
expressed as per liver slice, CYP2E activity declined by 50, 64 and 90% after 4, 8 and 12 
hours, of culture respectively. Levels then remained stable for up to 72 hours with about 
7% activity still remaining at this time point (Figure 7.6). The pattern in loss of activity
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was very similar when activity was expressed per mg of microsomal protein, with a loss 
of about 42% in activity during the first 4 hours of culture (Figure 7.6). Activity then 
continued to decline rapidly with about 50 and 20% remaining after 12 hours, levels then 
remained relatively stable even following 72 hours of culture.
Using specific antibodies to human CYP2E, immunoblot analysis showed apoprotein 
levels were stable for the first 8 hours of culture followed by a small decrease in band 
intensity after 12 hours with only a faint band being visible following 24 hours (Figure
7.7). Figure 7.7 shows bands above the cytochrome P450 region. The reason for this is 
not known, although it can be pointed out that they are not due to degradation as the 
molecular weight of these bands is higher than those of the cytochrome P450.
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Figure 7.6: Stability of CYP2E activity with culture time. p-Nitrophenol hydroxylase 
activity; 100% activity was 19.8 pmol m in‘ per mg microsomal protein and 11.2 pmol 
min^ per liver slice. All values are expressed as a percentage o f the zero time and 
results are presented as mean o f duplicates.
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Figure 7.7: Immunoblot analysiswith anti-CYP2E of solubilised hepatic microsomes 
derived from precision-cut human liver slices. Solubilised microsomal cultured 
proteins were resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-human CYP2E (diluted 1:000) 
followed by peroxidase-labelled anti-sheep IgG secondary antibody (diluted 1:2000). 
Letters A to G represents culture time periods i.e. 0, 4, 8, 12, 24, 48 and 72 hours. All 
lanes were loaded with 10jug protein. The first lane from the right illustrate the 
molecular weight markers
7.3.1.3 CYP3A Family
Testosterone 6p-hydroxylation was used as the substrate for measuring CYP3A activity 
using an HPLC method of detection. Figure 2.1 (Chapter 2), shows that 6p- 
hydroxytestosterone peak co-eluted with 16a-hydroxytestosterone, but because 6p- 
hydroxytestosterone is the major metabolite in humans, the peak was considered to be 
that of 6p-hydroxytestosterone.
When activity was expressed as per liver slice or in terms of microsomal protein, no 
difference in the rate of loss in activity was noted. No change in CYP3A activity 
occurred during the first 4 hours of culture, but then activity declined with about 57, 40, 
and 25 % activity remaining after 8, 12, and 24 hours of culture respectively (Figure 7.8). 
No activity was measurable following 48 and 72 hours of culture.
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Figure 7.8: Stability of CYP3A activity with culture time. Testosterone ôf-hydroxylase 
activity; 100% activity was 3.5 nmol m in' per mg microsomal protein and 4.9 nmol min 
' per liver slice. All values are expressed as a percentage o f the zero time and results 
are presented as mean o f duplicates.
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Figure 7.9: Immunoblot analysis with anti-CYP3A of solubilised hepatic microsomes 
derived from precision-cut human liver slices. Solubilised microsomal cultured 
proteins were resolved by 10% (w/v) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-human CYP3A (diluted 
1:1000) followed by peroxidase-labelled anti-rabbit IgG secondary antibody (diluted 
1:2000). Letters A to G represents the culture time periods i.e. 0, 4, 8, 12, 24, 48 and 72 
hours. All lanes were loaded with 10 pg protein. The first lane from the left illustrates 
the molecular weight markers.
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Immunoblot analysis of CYP3A apoprotein levels revealed a gradual decline with culture 
time to non-detectable levels after 72 hours (Figure 7.9).
7.3.1.4 CYP4A Family
+((0- 1)
The C O -hydroxylase activity towards lauric acid was used as an indicator of CYP4A 
A
activity. CYP4A activity was not detectable at any time point even in fresh human liver 
slices (zero-time point). Although immunoblot analysis showed the presence of CYP4A 
immuno-related protein, it should be noted that the antibody used was raised to rat 
CYP4A. Figure 7.10 shows a gradual decline in CYP4A apoprotein levels with culture 
time to undetectable levels after 72 hours.
Figure 7.10: Immunoblot analysis with anti-CYP4A o f solubilised hepatic microsomes 
derived from  precision-cut human liver slices. Solubilised microsomal cultured 
proteins were resolved by 10% (wdv) SDS PAGE and transferred electrophoretically to 
nitrocellulose. The immunoblot was carried out with anti-rat CYP4A (diluted 1:5000) 
followed by peroxidase-labelled anti-sheep IgG secondary antibody (diluted 1:2000). 
Letters A to G represents the culture periods i.e. 0, 4, 8, 12, 24, 48 and 72 hours. All 
lanes were loaded with 20pg protein, except for clqfibrate-induced rat liver microsomes 
derived from liver slices where only 5pg were loaded (H)
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7.3.1.5 NADPH-Cytochrome c Reductase
This is an important component of the cytochrome P450 system and its activity was, 
therefore, measured in human liver slices. When enzyme activity was expressed as per 
liver slice, there was a decline of about 27, 40, 60, and 66% in activity after 4, 8, 12, and 
24 hours of culture respectively (Figure 7.11). Activity continued to decline more 
gradually with approximately 10% remaining after 72 hours. When expressed in terms 
of microsomal protein, a similar pattern in the loss of activity was observed, although the 
drop in activity appeared to be less rapid (Figure 7.11). There was a decline of about 7, 
20, 35 and 57% in activity during the first 4, 8, 12, and 24 hours of culture. Loss in 
activity after this time point was very gradual, with about 32% activity still remaining 
following 72 hours of culture (Figure 7.11).
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Figure 7.11: Stability o f NADPH cytochrome P450 reductase activity with culture 
time. All values are expressed as a percentage o f the zero time, 100% activity was 42.2 
nmol min^ per mg microsomal protein, and 23.6 nmol min- per liver slice. Results are 
presented as mean o f duplicates.
Chapter 7; Stability o f Phase I and Phase II Drug Metabolising Enzymes in Human Hepatic Slices 2 0 7
7.3.2 Microsomal and Cytosolic Protein Levels in Human Hepatic Slices in Long­
term culture
Microsomal protein content decreased rapidly during the first 12 hours of culture to 
about 50% of its initial value (Figure 7.12), and then gradually declined to about a third 
of its initial value after 72 hours of culture. No dramatic change in cytosolic protein 
levels was apparent during the first 12 hours of culture (Figure 7.13). Following this 
time point, protein levels declined were very gradually to about half the initial value after 
72 hours in culture.
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Figure 1 A lxM icrosom alprotein content o f human liver slices in long term culture.
Results are present as mean o f duplicates
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Figure 7.13: Cytosolic protein content o f human liver slices in long term culture.
Results are present as mean o f  duplicates.
7.3.3 Stability of Phase II Drug Metabolising Enzymes
7.3.3.1 Total glutathione
Total glutathione levels did not ehange during the first 4 hours in eulture. After 8 hours 
there was a 25% drop in the levels followed by a transient increase after 12 hours (Figure 
7.14). Levels then declined rapidly, with about 40% of the initial value remaining 
following 24 hours of eulture. Levels then remained stable for up to 48 hours, with 
about 51% of the initial level still remaining.
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Figure 7.14: Stability o f total glutathione in human liver slices. All values are 
expressed as a percentage o f  the zero time, 100% level was 8.3nmol per liver slice. 
Results are presented as mean o f duplicates.
7.3.3.2 Glutathione reductase
Changes in glutathione reducatase activity were very much dependent on whether 
activity was expressed per mg cytosolic protein or per liver slice. When expressed in 
terms of per mg cytosolic protein, glutathione reductase activity appeared to remain 
fairly constant for up to 72 hours (Figure 7.15). However, when activity was expressed 
as per liver slice, then a gradual decline was observed with culture time with only about 
50% of the initial activity remaining following 72 hours of culture.
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Figure 7.15: Stability o f glutathione reductase activity following long-term culture. All
values are expressed as a percentage o f the zero time, 100% activity was 44,4 nmol min^ 
per mg cytosolic protein and 49.7  nmol min^ per liver slice. Results are presented as 
mean o f duplicates.
7.3.3.S Glutathione S-transferase
Cytosolic glutathione S-transferase activity was monitored using the substrates, CDNB 
and DCNB. However, no activity was measurable using the latter as the glutathione- 
accepting substrate. When the former served as the substrate, after 4 hours of culture, 
activity was nearly double that of the initial value (Figure 7.16). The pattern of changes 
in glutahtione S-transferase activity started to differ after 12 hours of culture depending 
on how the activity was expressed. When expressed per mg cytosolic protein, activity
Chapter 7; Stability o f Phase I and Phase II Drug Metabolising Enzymes in Human Hepatic Slices 211
appeared to remain stable with values equal to those of the zero time point even after 48 
hours, but then gradually declined with about 60% activity still remaining following 72 
hours of culture (Figure 7.16). However, loss of activity appeared more rapid when 
expressed as per liver slice, with about 60 and 25% activity remaining after 48 and 72 
hours culture respectively.
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Figure 7.16: Stability o f glutathione S-transferase activity following long-term culture.
All values are expressed as a percentage o f the zero time, 100% activity was 727.8 nmol 
min^ per mg cytosolic protein and 815.1 nmol min^ per liver slice. Results are presented 
as mean o f duplicates.
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7.4 DISCUSSION
To date very little information is available concerning the maintenance of the drug 
metabolising enzyme activities in human liver slices during culture. The majority of 
publications have so far been related to the in vitro induction of human cytochrome P450 
isoenzymes (Lake et ah, 1996a, 1997, and 1998). Decline in the human CYP1A2, 
CYP3A and CYP4A over a 72 hour time period has been previously reported (Lake et 
ah, 1996a, 1997), but only one time point was used in this study. However, a very recent 
study has evaluated the catalytic activities of drug metabolising enzymes in human liver 
slices for up to 4 days in culture (Vandenbranden et al., 1998).
The principal objective of the present study was to determine the stability of the Phase I 
and Phase II drug metabolising enzymes in commercially available human liver slices 
following long-term culture using diagnostic substrates and immunologically using 
Western blotting methods. Upon receipt of human tissue, metabolic viability o f the liver 
slices were assessed using the substrate 7-ethoxycouramin (for data refer to Chapter 6, 
section 6.3.2).
Due to the limited availability of a regular supply of human tissue and also the heavy 
cost, the present study was carried out utilising liver slices from only two humans. In 
addition, on occasions when human liver slices were available, on culturing for up to 72 
hours, analysis of metabolic viability using the substrate 7-ethoxycoumarin, revealed that 
the liver slices were not viable upon receipt. A lot of effort was made to use the same 
human subject for the determination of Phase I and Phase II enzyme systems as well as 
apoprotein levels, but this was not practically feasible. Therefore, donor 2 was used to
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Study the stability of CYPlAl, CYP1A2, CYP2E, CYP4A, NADPH cytochrome c- 
reductase and the Phase II enzymes. The other donor was used to investigate the 
stability of CYP2C, CYP3 A and CYP2D; in addition to the stability of cytochrome P450 
apoprotein levels with culture time (Donor 3).
The present study demonstrates that the rate of decline in individual enzyme activities 
may vary depending on whether activity is expressed in terms of per mg 
microsomal/cytosolic protein or as per liver slice. When expressed as per liver slice the 
rate of loss in activity almost always appears to be more rapid. When activities are 
expressed as per liver slice, the loss of protein during culture is not taken into account. A 
rapid decline in microsomal protein levels was observed during the first 12 hours of 
culture whereas cytosolic protein levels remained relatively stable suggesting that the 
cytosolic enzymes are generally more robust than the membrane-bound microsomal 
enzymes, and this is reflected in the stability of glutathione S-transferase and glutathione 
reductase activity. Whether the loss of protein is as a result of its decreased synthesis, 
increased breakdown, or a combination of these remains to be established. It is 
important to point out that the liver slices retain their ability to respond to cytochrome 
P450 inducing agents (Gokhale et al, 1995: Lake et al, 1993), implying that enzyme 
synthesis, and therefore, protein synthesis, is operative during the culturing process.
7.4.1 Cytochromes P450
In general, the activities of the cytochrome P450 isoforms studied decreased with culture 
time, although rate of decline varied amongst the different families. There was a marked 
difference between CYPlAl and CYP1A2 activities in culture. During the first 4 hours
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there was a loss of approximately 38% in CYPlAl activity but only a 10% loss in 
CYP1A2. CYPlAl activity then gradually declined to non-measurable levels after 48 
hours. Although, CYPl A2 activity also decreased with time there was still a substantial 
level of activity (40%) present after 72 hours of culture. Using the substrate 
ethoxyresorufin, Vandenbranden et al., (1998) studied CYP1A2 activity, and concluded 
that activity was highly variable among the slices fi*om different human livers. Out of 
the three donors studied the authors reported that two had no CYP1A2 activity after 48 
hours and the other had only about 10% activity still remaining after 72 hours of culture.
Immunoblotting methods utilising antibodies specific to CYPlAl and CYP1A2 showed 
only one band, the intensity o f which gradually declined with culture time. It can be 
assumed that this band is in fact CYP1A2, because CYPlAl is mainly an extrahepatic 
enzyme (Kawajiri and Hayashi, 1996). The immunoblot does not correlate well with the 
enzyme activities, but, it is important to note that different human subjects were used for 
the determination of enzyme activities and apoprotein levels, and in fact the donor used 
to study CYPlAl and CYPIA2 activity was a very heavy smoker (1 packet/day for 40 
years). Studies have shown that tobacco induces CYPlAl activity in the lung and 
human placenta (Sesardic et al, 1990) and in rats smoking has been shown to induce 
hepatic CYPlAl (Godden et al, 1987). This may also occur in humans, which may 
explain the high activity in CYPlAl observed in the present study. In contrast the 
subject used for the apoprotein study, was a non-smoker. It is also pertinent to point out 
that ethoxyresorufin 0-deethylase is also catalysed by CYP1A2, albeit at lower rates 
compared to CYPlAl (Namkung et al, 1988). It is, therefore, conceivable that the O- 
deethylation of ethoxyresorufin reflects largely CYP1A2 activity. Of interest is the
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observation that in untreated rats CYP2C6 is responsible for most of the ethoxyresorufin 
0-deethylase activity (Burke et ah, 1994).
CYP2C9 and CYP2D6 activities were not measurable even at zero time, possibly
suggesting that the donor maybe deficient in these two isoforms. However, CYP2D6
CYP2D
apoproteins was detected, but the levels were markedly lower compared to the r^ . It is 
important to note that the same human donor was used for the immunological and ^ 
substrate analysis, and the detection of this apoprotein is an indication that this subject 
was not deficient in the CYP2D6 protein. The activity of the CYP2C10 was not 
determined in the present study; however, apoprotein levels were measured and revealed 
a gradual decline with culture time. Apoprotein levels o f the CYP2C9 subfamily were 
not investigated due to the unavailability o f antibodies. Vandenbranden et ah, (1998) 
has shown that the catalytic activity o f CYP2C9 was very variable amongst the different 
human subjects, complete loss of activity ranged fi*om 8 to 72 hours. Activity of the 
CYP2E subfamily was fairly rapid during the first 12 hours in culture but then remained 
relatively stable with about 20% activity still remaining after 72 hours of culture.
No change in CYP3A activity was observed during the first 4 hours of culture, which 
then declined with about 57% and 40% activity still remaining after 8 and 12 hours of 
culture respectively. Following this time point, activity declined gradually to non- 
detectable levels at 48 hours and onwards. Immunoblot analysis showed a gradual loss 
in CYP3 A apoprotein levels, with culture time, with no band being visible after 72 hours 
of culture.
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The flavoprotein, NADPH-cytochrome P450 reductase is an essential component of the 
cytochrome P450-dependent drug oxidation system. It was therefore, considered 
pertinent to study the activity of this flavoprotein in precision-cut human liver slices. 
Although there was loss of activity with culture time a substantial amount (32%) was 
still measurable even after 72 hours. It can therefore, be concluded that the cytochrome 
P450 reductase is not likely to be the limiting factor accountable for the loss of P450 
activity in human liver slices in culture.
In conclusion there were important differences in the rates of loss o f the individual 
human cytochrome P450 enzyme activity with culture time. The stability o f the P450 
iso forms can be compared in two ways, (a) short term culture (0-12 hours) and (b) long 
term culture (24-72 hours) (Table 7.3). This is because there may be a rapid decline 
during the first 12 hours of culture, but then levels may remain stable for up to 72 hours, 
for example CYP2E. On the other hand loss of catalytic activity may be very gradual 
during the first few hours in culture, for example CYP1A2 and CYP3A.
Degree of stability
Cytochrome P450 Short term culture Long term culture
lA l 3 3
1A2 2 1
2D6
2E1 4 2
3A4 1 3
4A
Table 7.3: Stability o f cytochrome P450 isoforms in human liver slices in both short 
and long term culture. Cytochrome P450 activities graded according to their stability 
in culture, 1 being the most stable and 4 the least. No activity was detected for CYP2D6 
and GYP4A.
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7.4.2 Phase II enzyme activities
The cytosolic glutathione S-transferase activities were monitored using CDNB and 
DCNB (Awasthi et al, 1994; Habig et al, 1974). When DCNB was used as the 
glutathione-accepting substrate, no activity was measurable; this is because most of the 
human GSTs characterised so far have relatively higher GSH-conjugating activity 
towards CDNB as compared to other substrates. The minor isoenzyme GST 0, 
characterised from human liver is an exception since it shows no detectable activity 
towards CDNB,/?-nitro^benzylchloride being its preferred substrate (Meyer et al, 1991). 
Interestingly, a doubling of glutathione S-transferase activity was noted after the first 4 
hours in culture as compared to the initial activity. Enzyme activity then declined but 
there was a considerable amount (70%) still remaining, even after 72 hours in culture. 
Using the substrate 7-hydroxycoumarin, Vandenbranden et al (1998) demonstrated that 
sulphotransferase activity, although variable amongst different humans, declined at a rate 
similar to those of the cytochromes P450, in contrast to the present study. Although no 
activity was measurable after 72 hours, one of the human subjects in the above study still 
had about 40% activity even after 72 hours of culture. Glutathione reductase activity 
appeared to be a robust enzyme, with activity remaining intact even after 72 hours in 
culture. Total glutathione levels, were relatively stable during the first 12 hours and then 
declined with about 40 and 50% activity remaining following 24 and 72 hours, 
respectively. Together these observations indicate that human liver slices retain an intact 
glutathione S-transferase system even after 72 hours of culture. Earlier studies have 
shown that the Phase II conjugating system is also maintained in precision-cut rat liver 
slices during long culture periods (Hashemi et al, 1999a).
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In agreement with Vandenbranden et al. (1998), the present study shows that human 
cytochromes P450 decline in culture. It is important to note that this study utilised the 
dynamic organ culture system, and an incubator gassed with 95%Û2 / 5% CO2, whilst in 
the present study liver slices were cultured using the 12-well plate system in an incubator 
gassed with 95% air / 5% CO2 . It can therefore, be concluded that the method of culture 
and the use of 95% air as opposed to 95% O2 does not have a major affect on the stability 
of cytochromes P450 or the Phase II enzyme systems. In addition, these authors used 
whole homogenates for determination o f Phase I and Phase II enzymes as opposed to 
microsomal and cytosolic preparations, as was carried out in the present study. The use 
of whole homogenates may result in interference by non-microsomal enzymes, which 
may act on metabolic products of the cytochrome P450 system. Despite this obvious 
disadvantage, the majority of studies utilising tissue slices have employed whole 
homogenates for studying drug metabolising enzymes (Vandenbranden et al, 1998; 
Lake et al, 1997,1996a, 1993; Gokhale et al, 1997, 1995).
It is also pertinent to point out that Vandenbranden et al (1998) investigated solely the 
catalytic activities of drug metabolising enzymes and did not determine the levels of 
cytochrome P450 apoprotein. When activity was not measurable at zero time, the 
authors assumed that the human subject was deficient in that particular cytochrome 
P450. However, in the present study no CYP2D6 activity was measurable at zero time, 
but apoprotein levels were clearly detectable; therefore, the subject was not deficient in 
CYP2D6, but could be a CYP2D6 poor metaboliser of debrisoquine. The current study, 
and those described in chapter 4 clearly show that the cytochromes P450 do not lose their 
activity in a similar fashion. Consequently, it is conceivable that by the time the human
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liver slices are received by any laboratory, loss in activity of a particular P450 isoform 
may already have occurred.
7.4.3 Conclusion
In conclusion, the data presented in this study clearly show that the cytochromes P450 do 
not survive well in precision cut human liver slices with a considerable amount of 
activity being lost by 24 hours. In addition, the loss of activity of the different isoforms 
does not occur in the same time-dependent way; therefore, when this in vitro method is 
used the ratio of metabolites of a given xenobiotic may be different to that generated in 
vivo. Furthermore, the Phase II enzymes investigated appear to be far more robust than 
the Phase I enzyme systems and are even measurable after 72 hours in culture. As a 
result the metabolic profile of a given xenobiotic may alter in favour of Phase II 
metabolism if cultured beyond 8 hours. Therefore, further studies are required to 
determine a suitable culture system capable of maintaining cytochromes P450 in 
precision-cut human liver slices in long-term culture. Until then, care must be taken in 
the interpretation of the in vitro metabolite profile of compounds and the subsequent 
extrapolation of the data to the in vivo system.
CHAPTER 8
The Role of Cytochrome P450 Isoforms 
in the Metabolism of Melatonin
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8.1 INTRODUCTION
Over the past few years, the use of melatonin as a dietary supplement has increased 
significantly, as reflected by its sales, which now exceeds those of vitamin C in the United 
States (Bonn 1996). Despite the widespread use and the unrestricted availability of 
melatonin, little is known regarding its safety, and its potential to participate in drug 
interactions.
Melatonin (V-acetyl-5-methoxytryptamine) plays an important role in conveying the clock 
and calendar information to all living organisms, including man. This hormone is 
synthesised mainly in the pineal gland, and to a lesser extent, by extrapineal tissues such as 
the retina, Harderian gland, and gastrointestinal tract. The melatonin generating system is 
characterised by three basic features: (1) photosensitivity, (2) diurnal (or circadian) 
rhythmicity (with highest levels of the hormone production occurring at night), and (3) an 
age-related decrease in its activity.
8.1.1 T herapeutic Benefits o f  M elatonin
The availability of a compound able to rapidly shift the biological clock can benefit a large 
number of people. Circardian rhythm disturbance is associated with shift work, jet-lag, 
blindness, insomnia and old age. Until recently, bright light in suitable intensity and duration 
has been the only treatment. However, the role of melatonin in this area has become more 
evident.
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Studies have shown that large doses of up to 6.6 g during the day have no beneficial effects 
on patients suffering firom Parkinsons, Huntingdons chorea, schizophemia and depression 
(on the contraiy, the degree of depression was worsened). In addition it was found that 
such large doses of melatonin may lead to headache and abdominal cramps. Lower doses (2 
mg intranasally, 10-240mg by oral or intravenous administration) of melatonin still have the 
ability to induce transient sleepiness or sleep but is unable to maintain sleep as efficiently as 
conventional hypnotics (Arendt, 1988).
8.1.L I  Blindness
It is believed that about one third of blind individuals with sleeping problems may benefit 
from exogenously administered melatonin (5 mg) at bed-time. Such levels of melatonin are 
thought to stabilise the onset of sleep (Arendt and Aldous, 1988). However, only a limited 
number of studies have been reported in this area.
S.1.1.2 Insomnia
Patients suffering from delayed sleep phase insomnia (DSPI) are unable to sleep at socially 
acceptable hours at night, and sleep onset is delayed until early hours of the morning, and 
therefore, such individuals sleep during most of the day. Bright light in the early morning 
has been used to treat this condition by inducing phase advances of the clock. This 
treatment has been used successfiiUy although other studies have shown that the ingestion of 
melatonin (5 mg) at 2000 hours also advances sleep time significantly (Dahlitz et al, 1991).
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In recent studies using ten elderly patients suffering from chronic primary insomnia, 
melatonin (3 mg) dramatically improved sleep disturbances in elderly insomniacs (Monti et 
al, 1999).
8.LL3 Jet Lag and Shift Work
Studies have shown that jet lag both westwards and eastwards, can be reduced on average 
by 50% with properly timed treatment with melatonin (Arendt, 1988). The larger the 
number of time zones the greater the improvement (Nickelsen et al, 1991). Melatonin 
under these conditions leads to improved quality of sleep and greater daytime alertness, 
although a minority of subjects (10%) actually feel worse after melatonin administration 
(Skene et al, 1989). To date neither the dose nor the timing of melatonin administration has 
been fully optimised.
Very little research has been carried out on the use of melatonin in shift work although 
exposure to bright light during the night is beneficial to night shift workers (Czeisler et al, 
1990).
8.1.1.4 Protective Effects
Melatonin has been reported to reduce proliferation in many cell types, but the effect is small 
and the results are inconsistent. Melatonin, at concentrations of 10"^  to 10’^  M, when 
cultured with an overian adenocarcinoma cell line (BG-1), causes a 20-25% reduction in cell 
number (Petranka et al, 1999). The ability of melatonin to protect against whole body 
irradiation has been recently investigated (Vijayalaxmi et al, 1999). Mice were exposed to
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an acute whole-body gamma radiation dose (815 cGy) and were observed for mortality over 
a period of 30 days. Only 45% of the treated mice were still alive at the end of the 30 days. 
Animals pretreated with 125 mg/kg and 250 mg/kg melatonin exhibited an increase of 60% 
and 85%, respectively, in their survival at the end of the 30 days period. The authors, 
therefore, concluded that melatonin (at a dose as high as 250 mg/kg) is non-toxic, and that 
high doses of melatonin are effective in protecting mice from lethal effects of acute-whole 
body irradiation.
In addition, it is now known that melatonin is a free radical scavenger and antioxidant. It 
detoxifies a variety of free radicals and reactive oxygen intermediates including the hydroxyl 
radical. Moreover, it stimulates several antioxidative enzymes including glutathione 
peroxidase, glutathione reductase, glucose-6-phosphate dehydrogenase and superoxide 
dismutase; conversely, it inhibits a prooxidative enzyme, nitric oxide synthase (Reiter et al, 
1999).
8.1.2 Metabolism and Pharmacokinetics of Melatonin
Melatonin is metabolised primarily in the liver, where it undergoes Phase I and Phase II 
reactions (Figure 8.1). Melatonin undergoes hydroxylation, forming 6-hydroxymelatonin 
which is conjugated leading to the formation of sulphate and glucuronide conjugates. The 
relative amount of sulphate and glucuronide formation is thought to be species-dependent. 
However, studies have shown that in rodents and humans the major metabolite is the 
sulphate conjugate 6-sulphatoxymelatonin, accounting for about 55-80% of metabolism 
(Kveder and Mclsaac, 1961; Arendt, 1988) whilst only about 5-30% is glucuronide
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Figure 8.1: Metabolism of melatonin. Modified from Arendt (1993). (1) Melatonin, (2) 
6-hydroxymelatonin, (3) 6-sulphatoxymelatonin and (4) 6-hydroxymelatonin glucuronide, 
(5) V-acetyl-N2-formyl-5-methoxykynurenaramine and (6) V-acetyl-5- 
methoxykynurenamine, (7) V-acetylserotonin, (8) 5-methoxytryptamine and (9) 5- 
methoxyindole acetic acid.
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conjugated with glucuronide, 6-glucuronylmelatonin (Jones et al, 1969; Kopin et al, 1961; 
Kveder and Mclssac, 1961). 6-Sulphatoxymelatonin (aMT6s) is the major urinary 
metabolite, and has been shown to be a good index of pineal function (Bojkowski et al, 
1987; Young et al, 1985). A very close correlation has been found between plasma 
melatonin levels and both plasma and urinary aMT6s.
In humans and rodents, déméthylation of exogenous melatonin also takes place leading to 
the formation of A-acetyl serotonin glucuronide and sulphate (Leone and Silman, 1984). A 
further route via ring splitting to kynurenamine derivitaves is found in the brain (Hirata et 
al, 1974).
Following an exogenous dose of melatonin, the amount of the parent compound present in 
urine is as low as 0.01% (Vakkuri et a l, 1985). Melatonin has a short half-life, ranging 
between 20-60 minutes depending on species, with a large hepatic first pass effect and a 
biphasic elimination pattern. After an oral dose of melatonin to humans, a large inter­
individual variation (25-fold) has been observed which is thought to be due to the difference 
in absorption (Mallo et ah, 1990; Lane and Moss, 1985).
8.1.3 Principal Aim of the Study
The primary objective of the present study is to evaluate the role of individual cytochrome 
P450 enzymes in melatonin metabolism using the in vitro method of precision-cut rat 
hepatic slices.
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8.2 METHODS
For details of culture conditions and analysis o f the metabolite, 6-sulphatoxymelatonin 
(aMT6s) refer to sections 2.2.3, 2.2.3.3, and 2.2.11.2, respectively.
In order to investigate the role of cytochrome P450 isoforms in the metabolism of melatonin 
in precision-cut rat liver slices, male Wistar albino rats (200-25Og) were treated in vivo with 
established inducers of cytochromes P450 (Table 8.1).
Inducer Principal cytochromes P450 induced Dose
p-Naphthoflavone (BNF) CYP1A1/1A2 25 mg/kg in com oil
Phenobarbitone (PB) CYP2B 80 mg/kg in water
Isoniazid CYP2E 100 mg/kg in water
Dexamethasone CYP3A 30 mg/kg in com oil
Clofibrate sodium CYP4A 80 mg/kg in water
Table 8.1: Treatment o f Wistar rats with known P450 inducers. Animals were given 
single daily intraperitoneal injections for three consecutive days, and were killed on the 
fourth day by cervical dislocation.
Livers from the Wistar rats were excised and slices were prepared and cultured with 
melatonin (50pM), for various time periods. In addition, human liver slices from donor 1 
(for details of the donor refer to chapter 6, Table 6.1) were cultured for up to 6 hours with 
melatonin (50pM). At the end of each time point, the media was removed and analysed for 
the metabolite 6-sulphatoxymelatonin (aMT6s) as described in section 2.2.11.2.
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8.3 RESULTS
8.3.1 U se o f  Precision-C ut L iver Slices to D eterm ine M etabolism  o f  M elatonin
8.3.1.1 Effect o f Culture Medium on Sensitivity o f the Radioimmuno Assay (RIA)
The radioimmuno assay is always carried out to detect the metdbolite in urine, using tricine 
buffer only. However, to determine the metabolite, 6-sulphatoxymelatonin in the present 
study, aliquots of the culture medium had to be used. Therefore, it was necessary to assess 
the affect of the medium on the sensitivity of the assay. Three different standard curves 
were set up, (a) using tricine buffer only, (b) 10 pi culture medium plus tricine buffer, and 
(c) 100 pi culture medium plus tricine buffer. The total volume in each tube was 900pl at all 
times.
The three standard curves were virtually superimposed upon each, suggesting that the 
supplemented culture medium had no effect on the sensitivity of the assay (Figure 8.2). Since 
the use of 10 pi of medium showed the least interference with the tricine standard curve, aU 
subsequent studies were carried out using 10 pi of culture medium. In order to obtain 
results that fall within the range of the standard curve, samples had to be diluted accordingly. 
It is important to note that the same dilution factor was used for each standard curve.
8.3.1.2 Cumulative Metabolism o f Melatonin by Precision-Cut Rat Liver Slices
In order to investigate the metabolite of melatonin, sulphatoxymelatonin, rat liver slices 
were cultured in the presence of melatonin (50 pM) for various time points up to 72 hours. 
Liver slices readily metabolised melatonin in a time-dependent fashion for up to 5 hours, 
after which levels of aMT6s started to plateau (Figure 8.3). But after 24 hours incubation, 
the levels of aMT6s formed was approximately double those produced after 8 hours.
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Figure 8.2: Effect o f culture medium on 6-sulphatoxymelatonin (aMT6s) standard 
curve.
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Figure 8.3: Cumulative metabolism o f melatonin to 6-sulphatoxymelatonin by precision- 
cut rat liver slices. Liver slices were cultured in the presence of melatonin (50pM) for 
various time periods of up to 72 hours. Results are presented as Mean ±  SEM for 3 
animals. Each culture time was carried out in duplicate, similarly each analysis was 
carried out in duplicate. Liver slices were prepared from control rats.
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8.3.1.3 Cumulative Metabolism of Melatonin by Precision-Cut Human Liver Slices
Precision-cut human liver slices also metabolised melatonin in a time-dependent fashion 
(Figure 8.4). The formation of the metabolite, 6-sulphatoxymelatonin, suggests that the 
human liver slices are capable of metabolising melatonin and that the slices were 
metabolically viable for at least 5 hours in culture.
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Figure 8.4: Cumulative metabolism of melatonin to 6-sulphatoxymelatonin by precision- 
cut human liver slices. Liver slices from donor 1 were cultured in the presence o f  
melatonin (50juM) for up to 5 hours. Results are presented as mean o f duplicate cultures. 
Each analysis was carried out in duplicate.
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8,3,1.4 Metabolic viability of Precision-Cut Rat Liver Slices using Melatonin as the 
Substrate
In order to assess metabolic viability of the slices, they were preincubated for various time 
periods, and at the end of each time point, melatonin (50 pM) was added. Slices were then 
cultured for another hour, to allow metabolism to occur.
Figure 8.5 shows that rat liver slices were metabolically viable for at least 8 hours. Levels of 
the metabohte 6-sulphatoxymelatonin formed following 8 hours preincubation were almost 
the same as freshly cultured tissue slices i.e. zero hour preincubation time. After 24 and 72 
hours of incubation, the levels of 6-sulphatoxymelatonin were approximately 50%, and 25% 
the initial value, respectively. Therefore, although metabolic viability declined gradually with 
time, sufficient levels of the metabolite were still detectable even after 72 hours of culture.
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Figure 8.5: Metabolic viability of precision-cut rat liver slices using the substrate melatonin.
Liver slices from Wistar rats were incubated for various time periods up to 72 hours; at the end 
o f each time point, melatonin (50juM) was added and slices were allowed to incubate for a 
further 1 hour. Results are presented as Mean ±  SEM for three animals. Each time point was 
carried out in duplicate, and analysis o f the metabolites were similarly carried out in duplicate. 
Liver slices were prepared from control rats.
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8.3.2 R ole o f  C ytochrom e P450 Isoform s in the M etabolism  o f M elatonin
83,2,1 Effect o f Cytochrome P450 Inducers on Metabolism of Melatonin
To determine the role of different cytochrome P450 isoforms in the metabolism of 
melatonin, Wistar rats were treated with different P450 inducers (for details refer to Table 
8.1). Precision-cut liver slices were then prepared and cultured in the presence of melatonin 
(50 pM) for various time periods up to 5 hours, and the levels of 6-sulphatoxymelatonin 
were determined in the culture medium.
A time-dependent increase in the formation of the metabolite was observed irrespective of 
the type of P450 inducer used. However, the rate of metabolism, as assessed by the levels 
of metabolite produced, varied depending on the type of inducer. The most dramatic effect 
was observed with the use of precision-cut liver slices prepared from phenobarbitone- and 
p-naphthoflavone-treated rats (Figure 8.6). Phenobarbitone appears to increase melatonin 
metabolism to the 6-sulphatoxymelatonin metabolite by at least 2-fold, compared to the non­
treated, control animals, and this difference becomes more apparent at later time points. 
However, in comparison to controls, p-naphthoflavone increased the rate of metabolism of 
melatonin by 3 to 4-fold, and again this difference becomes more apparent with culture time 
(Figure 8.6). No significant difference in the rate of metabolism was observed with the 
other enzyme inducers.
It is important to note that some of the inducers were dissolved in distilled water and others 
in com-oü prior to administration to animals. Therefore, two sets of control animals were 
used (a) treated with com-oil only, and (b) treated with distilled water only. However,
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com-oil which was used as a vehicle for the enzyme inducer, had no effect on the 
metabolism of melatonin and because both values were very similar only one set of controls 
is presented in Figure 8.6.
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Figure 8.6: Effects o f cytochromes P450 inducers on the metabolism o f melatonin.
Precision-cut rat liver slices were prepared from Wistar rats treated with known P450 
inducers, and cultured in the presence o f melatonin (50pM) for various time points. After 
specified time periods, the culture medium was analysed fo r  the metabolite 6- 
sulphatoxymelatonin. Results are presented as Mean ±  SEM for three animals. Each 
incubation was carried out in duplicate, similarly each analysis was also carried out in 
duplicate.
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8.3.2.2 Effect o f Cytochrome P450 Inducers on Metabolism o f 6~Hydroxymelatonin
The metabolite, 6-sulphatoxymelatonin, was detected following incubation of liver slices 
from control rats with 6-hydroxymelatonin for 1 hour. But levels of the metabohte 
remained constant for up to 5 hours (Figure 8.7). A similar pattern was observed when liver 
shces from BNF-treated animals were used, although levels of the metabohte measured were 
significantly lower (~ 50%) than those obtained from controls (Figure 8.7). In contrast.
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Figure 8.7: Effect o f cytochrome P450 inducers on the metabolism o f 6- 
hydroxymelatonin. Liver slices from Wistar rats were cultured for up to 5 hours in the 
presence o f 6-hydroxymelatonin (50pM). After specified time periods, the medium was 
analysed for the metabolite, 6-sulphatoxymelatonin. Results are presented as Mean ±  SEM  
for 3 animals. Each time point was carried out in duplicate and each analysis was carried 
out in duplicate.
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6-hydroxymelatonin was metabolised in a time-dependent fashion for up to 4 hours, when 
slices from PB-treated rats were used (Figure 8.7). Levels of the metabolite measured after 
4 hours incubation, were approximately 8- and 3- fold higher that those of the BNF and 
control animals respectively.
8.4 DISCUSSION
Despite the popularity, and unrestricted availability of melatonin as a dietary supplement, 
very little is known regarding its safety and possible drug-drug interactions. The principal 
objective of the present study was therefore, to investigate the role of individual 
cytochromes P450 in the metabolism of melatonin using the in vitro method of precision-cut 
liver slices as set up in earlier studies (Chapter 3 page79).
In rodents and humans melatonin is metabolised primarily to 6-sulphatoxymelatonin 
(aMT6s). The plasma and urinary profiles of aMT6s faithfully reflects both the qualitative 
and quantitative aspects of melatonin secretion in humans, and consequently provide useful 
clinical data of pineal function (Arendt and Aldhous, 1988; Aldhous and Arendt, 1988). The 
radioimmunoassay (RIA) used in the present study is for urinaiy aMT6s (Aldhous and 
Arendt, 1988) which was modified from previously published methods (Arendt et al, 1985). 
Although originally designed for detection of the metabolite in urine, further modifications 
were carried out in order to measure aMT6S in tissue culture medium. It was therefore, 
necessary to revalidate the technique and determine whether the culture medium caused any 
interference. The two different volumes of the culture medium used had no apparent effect 
on the standard curve, both superimposing the standard curve used originally for the assay
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using tricine buffer only. In addition, due to the high concentration of aMT6s produced 
during the incubation, the culture medium had to be diluted accordingly which in turn 
minimised even further any variation that might have occurred in the standard curve.
8.4.1 Metabolic Viability
Metabolic viability of precision-cut rat liver slices was assessed in a previous study using the 
substrate 7-ethoxycoumarin (Hashemi et ah, 1999b). In the present study metabolic 
viability was also assessed but using the endogenous substrate, melatonin (50pM). Liver 
slices were preincubated for various time points, melatonin was added and slices were 
incubated for a further 1-hour. The concentration of the metabolite, aMT6s was then 
determined in the culture medium. No change in the formation of the metabolite was 
observed for up to 8 hours indicating that the slices were metabolically viable. However, 
following 24 hours of culture, the levels of 6-sulphatoxymelatonin were approximately 50% 
of the initial value. After 24 hours the viability of the slices declined gradually, with about 
25% of the initial level present after 72 hours of culture. In agreement with previous studies 
(Hashemi et al, 1999b) liver slices are viable for up to 8 hours in culture using the 12-well 
plate system and although viability declines following this time point, sufficient levels of the 
melatonin metabolite were still detectable even following 72 hours of culture. In contrast 
very low levels of 7-ethoxycoumarin metabolites were detectable after 72 hours culture in 
earlier studies (Hashemi et al, 1999b). This may be because the radioimmunoassay used to 
identify 6-sulphatoxymelatonin is a much more sensitive method of detection than the 
fluorimetric method used to determine 7-ethoxycoumarin metabolites.
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8.4.2.Cumulative Metabolism
In order to establish the linearity of 6-sulphtoxymelatonin generation with time, rat liver 
slices were cultured in the presence of melatonin (50 |iM) for various time periods up to 72 
hours. A linear increase in the production of 6-sulphatoxymelatonin was observed for up to 
5 hours, after which levels started to plateau. As a result for subsequent studies to determine 
the involvement of the cytochromes P450 in melatonin metabolism, liver slices were 
cultured for up to 5 hours. The plateau observed following 5 hours of culture is unlikely to 
be due to decrease in viability of the slices, since the results Jfrom the metabolic viability 
study suggests that no change occurred in the metabolic turnover of melatonin during the 
first 8 hours of culture. However, the plateau is probably due to, insufficient levels of the 
substrate remaining in the culture medium, after 5 hours. It is important to note that in the 
present study only the sulphate conjugated metabolite, 6-suIphatoxymelatonin was measured 
and does not take into account other metabolites such as the, 6-hydroxymelatonin 
glucuronide conjugate.
The cumulative metabolism of melatonin was also determined using human hepatic slices 
(for donor details refer to Chapter 6, Table 6.1). Incubation of human liver slices with 
melatonin resulted in a time-dependent metabolism generating 6-sulphatoxymelatonin. In 
comparison to the rat, slightly higher levels of 6-sulphatoxymelatonin, were formed by the 
human slices. Due to lack of time and limited availability of human tissue, this study was 
only carried out using liver slices from one human subject. Ideally this should be repeated 
utilising liver slices from at least three human donors as undoubtably a large inter-individual 
variation in melatonin metabolism would occur.
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8.4.3 Role of Individual Cytochromes P450 in Melatonin Metabolism 
Incubation of melatonin with liver slices from p-naphthoflavone (BNF)- and phenobarbitone 
(PB)-treated Wistar rats resulted in an approximately 4- and 2- fold increase in 6- 
sulphatoxymelatonin formation respectively. No significant changes in the levels of the 
sulphate conjugated 6-hydroxymelatonin were observed Avith other inducers employed in the 
present study, i.e. dexamethasone, clofibrate and isoniazid. It is well know that p- 
naphthoflavone mainly induces the CYPlAl and CYP1A2 isoforms whilst phenobarbitone 
mainly induces CYP2B1 and to a lesser extent CYP3A (loannides and Parke, 1990; Maurel, 
1996; Nims and Lubet, 1996). Dexamethasone however, primarily induces CYP3A but 
liver slices from dexamethasone pretreated rats showed no difference in the levels of the 
metabolite formation, as compared to the control, suggesting that CYP3A does not play a 
role in the metabolism of melatonin. Similarly no difference in the metabolic turnover of 
melatonin was observed in liver slices from clofibrate- or isoniazid-treated rats, therefore, 
implying that neither CYP2E nor CYP4A play a role in its metabolism to 6- 
sulphatoxymelatonin.
p-Naphthoflavone and phenobarbitone also induce some Phase II enzymes particularly the 
sulphate conjugating enzymes and the possibility that they also induce the sulphate 
conjugation of aMT6s can not be ruled out. Since the metabolite measured is sulphate 
conjugated, in order to determine whether the increase in metabolite formation observed is 
due to induction of cytochrome P450 metabolism rather than the induction of 
sulphotransferases, liver slices from p-naphthoflavone- and phenobarbitone-treated animals, 
were cultured with 6-hydroxymelatonin, and levels of the resulting 6-sulphatoxymelatonin
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were measured as previously described. It is important to point out that 6- 
hydroxymelatonin is very unstable and is readily oxidised, therefore, every attempt was 
made to prevent exposure to light, i.e. when the substrate was added to the culture well 
plates, the plates were immediately covered by aluminium foil prior to incubation.
In comparison to the controls, after 4 hours culture with 6-hydroxymelatonin, there was a 4- 
fold increase in the formation of 6-sulphatoxymelatonin by slices from phenobarbitone- 
induced rats. This is an indication that, at least partly, the induction of 6- 
sulphatoxymelatonin by phenobarbitone may represent an increase in sulphate conjugation of 
melatonin. In contrast, levels of 6-sulphatoxymelatonin by slices from p-naphthoflavone- 
treated rats were actually less than half of those in slices from control animals. It can 
therefore, be concluded that the CYPIA subfamily is involved in the metabolism of 
melatonin to the sulphate conjugate of 6-hydroxymelatonin and the increase in its formation 
observed after treatment with BNF is not the consequence of an increase in sulphate 
conjugation.
A very recent study by Yeleswaram et ah (1999) used p-lymphoblastoid cell lines that were 
engineered to express cDNAs for specific cytochrome P450 isoforms, to study the role of 
cytochrome P450 isoforms in melatonin metabolism. They utilised the following ten 
isoforms: CYPlAl, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, 
CYP2D6, CYP2E1, and CYP3A4. These authors monitored the concentration o f melatonin 
and did not determine the levels of any metabolites. Following incubation with CYPlAl 
and CYP1A2, only 10% and 8% of melatonin, respectively, remained while 3vith the other
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isoenzymes >95% of melatonin remained. The authors concluded that melatonin is 
metabolised only by CYPlAl and CYP1A2 in agreement with the results of the current 
study. It is important to point out that the cytochrome P450 isoforms used by Yeleswaram 
et al (1999) were of human origin.
Only a few of the current therapeutic drugs actually interact with the CYPl family such as 
theophylline and propranolol and these may lead to interactions when co-administered with 
melatonin. Furthermore, administration of certain therapeutic drugs such as omeprazole are 
known to lead to CYPIA induction (Diaz et al, 1990; Rost et al, 1992), whether melatonin 
can also act as an inducer of this subfamily remains to be established.
8.4.4 Conclusion
It can be concluded from the present study that the use precision-cut liver slices is an 
invaluable in vitro technique for studying the metabolism of endogenous substrates. This in 
vitro method was successfiiUy used to determine the role of cytochromes P450 in the 
metabolism of pharmacological doses of melatonin. In conclusion, in agreement with 
Yeleswaram et al (1999), CYPlAl and CYP1A2 may play an important role in the
metabolism of melatonin. It must be emphasised that in the present study pharmacological
j
concentrations of melatonin were used, and the finding from these studies cannot be 
extrapolated to the metabolism of the extremely low physiological concentrations of the 
hormone. Finally, care should be exercised where patients are prescribed drugs that rely on 
CYPIA for their metabolism who also take melatonin supplements.
CHAPTER 9
Discussion
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9.1 DISCUSSION
Development of alternative in vitro models for xenobiotic metabolism and toxicity studies 
have occupied a considerable amount of research time, not only because of public concern 
for animal welfare, but also because of the economic advantages. Moreover, in vitro models 
allow the use of human tissue to enable direct extrapolation of data to humans in vivo.
A number of in vitro models have been used for studying drug metabolism, such as, 
subcellular fractions, isolated or cultured hepatocytes and precision-cut liver slices, the use 
of which have been discussed in Chapter 1, section 1.3. Primary hepatocyte cultures and 
precision-cut liver slices provide a more physiological system than the other in vitro systems 
frequently used e.g. microsomes, as they contain both Phase I and Phase II drug 
metabolising enzymes, and utilise physiological cofactor levels. This is in contrast to 
microsomes whereby xenobiotic metabolic reactions are restricted to Phase I metabolism 
and glucuronidation in the presence of exogenous, non-physiological concentrations of 
cofactors. However, both hepatocyte culture and precision-cut tissue slices have their 
strengths and limitations.
Primary hepatocyte culture is a well-established, and widely employed in vitro procedure
whereby, using special modifications such as co-culture of hepatocytes with rat epithelial 
can be maintained in long-term culture
cells^(Guguen-Guillouzo et al, 1983; Begue et al, 1984). In addition dead cells can easily 
be eliminated from cultures. However, the cell isolation procedure can be difficult and time 
consuming and requires the use of proteolytic enzymes, as a result of which cells undergo a 
number of irreversible biochemical and morphological changes in culture, making 
extrapolation of results to the in vivo situation less certain (Bars et al, 1989; Dich et al.
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1988; Guillouzo 1986; Suoliima and Pitkaranta, 1986; Grant and Hawksworth, 1986; Forster 
et al, 1986). Furthermore, hepatocytes only make up 70-75% of the cell types in the liver, 
and so the use of hepatocyte cultures largely ignores the role of nonparencymal cells such 
as, Kupffer cells, endothelial cells, fat storing cells and pit cells, in xenobiotic metabolism.
Precision-cut tissue slices have a number of advantages over other in vitro systems. Since 
intact tissue is used, all cell types are present and intercellular communication between all 
cell types is active, thus providing a system that closely represents the whole organ, and is 
consequently closer to the in vivo situation. Moreover, morphological evaluation of tissue 
architecture is also possible. Technically speaking, using the same preparation procedure in 
all species, slices are relatively simple to prepare from almost any organ especially those 
that are frequently targets of toxicity, such as the liver (Smith et al, 1985), lung (Price et al, 
1995a, 1995b; Fisher et al, 1994), and kidney (Ruegg, 1994) thus, enabling interspecies 
studies to be carried out far more easily. Precision-cut tissue slices have been successfully 
used in this respect for interspecies comparison of toxicity (Fisher et al, 1991b; Price et al, 
1996), metabolism (Martin and Mclean, 1998; Connors et al, 1996; Steensma et al, 1994) 
hepatic enzyme induction (Drahushuk et al, 1999; Heinonen et al, 1996; Lake et al, 
1996a), and genotoxicity (Lake et al, 1999, 1998, 1996b; Beamand et al, 1998, 1996; 
Baumann ûf/., 1996).
The aim of the present study was to evaluate the use of precision-cut liver slices for studies 
of xenobiotic metabolism. To achieve this objective, the primary step was to establish the 
best culture system with respect to metabolic viability and structural integrity. The culture 
system of choice was then used in subsequent studies to determine the stability of Phase I
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and Phase II xenobiotic metabolising enzymes in long-term culture, using rat and human 
liver slices. This in vitro model was then finally used to investigate the role of cytochrome 
P450 isoforms in the metabolism of an endogenous substrate, melatonin, at non- 
physiological concentrations.
9.1.1 Incubation/Culture Conditions
In order to select a suitable culture system, two incubation systems, namely the dynamic 
organ culture (the most commonly used) and the multiwell plate system were used. 
Histological examination of hepatic slices cultured employing these two systems, showed 
that the slices in the multiwell plate system are viable for longer culture periods than those 
in the dynamic organ culture system. This is in contrast to studies reported by Fisher et al. 
(1995a, 1995b), who concluded that the dynamic organ culture is superior to the multiwell 
plate system. It is important to note that these authors employed only biochemical markers 
to assess viability, and unfortunately no values were provided for the zero time i.e. fresh 
slices; therefore it is difficult to determine the degree of change compared to fresh slices. 
Furthermore, following histological examination, the present study has shown that slices 
incubated in the multiwell plate system are better preserved, but levels of lactate 
dehydrogenase (LDH) leakage were similar in slices employing both culture systems 
suggesting that viability may be dependent on the parameter used.
The increase in the number of laboratories using precision-cut liver slices for xenobiotic 
metabolism and toxicity studies, has led to the development of a number of incubation 
systems and the use of a number of different viability parameters. For comparison of data 
between laboratories, it is essential for culture conditions and viability parameters to be
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standardised. It is important to include histological evaluation as a viability parameter 
because if cells are not maintained morphologically, they are unlikely to represent the in 
vivo situation. Morphological studies are not normally carried out simply because the 
procedure is time consuming and rather laborious. Although in the present study both light 
and electron microscopy were used, electron microscopy does not provide a general 
reflection of structural viability as only a small area of the tissue can be visualised under a 
very high power. Moreover, electron microscopy is a very time consuming technique that 
requires professional training, but light microscopy can illustrate all the cell types across the 
tissue thickness, and necrotic cells can easily be identified.
Using biochemical parameters alone does not give an indication of “real viability”. For 
example, potassium retention is often used to assess the viability of liver slices (Fisher et al, 
1995b; Parrish et al, 1995). However, in a study on the comparison of incubation systems 
and on the cold storage of slices, Olinga et al (1998) reported that the potassium 
concentration in the slice was retained while metabolic capacity clearly decreased. This 
observation tends to support the view that for xenobiotic metabolism studies, the metabolic 
rate of a standard chemical should be included as a viability indicator. It is evident that 
different viability parameters reflect different aspects of cell viability and so the choice of 
viability test should depend on the intended use of the system.
Similarly, the choice of the incubation system also depends on the nature of the experiment. 
Although it is apparent fi*om the current study that the dynamic organ culture system 
(DOCS) is not superior to the multiwell plate system, the DOCS is, however, the best 
system for testing volatile substrates as this system allows the incubation of liver slices in a
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closed environment (glass vial) with the test compound and hence prevents the evaporation 
of volatile substrates. However, the DOCS, does not allow rapid sampling and therefore, 
may not be an appropriate system for kinetic studies or metabolism studies. Consequently, 
there is a need for the standardisation of incubation systems, culture conditions (such as 
oxygen tension, high or low; medium and supplements, e.g. percentage of foetal calf serum 
to be used, and addition of hormones etc.) and viability parameters for both drug metabolism 
and toxicity studies to permit better comparison of data between laboratories.
Liver slices are normally incubated in control medium for periods of up to 2 hours prior to 
the start of any experiment in order for slices to reach equilibrium. This medium is then 
replaced with fresh medium to remove any damaged cells from the surface of slices and 
enzymes such as lactate dehydrogenase (LDH) and alanine aminotransferase (ALT), which 
may have been released from the damaged cells. Such long perincubation times also allow 
the liver slice K^, ATP and protein secretion levels to stabilise (Smith et al, 1986) which are 
important for toxicological studies. For drug metabolism studies however, a short 
preincubation time of about 10-30 min has been recommended (Bach et al, 1996; Worboys 
et al, 1995). The present study has shown a rapid decline in the cytochromes P450 during 
the first few hours of culture, which are iso form specific. It is therefore, vital to keep the 
preincubation time to a minimum to avoid the decline in certain P450 isoforms prior to the 
start of any experiment.
One of the major advantages of precision-cut tissue slice system is the ability to use human 
tissue to enable direct extrapolation to humans in vivo. With organisations being set up to 
supply human tissue slices for research, it was considered pertinent to determine the
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viability of such slices in long-term culture using the substrate 7-ethoxycoumarin, and 
morphologically using light and electron microscopy. Histological examination of cells 
across the thickness of human slices revealed that the cells are preserved very 3vell in their 
transport medium. An interesting observation made was that the results from the 
morphological evaluation showed that human liver slices were better maintained in culture, 
with very few vacuoles present in the cells, as compared to slices from Wistar albino rats. 
This finding was unexpected, mainly because the human liver slices were received 24 -  48 
hours after death, whilst rat liver slices were prepared immediately after being sacrificed. It 
may well be because human liver slices are better preserved than rat liver slices in the 
culture medium (RPMI 1640) used, or the transport buffer (Belzer solution) maintains the 
slices such that morphological changes in culture are at a minimum. An alternative 
explanation is that human livers were perftised, but in the rat liver experiments, the livers 
were not perfused prior to the slicing procedure, so that as a result of aggregation of blood 
cells in the sinusoids, diffusion of nutrients from the culture medium is impaired. But 
recently Price et al. (1998a) reported that perfusion of rat livers with BBSS, prior to 
preparation of tissue cores, does not enhance 7-ethoxycoumarin metabolism in rat liver 
slices. However, the authors used a short incubation time point of up to 120 minutes only. 
Whether the use of perfusion prior to slice preparation, affects structural integrity and helps 
to maintain hepatic cells in long-term culture, remains to be established. It is important to 
note that due to cost and lack of time, only one human donor was used for morphological 
studies, and consequently this study should be considered as preliminary work.
Currently it is assumed that the same culture medium/conditions can be used for maintaining 
tissue slices from different species. The medium used in the present study, RPMI 1640, has
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been used to culture liver slices from rat, mouse, guinea pig, cynomolgus monkey (Steensma 
et al, 1994) and human (Lake et al, 1998, 1997) in order to study species differences. 
However, fiirther studies should be carried out to determine the optimal culture conditions 
for liver slices from different species to ensure that any differences in the rate of metabolism 
or metabolites formed are solely due to differences between species and not because of the 
composition of the medium.
Metabolic viability o f human liver slices revealed that slices metabolised 7-ethoxycoumarin 
for up to 72 hours, although there was a significant decline in the levels o f metabolites 
formed following 24 hours of preincubation time, implying that this is a good system for 
determination of xenobiotic metabolism for at least 24 hours in culture. In contrast to both 
Wistar albino and Sprague-Dawley rats, a large variation in the metabolic turnover of 7- 
ethoxycoumarin was observed by human liver slices, both between donors, and liver slices 
from the same human donor, the possible reasons for which have been discussed in Chapter 
6, section 6.4. The differences noted, particularly between slices from the same donor, are 
of major concern as commercially available slices are increasingly being used for 
metabolism studies. It is therefore, recommended that a number of slices are used per time 
point in order to gain a better understanding of the in vivo situation.
Olinga et al (1998) investigated the effect of human liver source on the functionality of 
liver slices and isolated hepatocytes. The authors utilised (a) healthy liver tissue from 
patients undergoing partial hepatectomy and (b) donor tissue remaining after reduced-size or 
split-liver transplantation. There are fundamental differences in the use o f these two liver 
sources. Donor tissue is usually perfused with cold UW solution and does not lead to warm
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ischaemia, and cold preservation in UW solution can be carried out for up to 39 hours. But 
warm ischaemia of the liver tissue occurs during surgical procedures for hepatectomy 
(ranging from 5 to 115 minutes), and cold preservation in UW solution is limited to only 10- 
30 minutes. Using liver slices prepared from these two sources, Olinga et al (1998) 
reported that after 1 hour of incubation, potassium concentration in the liver slices from (b) 
was significantly higher than that in the slices from (a). Using lidocaine dééthylation as a 
measure of Phase I metabolism, slices from (a) produced significantly lower levels o f the 
metabolite compared to slices from (b). Interestingly no difference was reported between 
hepatocytes isolated from the two different sources. The authors therefore, concluded that in 
contrast to hepatocytes, the source of the human liver influences the functions of the liver 
slices.
Like every other technique the use of commercially available precision-cut human liver 
slices has its limitations, for example:
(a) Expense,
(b) Tissue availability,
(c) Variation in viability of slices from the same donor, and
(d) No prior knowledge of slice integrity upon receipt: for each experiment or experimental 
time point, slices must also be cultured for viability tests. At the end of the specified 
culture time point of, for example 72 hours, viability tests might reveal that liver slices 
were not viable upon receipt, thus valuable time and effort is wasted.
With increasing success in transplantation procedures in recent years, availability o f human 
tissue for research purposes is likely to become even more scarce. Proper cryopreservation
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can provide a more efficient use of the available human liver, allowing access to tissue at 
convenient hours. Cryopreservation o f liver slices can be of great benefit in drug 
development, as preservation of liver slices from different species including humans, can be 
used to select the best animal model for toxicity studies. A number of studies have been 
reported using different cryoprotectants and different freezing methods (De Kanter and 
Koster, 1995; Chesne et ah, 1993; Wishnies et al, 1991; Coundouris et al, 1990). 
Cryopreservation of liver slices is thought to be more successful than of isolated 
hepatocytes. Recovery of viable cells after thawing of cyropreserved human and rat 
hepatocytes is normally low (Coundouris et al, 1990 and 1993; Chesne et al, 1993). 
Furthermore, metabolic activity o f hepatocytes declines especially the Phase II enzymes 
(Adams et al, 1995; Diener et al, 1995; Diener and Oesch 1995; Coundouris et al, 1993). 
De Kanter and Koster (1995) have shown after thawing, Phase I and Phase II drug 
metabolising activity, is retained in liver slices. But further studies are required to perfect 
the art of cyropreservation of precision-cut tissue slices and the subsequent maintenance o f 
the slices in long term culture.
9.1.2 Stability of Cytochromes P450 in Culture
When determining the metabolism o f a given xenobiotic in vitro, it is important that the 
cytochrome P450 profile is maintained. The majority of studies have reported the induction 
of cytochrome P450s in precision-cut liver slice (Gokhale et al, 1997; Lake et al, 1996a; 
Gokhale et al, 1995), and only a limited number of studies have investigated the 
maintenance of cytochromes P450 in precision-cut liver slices (Vandenbranden et al, 1998). 
Although, earlier studies have shown that like hepatocyte cultures, total cytochrome P450 
content also declines after the first 24 hours of culture, in precision-cut liver slices (Wright
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and Paine, 1992). It has been reported that there is a loss of 70% in cytochrome P450 
concentration of primary cultures of rat hepatocytes over long culture periods of 24 hours 
(Paine and Legg 1978), although others have shown a decline of greater than 80% (Guzelian 
et al, 1977; Bissele/^n/., 1973).
The present study clearly demonstrates that cytochrome P450 activity is lost in precision-cut 
rat and human liver slices during long culture periods, and that the rate of decline is iso form- 
specific. Furthermore, the decline in cytochrome P450 activities in precision-cut liver 
slices, is not mirrored by a decrease in their corresponding apoprotein levels as detected 
immunologically. This may be because the loss of cytochromes P450 is associated v\dth a 
lack of haem prosthetic group incorporation into the apo-cytochrome. Steward et al (1985) 
reported a marked heterogeneity in the rates at which individual P450 forms are lost in 
hepatocyte culture, and that the cell culture conditions exert dramatic and selective effects 
on the concentrations of some of the P450 apoproteins and on the retention o f their haem 
prosthetic group. One other explanation may be that immunoblotting is a relatively sensitive 
method of detecting proteins, and thus the antibody may identify the apoprotein even if a 
small change in the apoprotein has occurred during culture. The NADPH-dependent 
reduction of cytochrome c, an indicator of the integrity of electron transfer to cytochrome 
P450, was still significantly active following 72 hours of culture, indication that a decline in 
cytochrome P450 activity in the intact slice is unlikely to be due to impairment of the 
electron transport chain.
The loss in P450 content in primary hepatocytes was originally thought to be due to the 
collagenase digestion routinely used for the isolation of cells. However, Wright and Paine
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(1992) reported that over a period of 48 hours cultured hepatocytes isolated by EDTA 
perfusion showed comparable losses of cytochrome P450 as cells isolated by perfusion with 
collagenase.
In primary hepatocyte cultures, the loss of P450 can be prevented by culturing the cells in a 
medium containing anyone of a number of pyridines that form ligands with cytochrome 
P450 (Paine and Villa 1980). Ligands protect protein from degradation (Ballard, 1977), the 
most potent being metyrapone (2-methyl-l,2-di-3-pyrindyl-propanone) and 3- 
hydroxypyridine (Paine et al, 1980). The mechanisms underlying the loss of cytochrome 
P450 in cultured hepatocytes are impaired synthesis and enhanced degradation, and these 
ligands maintain cytochrome P450 by affecting both processes (Paine and Villa, 1980). 
Furthermore, this decline can also be prevented partially by cycloheximide (Guzelian and 
Barwick, 1979), and may be associated with an increase in the activity of haem oxygenase 
(Bissel and Guzelian, 1975). Haem oxygenase is the rate-limiting enzyme in haem 
degradation and regulates the cellular content of haem (Immenschuh et al, 1998), thus 
further studies should be carried out to determine the fate of this enzyme in precision-cut 
liver slices in long-term culture. Addition of ô-aminolevulinic acid, dihydroxyacetone, 
ascorbic acid, and adenine to cell culture medium can also prevent, to some extent the 
decrease in cytochrome P450 (Guzelian and Bissel, 1974), as does supplementation of 
media with relatively high concentrations of hydrocortisone (0.1 pM) (Michalopoulos et al, 
1976).
It is conceivable that the mechanisms underlying the decline in cytochromes P450 precision- 
cut liver slices are similar to those of primary hepatocyte cultures although studies must be
Chapter 9: Discussion___________________________________________________________________________253
carried out to confirm this hypothesis. The reported loss of cytochrome P450 activities at 
different rates in both hepatocyte culture (Steward et al, 1985) and precision-cut liver slices 
(Chapter 4) suggests that the ratio of the metabolite of a xenobiotic under investigation in 
these in vitro systems may be different to that of an in vivo system and therefore, caution 
must be exercised in interpreting such data.
9.1.3 Stability of Phase II Enzymes
The present study has shown that the Phase II enzymes behave differently to each other in 
precision-cut rat and human liver slices. In general terms they appear to be more stable in 
long-term culture compared with cytochrome P450, with measurable levels even after 72 
hours of culture, with the exception of sulphotransferases. Interestingly, similar findings 
have also been reported for primary hepatocyte cultures (Grant and Hawkswoth, 1986).
Different kinetics was observed in glutathione-S-transferase activity in precision-cut rat liver 
slices, using the substrates CDNB and DCNB. When the former was used as the substrate, 
there was a gradual decline in activity with about 50% of the initial activity remaining after 
24 hours of culture and about 25% of the activity being retained after 72 hours. However, 
when DCNB served as the substrate a loss of 80% in activity was evident after just 24 hours 
with less than 10% of the activity remaining in the slices following 72 hours of culture. 
Similar observations have also been reported in primary hepatocyte cultures (Croci and 
Williams, 1985). Glutathione-S-transferase activity after 24 hours, tested towards DCNB 
diminished to 20% of the initial liver activity in cultured hepatocytes; but the activity tested 
towards CDNB was stable (Croci and Williams, 1985). Therefore, the isoenzymes of 
glutahione-S-transferase have differential stability during culture of precision-cut liver slices
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and primary hepatocyte cultures, comparable to previous observations with the cytochrome 
P450 isoforms in primary hepatocyte cultures (Steward et al, 1985) and precision-cut rat 
liver slices (Chapter 4). The glutathione-S-transferases exist as a superfamily o f proteins 
(Deleve and Kaplowitz, 1991) and because of the dissimilar kinetics observed employing the 
two different substrates, fiirther studies should be carried out to establish the stability of 
individual isoforms in precision-cut liver slices in long-term culture.
An increase (20%) in glucuronosyl transferase activity was noted following culturing of rat 
precision-cut liver slices for 24 hours (Chapter 5) and a doubling in 7-hydroxycoumarin 
glucuronosyl transferase activity has also been reported for human precision-cut liver slices 
after 8 hours culture (Vandenbranden et al, 1998). Using primary hepatocytes cultured for 
up to 72 hours, a 4-fold increase in glucuronosyl transferase activity has been reported to 
occur between 24 and 72 hours (Grant and Hawkswoth, 1986). Addition of cycloheximide 
to the culture medium of these hepatocyte cultures prevented the increase in glucuronosyl 
transferase activity after 48 hours, and these authors concluded that the increase in the 
enzyme activity was due to protein synthesis. However, this remains to be elucidated in 
precision-cut liver slices. The increase in activity o f the glucuronosyl transferase is thought 
to reflect de-differentiation of the hepatocytes in culture and development of a pre­
neoplastic pattern of drug metabolising activities (Toribara et al, 1984).
Comparison o f microsomal and cytosolic protein levels per slice, has shown that the rate of 
protein loss is more pronounced in the former, suggesting that the cytosolic enzymes are 
more robust than the membrane-bound microsomal enzymes (Hashemi et al, 1999a). 
Determination of Phase II drug metabolising enzymes indeed indicated that these enzymes
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are far more stable in long-term culture than the Phase I cytochromes P450 in both rat and 
human precision-cut liver slices. In view of this, metabolic profile of a xenobiotic may 
change in favour of Phase II metabolism after long culture periods of 12 hours.
The metabolism of the substrate metronidazole has been used to compare precision-cut rat 
liver slices with hepatocytes (in suspension and monolayer) and microsomes (Sidelmann et 
al, 1996). The metabolic pattern of this substrate is outlined in Figure 9.1. The initial 
metabolic rates towards formation of the three metabolites (Phase I metabolites, HM and 
MAA and the Phase II metabolite, M-glcU) were compared for each in vitro model. The 
relative amounts of M-glcU-HM-MAA for liver slices was 25 : 5 : 4, in hepatocytes in 
monolayer culture 25 : 10 : 8, in hepatocytes in suspension 25 : 10 : 10 and finally in 
microsomes 25 : 17 : 21. Interestingly the relative amount of the three metabolites in in vivo 
studies on the metabolism o f metronidazole were 25 : 4 : 5 of M-glcU, HM and MAA 
respectively, suggesting the metabolic pattern obtained following incubation with precision- 
cut liver slices resembles the in vivo data more than the other in vitro models. It is important 
to point out that the authors studied the metabolism of metronnidazole following a short 
incubation time of just 1-hour in culture.
Precision-cut liver slices was successfully used in the present study to determine the role of 
individual cytochrome P450 isoforms in the metabolism of the endogenous substrate 
melatonin using a short culture time period of up to 5 hours, suggesting that precision-cut 
liver slices is a valuable this in vitro model to study xenobiotic metabolism in short-term 
culture. These findings using liver slices have been confirmed (C. J. Snelling, personal 
communication) using isolated hepatic microsomes.
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Figure 9.1: Schematic representation of metabolic pattern of metronidazole.
Metronidazole (M), l-(hydroxyethyl)-2-hydrodcymethyl-5-nitroimidazole (HM), 1-
(hydroxyethyl) -2-carboxy-5-nitromidazole (MOOH), 2-methyl-5-nitroimidazole-l -acetic 
acid (MAA), metronidazole and its hydroxy metabolite conjugated with glucuronic acid (M- 
glcU and HM-glcU respectively), Sulphate conjugate (M-sulphate). Taken from Sidelmann 
etal. (1996).
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9.1.4 Conclusion
Apart from the technical problems of isolating hepatocytes, particularly from human liver, 
one of the major drawbacks of the use of primary hepatocyte culture has been the rapid 
decline in cytochrome P450 content. The present study has demonstrated that these 
enzymes behave in a very similar fashion in precision-cut liver slices, and this system does 
not provide an advantage over hepatocyte cultures in this respect. It does, however, better 
represent the whole organ, as all cell types are present, allowing morphological evaluation of 
tissue architecture. These combined with the easier slicing procedure which can be utilised 
to prepare tissue slices from different species including humans, reflects the superiority of 
the precision-cut liver slice procedure to the hepatocyte cultures.
Therefore, it may be concluded that in short term culture, precision-cut hver slices provides 
the best in vitro model for xenobiotic metabolism studies, a system that more closely 
resembles the in vivo situation. The successful use of any in vitro model system for 
xenobiotic metabolism studies requires the maintenance of both mixed fiinction oxidase 
(MFO) and conjugating enzyme activities. The data presented in the current study on hver 
slices, and those of the primary hepatocyte cultures clearly demonstrate that the balance 
between the oxidative enzyme activities and the different pathways of conjugation are 
altered during long-term culture.
Although the use of precision-cut liver slices is a valuable in vitro system for identifying 
routes of metabolism, more recently its application has extended to kinetic studies. Studies 
have been carried out to predict in vivo clearance of compounds taking into account CLmt 
and heptatic blood flow (Worboys et al, 1996). However, scaling CUnt on the basis of
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hepatocellularity of a slice is so far inadequate; using the compound ndansetron , it has been 
shown that, in contrast to microsomes and hepatocytes, liver slices are unable to accurately
predict the in vivo CLmt of odansetron (Worboys et ah, 1996).
The use of precision-cut tissue slices is still in its infancy, and further studies are required to 
establish optimum culturing conditions and maintenance of drug metabolising enzymes. 
Until then, care must be taken in the interpretation of the metabolic profile of compounds,
and in the subsequent extrapolation of the data to the in vivo system.
References
References_________________________________________________________________________________ 2 6 0
Adams, R.M., Wand, M,, Crane, A. M,, Brown, B., Darlington, G J. and Ledley, F.D. 
(1995). Effective cryopreservation and long-term storage of primary human hepatocytes 
with recovery of viability, differentiation, and replicative potential. Cell 
Transplantation, 4: 579-586.
Akerboom, T.P.H. and Sies, H. (1981). Assay of glutathione, glutathione disulfide and 
glutathione mixed disulfides in biological samples. Methods in Enzymology, 7; 373-382.
Aldhous, M.E. and Arendt, J. (1988). Radioimmunoassay for 6-sulphatoxymelatonin in 
urine using an iodinated tracer. Annals of Clinical Biochemistry, 25: 298-303.
Anders M.W. (1988). Glutathione-dependent toxicity: Biosynthesis and bioactivation of 
cytotoxic S-conjugates. ISI Atlas of Science: Pharmacology 2: 99-104.
Anders M.W., Lash L.H., Dekant W., Elfarra A.A. and Dohn D.R. (1988). Biosynthesis 
and biotransformation of glutathione S-conjugates to toxic metabolites. CRC Critical 
Reviews in Toxicology, 18: 311-341.
Aoyama, T., Korzekwa, K., Matsunanga, T., Nagata, K., Gillete, J., Gelboin, H.V. and 
Gonzalez, F.J. (1990). CDNA-directed expression of rat P450s IIAl and IIA2. Catalytic 
activities towards steroids and xenobiotics and comparison with the enzymes purified 
from liver. Drug metabolism and Disposition, 18: 378-382.
Arendt, J. (1993). The pineal gland: basic physiology and clinical implications. In 
DeGroot (Ed.) Endocrinology, Chapter 27.
Arendt, J. (1988). Melatonin. Clinical Endocrinology, 29: 205-229.
Arendt, J. and Aldous, M.E (1988). Synchronisation of a disturbed sleep-wake cycle in a 
blind man by melatonin treatment. Lancet, 1: 772-773.
i
Arendt, J., Bojkowski, C., Folkard, S., Franey, C., Minors, D., Waterhouse, J.M., Wever, 
R.A., Wildgruber, C. and Wright., (1985). Some effects of melatonin and the control of 
it’s secretion in man. In Photoperiodism, Melatonin and the Pineal, Ciba Foundation 
Symposium, 177, pp 266-283.
Arlotto, M.P., Greenway, D.J. and Parkinson, A. (1989). Purification of two isoenzymes 
of rat liver microsomal cytochrome P450 with testosterone 7-alpha-hydroxylase activity. 
Archives of Biochemistry and Biophysics, 270: 441-457.
Astrom, A. and De Pierre, J.W. (1985). Metabolism of 2-acetylaminofiuorene by 8 
different forms of cytochrome P450 isolated from rat liver. Carcinogenesis, 6: 113-120.
Awasthi, Y.C., Sarma, R. and Singhal, S.S. (1994). Human glutathione S-transferase. 
InternationalJournal of Biochemistry, 26: 295-308.
Ayrton, A.D., McFarlene, M., Walker, R., Neville, S. and loannides, C. (1990a). The 
induction of P450 1 proteins by aromatic amines may be related to their carcinogenic 
potential. Carcinogenesis, 11: 803-809.
References_________________________________________________________________________________ 261
Ayrton, A.D., McFarlene, M., Walker, R., Neville, S., Coombe, M.M. and loannides, C. 
(1990b). Induction of the P450 1 family of proteins by polycyclic aromatic 
hydrocarbons: possible relationship to their carcinogenicity. Toxicology, 60: 173-186.
Azri, S., Gandolfi, A.J. and Brendel, K. (1990a). Precision-cut liver Slices: an in vitro 
system for profiling potential hepatotoxicants. In Vitro Toxicology, 3: 309-320.
Azri, S., Gandolfi, A.J., and Brendel, K. (1990b). Carbon Tetrachloride toxicity in 
precision-cut liver slices. In Vitro Toxicology, 3: 127-138.
Azri, S., Mata, H.R., Gandolfi, A.J. and Brendel, K. (1990c). Carbon Tetrachloride induced 
cytochrome P-450 loss and lipid peroxidation in rat liver slices. Biological Reactive 
Intermediates IV, Press, New York 669-674.
Bach, P.H., Vickers, A.E.M., Fisher, R., Baumann, A., Brittebo, E., Carilile, D., Roster, 
H.J., Lake, B.G., Salmon, F., Sawyer, T.W. and Skibinski, G. (1996). The use of tissue 
slices for pharmacotoxicology studies. ATLA-Alternatives to Laboratory Animals, 24: 
893-923.
Balani, S.K., Pitzenberger, S.M., Schwartz, M.S., Ramjit, H.G. and Thompson, W.J.
(1995). Metabolism of L-689, 502 by rat liver slices to potent HIV-1 protease inhibitors. 
Drug Metabolism and Disposition, 23: 185-189.
and Scatina, J.
Ball, S.E., Thiel, V.E., Tio, C.O., Urn, H., Kao, J., Sisenwine, S.F.y^l996). ['"C] 7-
Ethoxycoumarin metabolism by precision-cut rat hepatic slices. Drug Metabolism and 
Disposition, 24: 383-389.
Ballard, F.J. (1977). In Essays in Biochemistry (Campbell, P.N. and Aldridge, W.N. 
eds) vol. 13 pp 1-3 7, Academic press, London.
Ballet, F., Bouma, M.E., Wang, S.R., Amit, N., Marais, J. and Infante, R. (1984). 
Isolation, culture and characterisation of adult human hepatocytes from surgical liver 
biopsies. Hepatology, 4: 849-854.
Barr, J., Weir, A.J., Brendel, K. and Sipes, I.G. (1991a). Liver slices in dynamic organ 
culture. I. An alternative in vitro technique for the study of rat hepatic drug metabolism. 
Xenobiotica,l\:'i2>\-?)2)9.
Barr, J., Weir, A.J., Brendel, K. and Sipes, I.G. (1991b). Liver slices in dynamic organ 
culture. II. An in vitro cellular technique for the study of integrated drug metabolism 
using human tissue. Xenobiotica, 21: 341-350.
Bars, R.G., Mitchell, A.M., Wolf, C.R. and Elcombe, C.R. (1989). Induction of 
cytochrome P450 in cultured rat hepatocytes. The heterogeneous localisation of specific 
isoenzymes using immunocytochemisty. BiochemicalJournal, 262: 151-158.
Bartsch, H., Castegnaro, M., Rojas, M., Camus, A.M., Alexandrov, K. and Lang, M. 
(1992). Expression of pulmonary cytochrome P450 lA l and carcinogen adduct formation 
in high risk subjects for tobacco-related lung cancer. Toxicology Letters, 64-5: 477-483.
References_________________________________________________________________________________ 2 6 2
Baumann, A., Kerdar, R.S., Cramer, P., Fesser, W., Blode, H., Salomon, A. and Kuhnz, W.
(1996). Use of rat and human liver slices for the detection of steroid hormone-induced 
DNA-adducts in vitro by means of the ^^P-postlabeling technique. Pharmacology and 
Toxicology, 78: 214-223.
Baur, H., Kasperek, S., Pfaff, E. andJToppe:^eyler,_Z,_(1975). Criteria of viability of 
isolated liver cells. Physiological Chemistry, 356: 827-838.
Beamand, J.A., Barton, P.T., Price, R.J. and Lake, B.C. (1998). Lack of effect of coumarin 
on unscheduled DNA synthesis in precision-cut human liver slices. Food and Chemical 
Toxicology, 36: 647-653.
Beamand, J.A., Price, R.J., Phillips, J.C., Butler, W.H., Glynne Jones, G.D., Osimitz, T.G., 
Gabriel, K.L., Preiss, F.J. and Lake, B.G. (1996). Lack of effect of piperonyl butoxide on 
unscheduled DNA synthesis in precision-cut human liver slices. Mutation Research, 371: 
273-282.
Beamand, J.A., Price, R.J., Blowers, S.D., Wield, P.T., Cunninghame, M.E. and Lake, B.G.
(1994). Use of precision-cut liver slices for studies of unscheduled DNA synthesis. Food 
and Chemical Toxicology, 32: 819-829.
Beamand, J.A., Price, R.J., Cunninghame, M.E. and Lake, B.G. (1993). Culture of 
precision-cut liver slices: Effect of some peroxisome proliferators. Food and Chemical 
Toxicology, 31: 137-147.
Beals, D. and McLean, A.E.M. (1995). Cell injury and protection in long-term incubation 
of liver slices after in vivo initiation with paracetamol: cell injury after in vivo initiation with 
paracetamol. Toxicology, 103: 113-119.
Berry, M.N. and Friend, D.S. (1972). High yield preparation of isolated rat liver 
parenchymal cells. A biochemical and ultrastructural study. Journal of Cell Biology, 43: 
506-520.
Begue, J.M., Guguen-Guillouzo, C., Pasdeloup, N. and Guillouzo A. (1984). Prolonged 
maintenance of active cytochrome P450 in adult rat hepatocytes co-cultured with another 
liver cell type. Hepatology, 4: 839-842.
Bisat, T., Brown, T.R., Migeon, C.J. and Berkovitz, G.D. (1989). Influence of cell 
culture conditions on aromatase activity in human genital skin fibroblasts. In Vitro 
Cellular and Development Biology, 25: 806-812.
Bissel, D.M. and Guzelian, O. (1975). Microsomal functions nad phenotypic changes in 
adult rat hepatocytes. Gene expression and carcinogenesis in cultured liver, pp. 119-136, 
New York, Academic Press.
Bissel, D.M., Hammaker, L.E. and Meyer, U.S. (1973). Paranchymal cells from adult rat 
liver in nonproliferating monolayer culture. Journal of Cell Biology, 59: 722-734.
References_________________________________________________________________________________ 263
Bojkowski, C.J., Arendt, J., Shih, M.C. and Marey, S.P. (1987). Melatonin secretion in 
humans assessed by measuring its metabolite 6-sulphatoxymelatonin. Clinical 
Chemistry, 33: 1343-1348.
Bonn, D. (1996). Melatonin’s multifarious marvels: Miracle or myth? Lancet, 347: 184.
Breen, J.G., Wilga, P.C., Choudhuri, S., Mast, R.W. and Mckim, J.M. (1996). A 
comparison between the Krumdieck and Brendel tissue sheers: assessment of viability 
using cadmium as a model toxicant. Fundamental and Applied Toxicology, 30: 253-254.
Brendel, K., Fisher RL., Krumdieck, L. and Gandolfi, A J. (1993). Precision-cut rat liver 
slices in dynamic organ culture for structure -  toxicity studies. Methods in Toxicology, 
Volume 1, In Vitro Biological System (Eds. Charles Tyson and John Frazier), Academic 
Press, pp. 222-230.
Brendel, K., Fisher RL., Krumdieck, L. and Gandolfi, A J. (1990). Precision-cut rat liver 
slices in dynamic organ culture for structure-toxicity studies. Journal of the American 
College of Toxicology, 9: 621-627.
Brendel, K., Gandolfi, A.J., Krumdieck, C.L. and Smith, P.F. (1987). Tissue slicing and 
culturing revisited. Trends in Parmacological Sciences, 8: 11-15.
Brown, A.P., Hastings, K.L., Gandolfi, A.J., Liebler, D.C. and Brendel, K. (1992). 
Formation and identification of protein adducts to cytosolic proteins in guinea pig 
exposed to halothane. Toxicology, 72: 281-295.
Bucher, J.R. and Roberts, R.J. (1981). Alpha-tocopherol (vitamin E) content of lung, 
liver and blood in the newborn rat and human infant: influence of hyperoxia. Journal of 
Pediatrics, 98: 806-811.
Buhler, R., Lindros, K.O., Nordling, A., Johansson, I. and Ingelman-Sundberg, M. 
(1992). Zonation of cytochrome P450 isozyme expression and induction in rat liver. 
European Journal of Biochemistry, 204: 407-412.
Burke, M.D., Thomson, S., Weaver, R.J., Wolf, C.R. and Mayer, R.T. (1994). 
Cytochrome P450 specificities of alkoxyresorufin 0-dealkylation in human and rat liver. 
Biochemical Pharmacology, 48: 923-936.
Burke, M.D. and Mayer, R.T. (1974). Ethoxyresorufin: Direct fluorimetric assay of 
microsomal 0-dealkylation which is preferentially induced by 3-methylcholanthrene. 
Drug Metabolism and Disposition, 3: 245-253.
Burnette, W.M. (1981). Western blotting -  electrophoretic transfer of proteins from 
sodium dodecyl sulphate-polyacrylamide gels to unmodified nitrocellulose and 
radiographic detection with antibody and radioiodinated protein-A. Analytical 
Biochemistry, 112: 195-203.
Butler, M.A., Guengerich, F.P. and Kadlubar, F.F. (1989a). Metabolic oxidation of the 
carcinogens 4- aminobiphenyl and 4,4’-methylene-bis(2-chloroaniline) by human hepatic
References_________________________________________________________________________________ 2 6 4
microsomes and by purified hepatic cytochrome P450 monoxygenase. Cancer Research, 
49: 25-31.
Butler, M.A., Iwasaki, M., Guengerich, F.P, and Kadlubar, F.F. (1989b). Human 
cytochrome P450 PA (P450 1A2), the phenacetin 0-deethylase is primarily responsible 
for the hepatic 3-déméthylation of caffeine and N-oxidation of carcinogenic arylamines. 
Proceedings of the National Academy of Sciences of the United States, 86: 7696-7700.
Butterworth, B.E., Ashby, J., Bermudez, E., Casciano, D., Mirsalis, J., Probst, G. and 
Williams, G. (1987). A protocol and guide for the in vitro rat hepatocyte DNA-repair assay. 
Mutation Research, 189: 113-121.
Butterworth, B.E., Bermudez, E., Smith-Oliver, T., Earle, L., Cattley, R., Martin, J., Popp, 
J.A., Strom, S., Jirtle, R. and Michaelopoulos, G. (1984). Lack of genotoxic activity of 
di(2-ethylhexyl)phthalate (DEHP) in rat and human hepatocytes. Carcinogenesis, 5: 1329- 
1335.
Campbell, A.K. and Siddle, K. (1971). Establishment of a hormonally sensitive organ 
culture for adult rat liver. Diabetologia, 9: 62.
Campbell, A.K. and Hales, C.N. (1971). Maintenance of viable cells in an organ culture of 
mature rat liver. Experimental Cell Research, 68: 33-42.
Carlberg, I. and Mannervik, B. (1975). Purification and characterisation of the flavoenzyme 
glutathione reductase from rat liver. Journal of Biological Chemistry, 250: 5475-5480.
Castro, J.A., Sasame, H.A., Sussman, H. and Gillette, J.R. (1968). Diverse effects of SKF 
525-A and anti oxidants on carbon tetrachloride-induced changes in liver microsomal P450 
content and ethylmorphine metabolism. Life Sciences, 7: 129.
Chapman, D.E., Michener, S.R. and Powis, G. (1993). In vitro metabolism of [^H] 2,6- 
dinitrotoluene by human and rat liver. Toxicology in Vitro, 7: 213-220.
Chenery, R.J., Ayrton, A. Oldham, H.G., Standring, P., Norman, S.J., Seddon, T. and Krby, 
R. (1987). Diazepam metabolism in cultured-hepatocytes from rat, rabbit, dog, guinea-pig, 
and man. Drug Metabolism and Disposition, 15: 312-317.
Chesne, C., Guyomard, C., Fautrel, A., Poullain, M.G., Fremond, B., De-Jong, H. and 
Guillouzo, A. (1993). Viability and function in primary culture of adult hepatocytes from 
various animal species and human beings after cryoperservation. Hepatology, 18: 406-414.
Clouser, T.E. (1977). Tissue bath improvements for the Oxford vibratome. Stain 
Technology, 52: 319-322.
Conney, A.H. (1967). Pharmacological implications of microsomal enzyme induction. 
Pharmacological Reviews, 19: 317-366.
References_________________________________________________________________________________ 265
Connors, M.S., Larrauri, A., Dannecker, R., Nufer, R., Brendel, K. and Vickers, A.E.M.
(1996). Biotransformation of a somatostatin analogue in precision-cut liver and kidney 
slices from rat, dog and man. Xenobiotica, 26: 133-141.
Connors, M.S., Malfatti, M.A. and Felton, J.S. (1995). The metabolism and DNA 
binding of cooked-food mutagen, 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine 
(PhIP) in precision-cut rat liver slices. Chemico-Biologicallnteractions, 96: 185-202.
Connors, MS., Rankin, D.R., Gandolfi, A.J., Krumdieck, C.L., Koep, L.J. and Brendel, K. 
(1990). Cocaine hepatotoxicity in cultured liver slices: a species comparison. Toxicology, 
61: 171-183.
Coundouris, J.A., Grant, M.H., Engeset, J., Petrie, J.C. and Hawksworth, G.M. (1993). 
Cryopreservation of human adult hepatocytes for use in drug metabolism and toxicity 
studies. Xenobiotica, 23: 1399-1409.
Coundouris, J.A., Grant, M.H., Simpson, J.G. and Hawksworth, G.M. (1990). Drug 
metabolism and viability studies in cryopreserved rat hepatocytes. Cryobiology, 27: 288- 
300.
Cravedi, J.P., PerudDurand, E. and Paris, A. (1998). Cytochrome P450 dependent 
metabolic pathways and glucuronidation in trout liver slices. Comparative Biochemistry 
and Physiology C-Pharmacology Toxicology and Endocrinology, 121: 267-275.
Crespi, C.L., Pennan, N., Leakey, J.A., Arlotto, M.P., Stark, A. Parkinson, A., Turner, T., 
Steimel, D.T., Rudo, K., Davies, R.L. and Langenbach, R. (1990). Human cytochrome 
P450 2A3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, 
comparison to nitrosamine activation by human cytochrome P450 2E1. Carcinogenesis, 
11: 1293-1300.
Croci, T. and Williams, G.M. (1985). Activities of several phase I and phase II xenobiotic 
biotransformation enzymes in cultured hepatocytes from male and female rats. 
Biochemical pharmacology, 34: 3029-3035.
Czeisler, C.A., Johnson, P.J., Duffy, J.F., Brown, E.N., Ronda, J.M. and Kronauer, R.E. 
(1990). Exposure to bright light and darkness to treat physiologic maladaptation to night- 
work. New England Journal of Medicine, 322: 1253-1259.
Dahlitz, M., Alvarez, B., Vignau, J., English, J., Arendt, J. and Parkes J.D. (1991). Delayed 
sleep phase syndrome response to melatonin. Lancet, 337: 1121-1124.
Dale, O., Gandolfi, A.J., Brendel, K. and Schuman, S. (1988). Rat liver slices and 
diazepam metabolism: in vitro interactions with volatile anaesthetic drugs and albumin. 
British Journal of Anaesthesia, 60: 629-696.
Dalet-Beluche, I., Boulenc, X., Fabre, G., Maurel, P. and Bonfils, C. (1992). Purification of 
two cytochrome P450 isozymes related to CYP2A and CYP3A gene families from monkey 
(baboon, Papio papio) liver microsomes. Cross reactivity with human forms. European 
Journal of Biochemistry, 204: 641-648.
References_________________________________________________________________________________ 2 6 6
Dansette, P.M., DuBois, G.C. and Jerina, D.M. (1979). Continuous fluorimetric assay of 
epoxide hydrase activity. Analytical Biochemistry, 97: 340-345.
Davidson, M.B. and Berliner, J.A. (1974). Acute effects of insulin on carbohydrate 
metabolism in rat liver slices: independence from glucagon. American Journal of 
Physiology, 227: 79-87.
De Belle, R.C., Blacklow, Bayland, V.R., Little, J.M. and Lester, R. (1976). Bile acid 
conjugation in foetal organ culture. American Journal of Physiology, 23: 1124-1128.
De Ferreyra, B.C., DeFenos, O.M., Bemacchi, A.S., DeCastro, C.R. and Castro, J.A.
(1979). Therapeutic effectiveness of cystamine and cysteine to reduce liver cell necrosis 
induced by several hepatotoxins. Toxicology and Applied Pharmacology, 48: 221.
DeJong, L.P.A. and Worling, G.Z. (1980). Reactivation of Acetylcholine esterase 
inhibited by 1,2,2-trimethylpropyl methylphosphon 0-enfluroidate (SOMAN) with H I-6 
and related oximes. Biochemical Pharmacology, 29: 2379.
Dekant W., Lash L.H. and Anders M.W. (1988). Fate of glutathione conjugates and 
bioactivation of cysteine S-conjugates by cysteine conjugate p-lyase. In Glutathione 
Conjugation: Its Mechanism and Biological Significance (H. Sies and B. Ketterer. Eds.)., 
pp. 415-447. Academic Press, Orlando.
De Kanter, R. and Roster, H.J. (1995). Cryopreservation of rat and monkey liver slices. 
Alternatives to Laboratory Animals, 23: 653-665.
DeLeve, L.D. and Kaplowitz, N. (1991). Glutathione metabolism and its role in 
hepatotoxicity. Pharmacology and Therapeutics, 52: 287-305.
Diaz, D., fabre. I., Daujat, M., Saintaubert, B., Bories, P., Michel, H. and Maurel, P. 
(1990). Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome 
P450. Gastroenterology, 99: 737-747.
Dich, J. and Grunnet, N. (1990). Primary cultures of rat hepatocytes. In Methods in 
Molecular Biology, Vol 5, edited by J.W., Pollard and J.M., Walker (Human Press: 
Clitton), pp. 161-175.
Dich, J., Vind, C. and Grunnet, N. (1988). Long-term cultures of hepatocytes: effect of 
hormones on enzyme activities and metabolic capacity. Hepatology, 8: 39-45.
Dickson, A.J. and Pogson, C.L (1977). The metabolic integrity of hepatocytes in 
sustained incubation. FEBS Letters, 83: 27-32.
Diener, B. and Oesch, F. (1995). Cryopreserved and hypothermically stored rat liver 
parenchymal cells as metabolising system in the Salmonella mutagenicity assay. 
Mutation Research, 335: 309-316.
Diener, B., Abdel-Latif, H., Arand, M. and Oesch, F. (1995). Xenobiotic metabolising 
enzyme activities and viability are well preserved in EDTA-isolated rat liver
References_________________________________________________________________________________ 267
parenchymal cells after cryopreservation. Toxicology and Applied Pharmacology, 130: 
149-153.
DiRenzo, A.B., Gandolfi, A.J., Brooks, S.D. and Brendel, K. (1985). Toxicity and 
biotransformation of volatile halogenated anesthetics in rat hepatocytes. Drug and 
Chemical Toxicology, 8: 207-218.
Dogterom, P. (1993). Development of a simple incubation system for metabolism 
studies with precision-cut liver slices. Drug Metabolism and Disposition, 21: 699-704.
Dogterom, P. and Rothuizen, J. (1993). A species comparison of tolbutamide 
metabolism in precision-cut liver slices from rat and dogs. Drug Metabolism and 
Disposition, 21: 705-709.
Doherty, J.R. (1987). The use of human saphenous vein in pharmacology. Trends 
Pharmacol. Sci., 8: 358-361.
Donato, M.T., Castell, J.V. and Gomezelechon, M.J. (1995). Effect of model inducers 
on cytochrome P450 activities in human hepatocytes in primary culture. Drug 
Metabolism and Disposition, 23: 553-558.
Drahushuk, A.T., McGarrigle, B.P., Slezak, B.P., Stegeman, J.J. and Olson, J.R. (1999). 
Time-and concentration-dependent induction of CYPlAl and CYP1A2 in precision-cut 
rat liver slices incubated in dynamic organ culture in the presence of 2, 3, 7, 8- 
tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology, 155: 127-138.
Drahushuk, A.T., McGarrigle, B.P., Tai, T.L., Kitareewan, S., Goldstein, J.A. and Olson, 
J.R. (1996). Validation of precision-cut liver slices in dynamic organ culture as an in 
vitro model for studying CYPlAl and CYP1A2 induction. Toxicology and Applied 
Pharmacology, 140: 393-403.
Eamshaw, D., Dale, J.W., Goldfarb, P.S. and Gibson, G.G. (1988). Differential splicing on 
the 3’ non-coding region of rat cytochrome P452 (P450 4A1) mRNA. FEBS Letters, 236: 
357-361.
Edwards, A.M., Glistak, M.L., Lucas, G.M. and Wilson, P.A. (1984). 7-Ethoxycoumarin 
deethylase activity as a convenient measure of liver drug metabolising enzymes: regulation 
in cultured rat hepatocytes. Biochemical Pharmacology, 33: 1537-1546.
Eichelbaum, M. and Gross, A.S. (1990). The genetic-polymorphism of debrisoquine 
sparteine metabolism-clinical aspects. Pharmacology and Therapeutics, 46: 377-394.
Ekins, S. (1996). Short-term maintenance of Phase I and II metabolism in precision-cut 
liver slices in dynamic organ culture. Drug Metabolism and Disposition, 24: 364-366.
Elshove, A. and Van Rossum, G.D.V. (1963). New movement of sodium and potassium 
and their relation to respiration in slices of rat liver incubated in vitro. Journal of 
Physiology, 168: 531-533.
References_________________________________________________________________________________ 268
Eugene, H., Jansen, J.M. and de Fluiter, P. (1992). Detection of the enzymatic activity of 
cytochrome P450 enzymes by high-performance liquid chromatography. Journal of 
Chromatography, 580: 325-346.
Fisher, J.L., Shaughnessy, R.P., Jenkins, P.M., Austin, M.L., Roth., Gandolfi, A.J. and 
Brendel, K. (1995a). Dynamic organ culture is superior to multiwell plate culture for 
maintaining precision-cut tissue: optimization of tissue culture, part 1. Toxicology Methods, 
5:99-113.
Fisher, R.L., Hasal, S.J., Sanuik, J.T., Gandolfi, A.J. and Brendel, K. (1995b). 
Determination of optimal incubation media and suitable slice diameters in precision-cut 
liver slices; optimization of tissue culture. Part 2. Toxicology Methods, Si 115-130.
Fisher, R.L., Smith, M.S., Hasal, S.L., Hasal, K.S., Gandolfi, A.J. and Brendel, K. (1994). 
The use of human lung slices in toxicology. Human and experimental Toxicology, 13: 466- 
471.
Fisher, RL., Gandolfi, A.J., Sipes, I.G. and Brendel, K. (1993). Culture medium 
composition affects the relative toxicities of chlorobenzenes in rat liver slices and the 
isolated perfused liver. Drug and Chemical Toxicology, 16: 321-339.
Fisher, R , Barr, J., Zukoskil, C.F., Putman, C.W., Sipes, I.G., Gandolfi, A.J. and Brendel, 
K. (1991a). In vitro hepatotoxicity of 3-dichlorobenzene isomers in human liver slices. 
Human and Experimental Toxicology, 10: 357-363.
Fisher, R , Nau, H., Gandolfi, A.J. and Brendel, K. (1991b). Toxicity of valporic acid in 
Sprague-Dawley rat and domestic pig liver slices. Toxicology in Vitro, 5: 201-205.
Fisher, R , Smith, P.F., Gandolfi, A.J., Sipes, I.G., Krumdieck, C. and Brendel, K. (1990). 
Toxicity of chlorobenzenes in cultured rat slices. In Vitro Toxicology, 3: 181-194.
Fisher, R , Hazlik, R.P., Gandolfi, A.J. and Brendel, K. (1988). Toxicity of ortho­
substituted bromobenzenes to Precision-cut rat liver slices. FASEB Journal, 2: A1135.
Forrester, L.M., Henderson, C.J., Glancey, M.J., Back, D.J., Park, B.K., Ball, S.E., 
Kitteringham, N .R, McLaren, A.W., Miles, J.S., Skett, P. and Wolf, C.R. (1992). 
Relative expression of cytochrome P450 isoenzymes in human liver and association with 
the metabolism of drugs and xenobiotics. Biochemical Journal, 281: 359-368.
Forster, U. Luippold, G. and Schwarz, L.R. (1986). Induction of monooxygenase and 
UDP-glucuronosyltransferase activities in primary cultures of rat hepatocytes. Drug 
Metabolism and Disposition, 14: 353-360.
Fry, J.R. and Bridges, J.W. (1979). Use of primary hepatocyte cultures in biochemical 
toxicology. Review in biochemical Toxicology. Reviews in Biochemicaol Toxicology, 
1: 201-247.
Fujii-Kuriyama, Y., Mizukami, Y., Kawajiri, K., Sogawa, K. and Muramatsu, M. (1982). 
Primary sturcture of a cytochrome P450: coding nucleotide sequence of phénobarbital-
References_________________________________________________________________________________ 2 6 9
inducible cytochrome P450 cDNA from rat liver. Proceedings of the National Academy 
of Sciences, USA, 79: 2793-2797.
Fukuda, H. and Iritani, N. (1987). Effects of amino-acid composition of the medium and 
additions of fatty acid derivatives on the induction of lipogenic enzymes in cultured 
hepatocytes. Biochemica and Biophysica Acta, 920: 56-61.
Fuduka, T., Imai, Y., Komori, M., Nakamura, M., Kusunose, E., Satouchi, K. and 
Kusunose, M. (1994). Different mechanisms of regioselection of fatty acid 
hydroxylation by laurate (co-l)-hydroxylation P450s, P4502C2 and P4502E1. Journal of 
Biochemistry, 115: 338-344.
Gandolfi A.J., Brendel K., Fisher R.L. and Michaud J-P. (1995). Use of tissue slices in 
chemical mixture toxicology and interspecies investigations. Toxicology, 105: 285-290.
Ghantous, H.N., Fernando, J., Gandolfi, A.J. and Brendel, K. (1992a). Sevoflurane is 
biotransformed by Guinea pig liver slices but causes minimal cytotoxicity. Anaesthesia and 
Analgesia, 75: 436-440.
Ghantous, H.N., Fernando, J., Gandolfi, A.J. and Brendel, K.l[1992b). Inhibition of protein 
synthesis and secretion by volatile anaesthetics in guinea pig liver slices. In Biological 
Reactive Intermediates TV, 283: 725-730.
Ghantous, H.N., Fernando, J., Deith, R., Gandolfi, A.J. and Brendel, K. (1992c). Effects of 
the volatile anaesthetics on protein synthesis and secretion in guinea pig liver slices. British 
Journal of Anaesthesia, 68: 172-177.
Ghantous, H.N., Fernando, J., Gandolfi, A.J. and Brendel, K. (1991). Minimal 
biotransformation and toxicity of Desflurane in guinea pig liver slices. Anaesthesia and 
Analgesia, 72: 796-800.
Ghantous, H.N., Fernando, J., Gandolfi, A.J. and Brendel, K. (1990a). 
Biotransformation of halothane in guinea pig liver slices. Drug Metabolism and 
Disposition, 18: 514-518.
Ghantous, H.N., Fernando, J., Morgan, S.E., Gandolfi, A.J. and Brendel, K. (1990b). 
Precision-cut guinea pig liver slices as a tool for studying of volatile anaesthetics. ATLA- 
Alternatives to Laboratory Animals, 18: 191-199.
Gibson, G.G. and Skett, P. (1986). Introduction to drug metabolism. Chapman and Hall, 
UK. pp 43-44.
Godden, P.M.M., Kass, G., Mayer, R.T. and Burke, M.D. (1987). The effect of 
cigarette-smoke compared to 3-methylcholanthrene and phenobarbitone on 
alkoxyresorufin metabolism by lung and liver microsomes from rats. Biochemical 
Pharmacology, 36: 3393-3398.
References_________________________________________________________________________________ 270
Goethals, F., Deboyser, D,, Lefebvre, V., de Coster, I. and Roberffoid, M. (1990). Adult 
rat liver slices as a model for studying the hepatotoxicity of vincaalkaloids. Toxicology 
in vitro, 4: 435-438.
Gokhale, MS., Buton, TE., Zurlo, J. and Yager, J.D. (1997). Cytochrome P450 
isoenzyme activities in cultured rat and mouse liver slices. Xenobiotica, 27: 341-355.
Gokhale, M.S. Bunton, T.E., Zurlo, J. and Yager, J.D. (1995). Cytochrome P450 
1A1/1A2 induction, albumin secretion, and histological changes in cultured rat liver 
slices. In Vitro Toxicolocy, 8: 357-368.
Goldstein, J.A. and de Morais, S.M.F. (1994). Biochemistry and molecular biology of the 
human CYP2C subfamily. Pharmacogenetics, 4: 285-299.
Gonzalez, F.J. (1996). The CYP2D subfamily. In: Cytochromes P450 metabolic and 
toxicological aspects. Edited by C. Ioannides,CRC Press, Inc. ppl93.
Gonzalez, F.J. and Gelboin, H.V. (1994). Role of human cytochrome P450 in the metabolic 
activation of chemical carcinogens and toxins. Drug Metabolism and Disposition, 26: 165- 
183.
Gonzalez, F.J., Matsunage, T., Nagata, K., Meyer, U.A., Nebert, D.W., Pastewka, J., 
Kozak, C.A., Gillette, J.J., Gelboin, H.V. and Hardwick, J.P. (1987). Debrisoquine 4- 
hydroxylase; characterisation of a new P450 gene subfamily, regulation, chromosomal 
mapping, and molecular analysis of the DA rat polymorphism. DNA-A Journal of 
Molecular and Cellular Biology, 6: 149-161.
Grant, M.H. and Hawksworth, G.M (1986). The activity of UDP-glucuronyl-transferase, 
sulphotransferase and glutathione S-transferase in primary cultures of rat hepatocytes. 
Biochemical Pharmacology, 35: 2979-2982.
Grisham, J.W. (1979). Use of hepatic cell culture to detect and evaluate mechanisms of 
action of toxic chemicals. Reviews in Experimental Pathology, 20: 123-210.
Guarino, A.M. Gram, T.E., Gigon, P.L., Green, F.E. and Gillette, J.R. (1969). Changes in 
the Michaelis constants for aniline in hepatic microsomes from phenobarbitone-treated rats. 
Molecular pharmacology, 5: 131-136.
Guengerich, F.P. (1987). Enzymology of rat liver cytochrome P450, in Mammalian 
Cytochromes P450, Vol. 1, Guengerich, F.P., Ed., CRC Press, Boca Raton, Chap. 1.
Guengerich, F.P. and Shimada, T. (1991). Oxidation of toxic and carcinogenic chemicals 
by human cytochrome P450 enzymes. Chemical Research in Toxicology, 4: 391-407.
Guengerich, F.P., Kim, D.H. and Iwasaki, M. (1991). Role of human cytochrome P450 
IIEl in the oxidation of many low molecular weight cancer suspects. Chemical Research in 
Toxicology, 4: 168-179.
References_________________________________________________________________________________ 271
Guguen-Guillouzo, C. and Guillouzo, A. (1983). Modulation of functional activities in 
cultured hepatocytes. Molecular and Cellular Biochemistry, 53: 35-56.
Guillouzo, A. (1986). Use of isolated and cultured hepatocytes for xenobiotic metabolism 
and cytotoxicity studies. In: Isolated and Cultured Hepatocytes (Eds. Guillouzo A and 
Guguen-Guillouzo C), pp. 313-332. John Libbey-Eurotext, INSERM, Paris.
Gunawardhana, L., Barr, J., Weir, A.J., Brendel, K. and Sipes A.I. (1991). The N- 
acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic 
organ culture. Drug Metabolism and Disposition, 19: 648-654.
Guzelian, P.S. and Barwick, J.L. (1979). Inhibition by cycloheximide of degradation of 
cytochrome P450 in primary cultures of adult rat liver paranchymal cells and in vivo. 
BiochemicalJournal, 180: 621-630.
Guzelian, P.S., Bissel, D.M. and Meyer, U.A. (1977). Drug metabolism in adult rat 
hepatocytes in primary culture. Gastroenterology, 111 1232-1239.
Guzelian, P.S. and Bissell, D.M. (1974). Metabolic factors in the regulation of 
cytochrome P450. Studies in rat hepatocytes monolayer culture. Federation 
Proceedings, 33: 1246.
Habig, W.A., Pabst, M.E. and Jakoby, W.B. (1974). Glutathione-S-transferase. The first 
enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249: 
7130-7139.
Hammons, G.J., Guengerich, P.P., Weis, C.C., Beland, F.A. and Kadlubar, F.F. (1985). 
Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic 
microsomes and by purified flavin-containing and cytochrome P450 monooxygenases. 
Cancer Research, 45: 3578-3585.
Hanna P.E. and Banks R.B. (1985). Arylhydroxylamines and arylhydroxamic acids: 
conjugation reactions. In Bioactivation of Foreign Compounds (W.M. Anders, Ed.), pp. 
375-402. Academic Press, Orlando.
Harris, J.W., Rahman, A., Kim, B.R., Guengurich, F.P. and Collins, J.M. (1994). 
Metabolism of Taxol by Human Hepatic Microsomes and Liver slices: Participation of 
Cytochrome P-450 3A4 and an unknown P-450 enzyme. Cancer Research, 54: 4026-4035.
Hart, A., Mattheyse, F.J. and Balinsky, J.B. (1983). An organ culture of postnatal rat liver 
slices. In vitro -Journal of the Tissue Culture Association, 19: 841-852.
Hashemi, E., Till, C. and loannides, C. (1999a). Stability of phase II conjugation 
systems in cultured precision-cut rat hepatic slices. Toxicology In Vitro, 13: 459-466.
Hashemi, E., Dobrota, M., Till, C. and loannides, C. (1999b). Structural and functional 
integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the 
dynamic organ and multiwell plate culture procedures. Xenobiotica, 29: 11-25.
References_________________________________________________________________________272
Heinonen, J.T., Fisher, R., Brendel, K. and Eaton, D.L. (1996). Determination of 
Aflotoxin Bi biotransformation and binding to hepatic macromolecules in human 
precision-cut liver slices. Toxicology and Applied Pharmacology, 136: 1-7.
Hinson, J.A., Pumford, N.R. and Nelson, S.D. (1994). The role of metabolic activation in 
drug toxicity. Drug Metabolism Reviews, 26: 395-412.
Hirata, F., Hayishi, O. and Tokuyama, T. (1974). In vitro and in vivo formation of two new 
metabolites of melatonin. Journal of Biological Chemistry, 249: 1311-1313.
Ichihara, A., Nakamura, T., Tanaka, K., Tomita, Y., Aoyama, K., Kato, S. and Shinno, H.
(1980). Biochemical functions of adult rat hepatocytes in primary culture. Annals of the. 
New York Academy of Sciences, 354: 77-84.
Ichihara, A., Nakamura, T. and Tanaka, K. (1982). Use of hepatocytes in primary culture 
for biochemical studies on liver function. Molecular and Cellular Biochemistry, 43: 145- 
160.
Immenschuh, S., Kietzmann, T., Hineke, V., Wiederhold, M., Katz, N. and MullerEberhard, 
U. (1998). The rat heme oxygenase-1 gene is transcriptionally induced via the protein 
kinase a signalling pathway in rat hepatocyte cultures. Molecular Pharmacology, 53: 483- 
491.
loannides, C. and Parke, D.V. (1990). The cytochrome P450 I gene family of microsomal 
haemoproteins and their role in the metabolic activation of chemicals. Drug Metabolism 
Reviews, 22: 1-85.
loannides, C., Cheung, Y.-L., Wilson, J., Lewis, D.F.V. and Gray, T.J.B. (1993). The 
mutagenicity and interactions of 2-(acetylamino)-fluorene and 4-(acetylamino)-fluorene 
with cytochrome P450 and the aromatic hydrocarbon receptor may explain the difference in 
their carcinogenic potency. Chemical Research in Toxicology., 6: 535-541.
Jansson, I., Mole, J. and Schenkman, J.B. (1985). Purification and characterisation of a new 
form (RLM2) of liver microsomal cytochrome P450 from untreated rat. Journal of 
Biological Chemistry, 260: 7084-7093.
Jewell, S.A., Bellomo, G., Thor, H., Orrenius, S. and Smith, M.T. (1982). Bleb formation 
in hepatocytes during drug metabolism is caused by disturbances in Thiol and calcium ion 
homeostasis. Science, 217: 1257-1259.
Jones, R.L., McGreer, P.L. and Greiner, A.C. (1969). Metabolism of exogenous melatonin 
in schizophemic and non-schizorphemic volunteers. Clinica Chimica Acta, 26: 281-285.
Kadlubar, F.F., Butler, M.A., Kardelik, K.R., Chou, H.C and Lang, N.P. (1992). 
Polymorphisms for aromatic amine metabolism in humans: Relevance for human 
carcinogensis. Environmental Health Perspectives, 98: 69-74.
References_________________________________________________________________________________ 273
Karki, N.T., Pokela, R., Nuutinen, L. and Pelkonen, O. (1987). Aryl hydrocarbon 
hydroxylase in lymphocytes and lung tissue from lung cancer patients and control. 
InternationalJournal of Cancer, 39: 565-570.
Kawajiri, K. and Hayawhi, S. I. (1996). The CYPl family. In Cytochrome P450 metabolic 
and toxicological aspects. Edited by C. loannides, CRC Press, Inc. pp 81.
Kehrer, J.P. and Autor, A.P. (1978). The effect of dietary fatty acids on the composition of 
adult rat lung lipids; relationship to oxygen toxicity. Toxicology and Applied 
Pharmacology, 44: 423-430.
Kopin, I.J., Pare, C.M.B., Axelrod, J. and Weissbach, H. (1961). The fate of melatonin in 
animals. Journal of Biological Chemistry, 236: 3072-3075.
Korzekwa, K.R. and Jones, J.P. (1993). Predicting the cytochrome P450 mediated 
metabolism of xenobiotics. Pharmacogenetics, 3: 1-18.
Korzekwa, K.R., Trager, W.F., Nagata, K., Parkinson, A. and Gillette, J.R. (1990). Isotope 
effect studies on the mechanism of the cytochrome P450 2A1-catalysed formation of delta 
6-testosterone from testosterone. Drug Metabolism and Disposition, 18: 974-979.
Krebs, H.A., Cornell, N.W.M Lund, P. and Hems, R. (1974). Isolated liver cells as 
experimental material. In; Lundquish f, tugstrup n (eds.). Regulation of hepatic 
metabolism. Munksguard, Copenhagen, pp 726-750.
Krumdieck, C.L., Dos Santos, J.S. and Ho, K.J. (1980). A new instrument for the rapid 
preparation of tissue slices. Analytical Biochemistry, 104: 118-123.
Kveder, S. and Mclsaac, W.M. (1961). The metabolism of melatonin (|N-acetyl-5- 
methoxytryptamine) and 5-methoxytryptamine. Journal of Biological Chemistry, 236: 
3214-3220.
Lake, B.G. and Lewis, D.F.V. (1996). The CYP4A family. In cytochromefP450: 
Metabolic and Toxicological Aspects, loannides C (ed) CRC Press Inc. Boca Raton, pp. 
271-279.
Lake, B.C., Beamand, J.A., Tredger, J.M., Barton, P.T., Renwick, A.B. and Price, R.J. 
(1999). Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human 
rat liver slices. Mutation Research-Genetic Toxicology and Environmental Mutagenesis, 
440: 91-100.
Lake, B.G., Tredger,, J.M., Renwick, A.B., Barton, P.T. and Price, R.J. (1998). 3,3’- 
Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices. 
Xenobiotica 28: 803-811.
Lake, B.G., Ball, S.E., Renwick, A.B., Tredgers, J.M., Kao, J., Beamand, J.A. and Price 
R.J. (1997). Induction of CYP3A isoforms in cultured precision-cut human liver slices. 
Xenobiotica 27: 1165-1173.
References_________________________________________________________________________________ 274
Lake, B.G., Charzat, C., Tredger , J.M., Renwick, A.B., Beamand, J.A. and Price, R.J. 
(1996a). Induction of cytochrome P450 isoenzymes in cultured precision-cut rat and 
human liver slices. Xenobiotica 26: 297-306.
Lake, B.G., Beamand, J. A., Wield, P.T. and Price, R.J. (1996b). Use of precision-cut 
liver slices to evaluate species differences in 2-acetylaminofluorene-induced 
unscheduled DNA synthesis. Toxicology and Applied Pharmacology, 138: 231-241.
Lake, B.G., Sauer, M.J., Esclangon , F., Beamand, J.A., Price, R.J. and Walters, D.G.
(1995). Metabolism of coumarin by precision-cut calf liver slices and calf liver 
microsomes. Xenobiotica, 25: 133-141.
Lake, B.G., Beamand, J.A. Japenga, A.C. Renwick, A., Davies, S. and Price, R.J. (1993). 
Induction of cytochrome P-450-dependent enzyme activities in cultured rat liver slices. 
Food and Chemical Toxicology, 31: 377-386.
Lane, E.A. and Moss, H.B. (1985). Pharmacokinetics of melatonin in man: first pass 
hepatic metabolism. Journal of Clinical Endocrinology and Metabolism, 61: 1214-1216.
Larrey, D., Distlerath, L.M., Dannan, G.A., Wilkinson, G.R. and Guengerich, F.P. 
(1984). Purification and characterisation of the rat liver microsomal cytochrome P450 
involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in 
oxidative drug metabolism. Biochemistry, 23: 2787-2795.
Laskin, D.L. (1990). Parencymal and nonparenchymal cell interactions in 
hepatotoxicity. Biological Reactive Intermediates IV, Edited by C.M. Plenum Press, 
New York, pp 449-505.
LeBigot, J.F., Begue, J.M., Kiechel, J.R. and Guillouzo, A. (1987). Species-differences 
in metabolism of ketotifen in rat, rabbit and man —demonstration of similar pathways in 
vivo and in cultured-hepatocytes. LifeSciences, 40: 883-890.
Leeman, W.R., van de Gevel, LA. and Rutten A.A.J.J.L. (1995). Cytotoxicity of retinoic 
acid, menadione and aflatoxin Bi in rat liver slices using netwell inserts as a new culture 
system. Toxicology in Vitro, 9: 291-298.
Leone, R.M. and Silman, R.E. (1984). Melatonin can be differentially metabolised in the 
rat to produce N-acetylserotonin in addition to 6-hydroxymelatonin. Endocrinology, 14: 
1825-1831.
Lewis, D.F.V., loannides, C. and Parkç^D.V. (1986). Molecular dimensions of the 
substrates binding site of cytochrome P448. Biochemical Pharmacology, 35: 2179-2185.
Lowry, O.H., Rose-:brough, N.J., Farr, A.L. and Randall, R.J. (1951). Protein 
determination with the folin phenol reagent. Journal of Biological Chemisty, 193: 265- 
275.
Lu, A.Y.H. and West, S.B. (1980). Pharmacological Reviews, 31: 277.
References_________________________________________________________________________________ 275
Lubet, R.A., Syi, J.L., Nelson, J.O. and Nims, R.W. (1990). Induction of hepatic 
cytochrome P450 mediated alkoxyresorufin 0-dealkylase activities in different species 
by prototype P450 inuducers. Chemico-Biological Interactions, 75: 325-339.
Lubet, R.A., Mayer, R.T., Cameron, J.W., Nims, R.W., Burke, M.D., Wolff, T. and 
Guengerich, F.P. (1985). Dealkylation of pentoxyresorufin: a rapid and sensitive assay 
for measuring induction of cytochrome (s) P450 by phénobarbital and other xenobiotics 
in the rat. Archives of Biochemistry and Biophysics, 238: 43-48.
Mallo, C., Zaidan, R., Galy, G., Vermeulen, E., Brun, J., Chazot, G. and Claustrat, B.
(1990). Pharmacokinetics of melatonin in man after intravenous infusion and bolus 
injection. European Journal of Clinical Pharmacology, 38: 297-301.
Marinello, A.J., Bansal, S.K., Paul, B., Koser, P.L., Love, J., Struck, R.F. and Gurtoo, 
H.L. (1984). Metabolism and binding of cyclophosamide and its metabolite acrolein to 
rat hepatic microsomal cytochrome P45. Cancer Research, 44: 4615-4621.
Marshall, T.A. and Roberts, R.J. (1990). In vitro and in vivo assessment of lipid 
peroxidation of infant nutrient preparations: effect of nutrition on oxygen toxicity. 
Journal of the American College of Nutrition, 9: 190-199.
Martin, F.L. and McLean, A.E.M. (1998). Comparison of paracetamol-induced 
hepatotoxicity in the rat in vivo with progression of cell injury in vitro in rat liver slices. 
Drug and Chemical Toxicology, 21: 477-494.
Mathis, G.A., and Sirica, A.E. (1990). Effects of medium and substratum conditions on 
the rates of DNA synthesis in primary cultures of bile ductular epithelial cells. In Vitro 
Cellular and Developmental Biology, 26: 113-118.
Matsunaga, E., Umeno, M. and Gonzalez, F.J. (1990). The rat P450 2D subfamily: 
complete sequences of four closely linked genes and evidence that gene conversions 
maintained sequence homogeneity at the heme-binding region of the cytochrome P450 
active site. Journal of Molecular Evolution, 3: 155-169.
Matsunaga, T., Nagata, K., Holsztynska, E.J., Lapenson, D.P., Smith, A., Kato, R., 
Gelboin, H.V., Waxman, D.J. Gonzalez, F.J. (1988). Gene conversion and differential 
regulation in the rat P4502A gene subfamily -  purification, catalytic activity, cDNA and 
deduced amino-acid sequence, and regulation of an adult male-specific hepatic 
testosterone 15a-alpha-hydroxy. Journal of Biological Chemistry, 263: 17995-18002.
Maurel, P. (1996). The CYP3 Family. In: Cytochromes P450, Metabolic and 
Toxicological Aspects. Ed. C. loannides, CRC Press, pp 49.
Maurice, M., Pichard, L., Daujat, M., Fabre, L, Joyeux, H., Domergue, and J. Maurel, P.
(1992). Effects of imidazole derivatives on cytochromes P450 from human hepatocytes 
in primary cultures. FASEB Journal, 6: 752-758.
Mcllwain, H. and Buddie, H.L. (1953). Techniques in tissue metabolism. I. A 
mechanical chopper. Journal of biochemistry, 53: 412-420.
References_________________________________________________________________________________ 276
Meyer, U.A. (1991). Molecular mechanism causing genetic polymorphism of drug 
metabolising enzymes. Frontiers in Biotransformation, 9: 215-245.
Meyer, D.J., Coles, B., Pemble, S.E., Gilmore, K.S., Fraser, G.M. and Ketterer, B.
(1991). Theta, a new class of glutathione transferases purified from rat and man. 
BiochemicalJournal, 274: 409-414.
Michalopoulos, G., Satler, C.A., Satler, G.L. and Pitot, H.C. (1976). Cytochrome P450 
induction by phénobarbital and 3-methylcholanthrene in primary cultures of hepatocytes. 
Science, 193: 907-909.
Mikus, G., Bochner, F.., Eichelbaum, M., Horak, P., Somogyi, A.A. and Spector, S. (1994). 
Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 
(debrisoquine/sparteine) polymorphism. Journal of Pharmacology and Experimental 
Therapeutics, 268: 546-551.
Miller, W.L. (1988). Molecular biology of steroid-hormone synthesis. Endocrine Reviews, 
9: 295-318.
Miller, M.G., Beyer, J., Hall, G.L., Degraffenried, L.A. and Adams, P.E. (1993). Predictive 
value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model 
hepatoxicant. Toxicology and Applied Pharmacology, 122:108-116.
Miners, J.O. and Birkett, D.J. (1996). Use of tolbutamide as a substrate probe for human 
hepatic cytochrome P450 2C9. Methods in Enzymology, 212: 139-145.
Monti, J.M., Alvarino, F., Cardinali, D., Savio, I. and Pintos, A. (1999). 
Polysomnographic study of the effect of melatonin on sleep in elderly patients with 
chronic primary insomnia. Archives of Gerontology and Geriatrics, 28: 85-98.
Morel, F., Beaune, p.H., Ratanasavanh, D., Flinois, J.P., Yang, C.S., Guengerich, F.P. 
and Guillouzo, A. (1990). Expression of cytochrome P450 enzymes in cultured human 
hepatocytes. European Journal of Biochemistrty, 191: 437-444.
Muller, D., Glbckner, R. and Rost, M. (1996). Monooxygenation, cytochrome P450 lA l 
and P450 lAl-mRNA in rat liver slices exposed to beta-naphtafiavone and 
dexamethasone in vitro. Experimental and Toxicologic Pathology, 48: 433-438.
Murphy, A.T., Lake, B.G., Bernstein, J.R., Franklin, R.B. and Gillespie, T.A. (1998). 
Characterization of olanzapine (LYl 70053) in human liver slices by liquid 
chromatography tandem mass spectrometry. Journal of Mass Spectrometry, 33: 1237- 
1245.
Murray, M. and Reidy, G.F. (1990). Selectivity in the inhibition of mammalian 
cytochrome P450 by chemical agents. Pharmacological Reviews, 42: 85-101.
Namkung, M.J., Yang, H.L., Hulla, J.E. and Juchau, M.R. (1988). On the substrate 
specificity of cytochrome P450 IIIAl. Molecular Pharmacology, 34: 628-637.
References_________________________________________________________________________________ 277
Nebert, D.W. (1991). Role of genetics and drug metabolism in human cancer risk. 
Mutation Research, 247: 267-281.
Nebert, D.W., Gonzalez, F.J. (1987). P450 genes: structure, evolution and regulation. 
Annual Reiews ofBiochemisty, 56: 945-993.
Nebert, D.W., Nelson, D.R., Coon, M.J., Estabrook, R.W., Feyereisen, R., Fujikuriyama, 
Y., Gonzallez, F., Guengerich, P.F., Gunsalus, I.C., Johnson, E.F., Loper, J.C., Sato, R., 
Waterman, M.R. and Waxman, D.J. (1991). The P450 Superfamily: update on new 
sequences, gene mapping, and recommended nomenclature. DNA and Cell Biology, 10: 1- 
14.
Nedelcheva, V. and Gut, I. (1994). P450 in the rat and man: methods of investigation, 
substrate specificities and relevance to cancer. Xenobiotica, 24: 1151-1175.
Nelson, D.R. and Strobel, H.W. (1987). Evolution of cytochrome P450 proteins. 
Molecular Biology and Evolution, 4: 572-593.
Nelson, D.R, Koymans, L., Kamataki, T., Stegeman, J.J., Feyereisen, R , Waxman, D.J., 
Waterman, M.R, Gotoh, O. Coon, M.J., Estabrook, R.W., Gunsalus, I.C. and Nebert, D.W.
(1996). P450 superfamily: update on new sequences, gene mapping, accession numbers 
and nomenclature. Pharmacogenetics, 6: 1-42.
Nelson, D.R, Kamataki, T., Waxman, D.J., Guengerich, F.P., Estabrook, R.W., Feyereisen, 
R , Gonzalez, F.J., Coon, M.J., Gunsalus, I.C., Gotoh, O., Okuda, K. and Nebert, D.W.
(1993). The P450 superfamily: update on new sequences, gene mapping, accession 
numbers, early trivial names of enzymes and nomenclature. and Cell Biology, 12: 1- 
51.
Nickelsen, T., Lang, A. and Bergau, L. (1991). The effect of 6-, 9- and 11-hour time shifts 
on circardian rhythms: adaptaion of sleep parameters and hormonal patterns following the 
intake of melatonin or placebo. In Adrent J, Pevet P (eds) Adv Pineal Res, 5: 303-306.
Nieminen, A.L., Gores, G.J., Wray, B.E., Tanaka, Y., Herman, B. and Lemasters, J.J.
(1988). Calcium dependence of bleb formation and cell death in death in hepatocytes. Cell 
Calcium, 9: 237-246.
Nims, R.W. and Lubet, R A  (1996). The CYP2B subfamily. In: Cytochromes P450 
Metabolic and Toxicological Aspects. Ed. C. loannides, CRC Press, pp. 141-142.
Okey, A.B. (1990). Enzyme induction in the cytochrome P450 system. Pharmacological 
Therapeutics, 45: 241-298.
Olinga, P., Merema, M., Hof, I.H., De Jong, K.P., Slooff, M.J.H., Meijer, D.K.F. and 
Groothuis, G.M.M. (1998). Effect of human liver source on the functionality of isolated 
hepatocytes and liver slices. Drug Metabolism and Disposition, 26: 5-11.
References_________________________________________________________________________________ 278
Olinga, P., Meijer, D.K.F., Slooff, MJ.H. and Groothuis, G.M.M. (1997a). Liver slices 
in in vitro pharmacotoxicology with special reference to the use of human liver tissue. 
Toxicology in Vitro, 12: 77-100.
Olinga, P., Groen, K., Hof, I.H., Dekanter, R., Koster, H.L, Leeman, W.R., Rutten, 
A.A.J.J.L., VanTwillert, K. and Groothuis, G.M.M. (1997b). Comparison of five 
incubation systems for rat liver slices using functional and viability parameters. Journal 
of Pharmacology and Toxicological Methods, 38: 59-69.
Olinga, P., Merema, M.J., Meijer, D.K.F., Slooff, M.J.H. and Groothuis, (1993). Human 
liver slices express the same lidocaine biotransformation rate as isolated human 
hepatocytes. ATLA-Altematives to Laboratory Animals, 21:466-468.
Omura, T. and Sato, R. (1964). The carbon monoxide binding pigment of liver 
microsomes. I. Evidence for its haemoprotein nature. Journal of Biological Chemistry, 239: 
2370-2378.
Orrenius, S., Thor, H. and Bellomo, G. (1984). Alternations in thiol and calcium ion 
homeostasis during hydroperoxide and drug metabolism in hepatocytes. Biochemical 
Society Transactions, 12: 23-28.
Paine, A.J. (1990). The maintenance of cytochrome P450 in rat hepatocyte culture; some 
applications of liver cell cultures to the study of drug metabolism, toxicity and the 
induction of the P450 system. Chemico-Biologicallnteractions, 74: 1-31.
u-
Paine, A.J. and Villa, P. (1980). Ligands maintain cytochrome Ç50 in liver cell culture 
by affecting its synthesis and degradation. Biochemical and Biophysical Research 
Communication, 97: 744-750.
Paine, A.J. and Legg, R.F. (1978). Apparent lack of correlation between the loss of 
cytochrome P450 in hepatic parenchymal cell culture and the stimulation of haem 
oxygenase activity. Biochemical and Biophysical Research Communications, 81: 672- 
679.
Paine, A.J., Villa, P. and Hockin, J. (1980). Evidence that ligand formation is a 
mechanism underlying the maintenance of cytochrome P450 in rat liver cell culture. 
Biochemical Journal, 188: 937-939.
Parker, G.L. and Orton, T.C. (1980). Induction by oxyisobutyrates of hepatic and kidney 
hydroxylation of fatty acids. In: Biochemistry, Biophysics and Regulation of Cytochrome 
P450. Gustafsson J.A. (ed.), Elsevier/North Holland, Amsterdam, pp 373-377.
Parker, R.J., Collins, J.M. and Strong, J.M. (1996). Identification of 2,6-Xylidine as a 
major lidocaine metabolite in human liver slices. Drug Metabolism and Disposition, 24: 
1167-1173.
Parrish, A.R., Gandolfi, A.J. and Brendel K. (1995). Precision cut liver slices: applications 
in pharmacology and toxicology. Life sciences, 57:1887-1901.
References_________________________________________________________________________________ 2 7 9
Parrish, A.R., Shipp, N.G., Spall, R.D., Dorr, R.T., Krumdieck, C.L., Gandolfi, A.J. and 
Brendel, K. (1992). Organ culture of rat myocardial slices: alternative in vitro tool in organ 
specific toxicology. Toxicology Methods, 2: 101-111.
Pasanen, M., Haaparanta, T., Sundin, H., Sivonen, P., Vahakangas, K., Raunio, H., 
Hines, R., Gustaffson, J.-A. and Pelkonen, O. (1990). Immunochemical and molecular 
biological studies on human placental cigarette smoke-inducible cytochrome P450 
dependent monooxygenase activities. Toxicology, 62: 175-187.
Paul, D., Standifer, K.M., Inturrisi, G.E. and Pasternak, G.W. (1989). Pharmacological 
characterisation of morphine 6p-glucuronide: a very potent morphine metabolite. 
Journal of Pharmacology and Experimental Therapeutics, 251: 477-483.
Pearce, R. Greenway, D. and Parkinson, A. (1992). Species differences and interindividual 
variation in liver microsomal cytochrome P450 2A enzymes: Effects on coumarin, 
dicumarol, and testosterone oxidation. Archives of Biochemistry and Biophysics, 298: 211- 
225.
Peters, T. Jr. (1983). Methods of studying secretion in vivo and in liver slices. Plasma 
protein secretion by the liver, edited by H. Glumann, T. Peters, Jr, and Redman C. (London: 
Accademic Press) pp 95-131.
Petranka, J., Baldwin, W., Biermann, J., Jayadev, S., Barrett, J.C. and Murphy, E. (1999). 
The oncostatic action of melatonin in an ovarian carcinoma cell line. Journal of Pineal 
Research, 26: 129-136.
Phelps, J.S., Gandolfi, A.J., Brendel, K. and Dorr, R.T. (1987). Cisplatin Nephrotoxicity: In 
Vitro studies with Precision-cut rabbit renal cortical slices. Toxicology and Applied 
Pharmacology, 90: 501-512.
Phillipson, G.E., Godden, P.M.M., Lum, P.Y., loannides, G. and Park^D.V. (1984). 
Determination of cytochrome P-448 activity in biological tissue. Biochemical Journal, 
221: 81-88.
Powis, G., Jardine, L, Van-Dyke, R., Weinshilboum, R., Moore, D., Wilke, T., Rhodes, 
W., Neslon, R., Benson, L. and Szumlanski, G. (1988). Foreign compounds metabolism 
studies with human liver obtained as surgical waste. Relation to donor characteristics 
and effects of tissue storage. Drug Metabolism and Disposition: the Biological Fate of 
Chemicals, 16: 582-589.
Price, R.J., Renwick, A.B., Barton, P.T., Houston, J.B. and Lake, B.G. (1998a). 
Influence of slice thickness and culture conditions on the metabolism of 7- 
ethoxycoumarin in precision-cut rat liver slices. ATLA-Alternatives to Laboratory 
Animals, 26: 541-548.
Price, R.J., Ball, S.E., Renwick, A.B., Barton, P.T., Beamand, J.A., and Lake, B.G. 
(1998b). Use of precision-cut liver slices for studies of xenobiotic metabolism and 
toxicity: comparison of the Krumdieck and Brendel tissue sheers. Xenobiotica, 28: 361- 
371.
References_________________________________________________________________________________ 280
Price, R.J., Mistry, H., Wield, P.T., Renwick, A.B., Beamand, J.A. and Lake, B.G. (1996). 
Comparison of the toxicity of allyl alcohol, coumarin and menadione in precision-cut rat, 
guinea-pig, Cynomolgus monkey and human liver slices. Archives in Toxicology, 71: 107- 
111.
Price, R.J., Renwick, A.B., Beamand, J.A., Esclangon, F., Wield, P.T., Walters, D.G. and 
Lake, B.G. (1995a). Comparison of the metabolism of 7-ethoxycoumarin and coumarin in 
precision-cut rat-liver and lung slices. Food and Chemical Toxicology, 33: 233-237.
Price, R.J., Renwick, A.B., Wield, P.T., Beamand, J.A. and Lake, B.G. (1995b). Toxicity 
of 3-methylindole, 1 -nitronaphthalene and paraquat in precision-cut rat lung slices. 
Archives of Toxicology, 69: 405-409.
Pyykko, K., Tuimala, R., Aalto, L. and Perkio, T. (1991). Is aryl-hydrocarbon hydroxylase 
activity a new prognostic indicator for breast cancer? British Journal of Cancer, 63: 596- 
600.
Reinke, L.A. and Moyer, M.J. (1985). p-Nitrophenol hydroxylation: microsomal oxidation 
which is highly inducible by ethanol. Drug Metabolism and Disposition, 13: 548-552.
Reiter, R.J., Tan, D.X., Cabrera, J., Darpa, D., Sainz, R.M., Mayo, C. and Ramos, S. (1999). 
The oxidant/antioxidant network: Role of melatonin. Biological Signal and Receptors, 8: 
56-63.
Rekka, E., Ayalogu, E.O., Lewis, D.F.V., Gibson, G.G. and loannides, C. (1994). 
Induction of hepatic microsomal CYP4A activity and of peroxisomal p-oxidation by two 
non-steroidal antiinflammatory àmgs. Archives of Toxicology, 68: 73-78.
Richards, C.D. and Sercombe, R. (1970). Calcium, magnesium and electrical activity of 
guinea pig olfactory cortex in vitro. Journal of Physiology, 211: 571-584.
Richards, C.D. and Sercombe, R. (1968). Electrical activity observed in guinea pig 
olfactory cortex maintained in vitro. Modification by changes in ionic composition of 
bathing medium. Journal of Physiology, 197: 667-683.
Richards, C.D. and Tegy, W.J.B. (1977). Superfusion chamber suitable for maintaining 
mammalian brain tissue slices for electrical recording. British Journal of Pharmacology, 
59:526.
Richardson, K.C., Jarret, L. and Finke, E.H. (1960). Embedding of epoxy resins for 
ultrathin sectioning in electron microscopy. Stain Technology, 35: 313.
Roberts, R.J. (1979). Implications of nutrition in oxygen-related pulmonary disease in the 
human premature infant. Advances in Pharmacology and Therapeutics, 8: 53.
Ronis, M.J.J., Lindros, K.O. and Ingelman-Sundegerg M. (1996). The CYP2E subfamily. 
In Cytochromes P450: Metabolic and Toxicological Aspects, loarmides C (ed) CRC Press 
Inc. Boca Raton, pp. 211-239.
References_________________________________________________________________________________ 281
Rost, K.L., Brosicke, H, Scheffler, M. and Roots, I. (1992). Dose dependent induction of 
CYP1A2 activity by Omeprazole. International Journal of Clinical Pharmacology and 
Therapeutics, 30: 542-543.
Ruegg, C.E. (1994). Preparation of precision-cut renal slices and renal proximal tubular 
fragments for evaluating segment-specific nephrotoxicity. Journal of Pharmacological and 
ToxicologicalMethods, 31: 125-133.
Ruelius, H.W.(1987). Extrapolation from animals to man: predictions, pitfalls and 
perspectives. Xenobiotica, 17: 255-265.
Sakamoto, K., Kirita, S., Baba, T., Nakamura, Y., Yamazoe, Y., Kato, R., Takanaka, A. and 
Matsubara, T. (1995). A new cytochrome P450 form belonging to the CYP2D in dog liver 
microsomes: purification, cDNA cloning, and enzyme characterisation. Archives of 
Biochemistry and Biophysics, 319: 372-382.
Sano, M., Motchnik, P.A. and Tappel, A.L. (1986). Halogenated hydrocarbon and 
hydroperoxide induced peroxidation in rat tissue slices. Journal of Free Radical Biology 
and Medicine, 2:41-48.
Sarkar, S., Bhatnagar, D. and Yadav, P. (1994). Cadmium-induced lipid peroxidation in 
rat liver slices: A possible involvement of hdyroxyl radicals. Toxicology in Vitro, 8: 
1239-1242.
Schenider, Y.J. and Lavoix, A. (1990). Monoclonal antibody production in semi- 
continuous serum free -  and protein -  free culture: Effects of glutamine concentration 
and culture conditions on cell growth and antibody secretion. Journal of Immunological 
Methods, 12: 251-268.
Sekura, R.D., Duffel, M.W. and Jokoby, W.B. (1981). Aryl sulphotransferases. 
Methods in Enzymology, 11: 191-199.
Sesardic, D., Pasanen, M., Pelkonen, O. and Boobif , A.R. (1990). Differential 
expression and regulation of members of the cytochrome P4501A gene subfamily in 
human tissue. Carcinogenesis, 11: IIS3.
Sesardic, D., Boobis, A.R., Edwards, R.J. and Davies, D.S. (1988). A form of 
cytochrome P450 in man, orthologous to form d in the rat, catalyses the 0-deethylation 
of phenacetin and is inducible by cigarette smoking. British Journal of Clinical 
Pharmacology, 26: 363-372.
Shimada, T. and Guengerich, P.P. (1990). Inactivation of 1, 3-dinitropyrene, 1, 6- 
dinitropyrene and 1, 8- dinitropyrene by cytochrome P450 enzymes in human and rat 
liver microsomes. Cancer Research, 50: 2036-2043.
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. and Guengerich, P.P. (1994). 
Interindividual variations in human liver cytochrome P450 enzymes involved in the 
oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30
References_________________________________________________________________________ 282
Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 
270: 414-423.
Shimada, T., Yamazaki, H., Shimura, H., Tanaka, R. and Guengerich, P.P. (1990). 
Metabolic deactivation of furylfluramide by cytochrome P450 in human and rat liver 
microsomes. Carcinogenesis, 11: 103-110.
Shimada, T., Iwasaki, M., Martin, M.V. and Guengerich, P.P. (1989). Human liver 
microsomal cytochrome P450 enzymes involved in the bioactivation of procarcinogens 
detected by umv response in Salmonella Typhimurium TA 1525/PSK1002. Cancer 
Research, 49: 3218-3228.
Sidelmann, U.G., Cornett, C., Tjomelund, J. and Hansen, S.H. (1996). A comparative 
study of precision cut liver slices, hepatocytes, and liver microsomes from the Wistar rat 
using metronidazole as a model substance. Xenobiotica, 26: 709-722.
Singh, Y., Cooke, J.B., Hinton, D.E. and Miller, M.G. (1996). Trout liver slices for 
metabolism and toxicity studies. Drug Metabolism and Disposition, 24: 7-14.
Sipes, I.G., Pisher, R.L., Smith, P.P., Stine, E.R., Gandolfi, A.J. and Brendel, K. (1987). 
A dynamic liver culture system: a tool for studying chemical biotransformation and 
toxicity. Archives of Toxicology Supplement, 11:20-33.
Skene, D.J., Aldhous, M. and Arendt, J. (1989). Melatonin, jet-lag and the sleep-wake 
cycle. In Home J (ed): Sleep ’88, Proceedings of the European Sleep Congress, 
Jerusalem, 1988, pp 39-41, Karger, Basel.
Smith M.T., Watt J.A. and Cramond T. (1990). Morphine-3-glucuronide-a potent 
antagonist of morphine analgesia. Life Sciences, 47: 579-585.
Smith, P.P., McKee, R., Gandolfi, A.J., Krumdieck, C.L., Pisher, R. and Brendel, K.
(1989). Precision-cut liver slices: a new in vitro tool in toxicology. In in vitro Toxicology: 
Models Systems and Methods. Edited by C.A. McQeen. pp 93-130. Telford Press, New 
Jersey.
Smith, P.P., Pisher, R., Shumat, P.J., Gandolfi, A.J., Krumdieck, C.L. and Brendel, K.
(1987). In vitro cytotoxicity of allyl alcohol and bromobenzene in a novel organ culture 
system. Toxicology and Applied Pharmacology, 87: 509-522.
Smith, P.P., Krack G., McKee, R.L., Johnson, D.G., Gandolfi, AJ., Hmby, V.J., 
Krumdieck, C.L. and Brendel, K. (1986). Maintenance of adult rat liver in dynamic 
organ culture. In vitro Cellular and Developmental Biology, 22: 706-712.
Smith, P.P., Gandolfi, A.J., Krumdiecdk, C.L., Putman, C.W., Zukoski, C.P., Davis, 
W.M. and Brendel, K. (1985). Dynamic organ culture of precision liver slices for in 
vfrro toxicology. Life Science, 36: \2>61-\2>15.
Sonderfan, A.J., Arlotto, M.P. and Parkinson, A. (1989). Identification of the 
cytochrome P450 isoenzymes resposible for testosterone oxidation in rat lung, kidney.
References_________________________________________________________________________________ 283
and testis: Evidence that cytochrome P450a (P450 2A1) is the physiologically important 
testosterone 7-alpha-hydroxylase in rat testi. Endocrinology, 125: 857-866.
Song, B.J., Gelboin, H.V., Park, S.S., Tsukos, G.C. and Friedman, F.K. (1985). 
Monoclonal antibody directed radioimmunoassay detects cytochrome P450 in human 
placenta and lymphocytes. Science, 228: 490-492.
Spatzenegger, M. and Jaegger, W. (1995). Clinical importance of hepatic cytochrome P450 
in drug metabolism. Drug Metabolism Reviews, 27: 397-417.
Stacey, N.H. and Preistly, B.G. (1978). Dose-dependent toxicity of carbon tetrachloride in 
isolated rat hepatocytes and the effects of hepatoproteetive treatments. Toxicology and 
Applied Pharmacology, 45:29-39.
Stadie, W.C. and Riggs, B.C. (1944). Microtome for the preparation of tissue slices for 
metabolic studies of surviving tissues in vitro. Journal of Biological Chemistry, 154: 
687-690.
Steensma, A., Beamand, J.A. Walters, D.G., Price, R.J. and Lake, B.G. (1994). 
Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea pig, Cynomolgus 
monkey and human precision-cut liver slices. Xenobiotica, 24: 893-907.
Steward, A.R., Dannan, G.A., Guzelian, P.S. and Guengerich, P.P. (1985). Changes in the 
concentration of seven forms of cytochrome P450 in primary cultures of adult hepatocytes. 
Molecular Pharmacology, 27: 125-132.
Storey, I.D.E. (1950). The synthesis of glucuronides by liver slices. Biochemistry Journal, 
47: 212-222.
Sugita, O., Sassa, S., Miyairi, S., Fishman, J., Kubota, I., Noguchi, T. and Kappas, A.
(1988). Cytochrome P450 C-M/P: A new constitutive form microsomal cytochrome P450 
in male and female rat liver with estrogen 2- alpha hydroxylase and 16 a-hydroxylase 
activity. Biochemistry, 27: 678-686.
Suolinna, E.M. and Pitkaranta, T. (1986). Effect of culture age on drug metabolising 
enzymes and their induction in primary cultures of rat hepatocytes. Biochemical 
Pharmacology, 35: 2241-2245.
Swinney, D.C., Ryan, D.E., Thomas, P.E. and Levin, W. (1987). Regioselective 
progesterone hydroxylation catalysed by 11 rat hepatic cytochrome P450 isoenzymes. 
Biochemistry, 26: 7073-7083.
Tamburini, P., Masson, H.A., Bains, S.K., Makowski, R.J., Morris, B. and Gibson, G.G.
(1984). Multiple forms of hepatic cytochrome P450: Purification, characterisation and 
comparison of a novel clofibrate-induced isozyme with other major forms of cytochrome 
P450. European Journal of Biochemistry, 139: 235-246.
References_________________________________________________________________________________ 284
Tennenbaum, T., Yuspa, S.H. and Kapitulnik, J. (1990). Magnesium and phosphate 
enrichment of culture medium stimulates the proliferation of epidermal cells from 
newborn and adult mice. Journal of Cellular Physiology, 143: 431-438.
Thompson, D.C., Perera, K. and London, R. (1996). Metabolism and toxicity of 4- 
hydroxyphenylacetone in rat liver slices: comparison with acetaminophen. Drug 
Metabolism and Disposition, 24: 866-871.
Thompson, D.C., Perera, K., Fisher, R. and Brendel, K. (1994). Cresol isomers: 
Comparison of toxic potency in rat liver slices. Toxicology and Applied Pharmacology, 
125: 51-58.
Toribara, N.W., Kirkpatrick, R.B., Falany, C.N., La Brecque, R. and Tephly, T.R. (1984). 
Sequential-changes in primary rat hepatocyte monolayer culture; UDP- 
glucuronyltransferase activities show a preneoplastic-like pattern. Hepatology, 4: 1054.
Towbin, H., Stachelin, T. and Gordon, J. (1979). Electrophoretic transfer of proteins from 
polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. 
Proceedings of the National Academy of Science, USA, 76: 4350-4355.
Trowell, O.A. (1959). The culture of mature organs in synthetic medium. Experimental 
Cell Research, 16: 118-147.
Ueda, S., Cook, M. and Alak, A.M. (1996). In vitro metabolic studies of tacrolimus 
using precision-cut rat liver slices. Journal of Pharmaceutical and Biomedical Analysis, 
15: 349-357.
Vahakangas, K., Raunio, H., Pasanen, M., Sivonen, P., Park, S.S., Gelbein, H.V. and 
Pelkonon, O. (1989). Comparison of the formation of benzo(a)pyrene diolepoxide-DNA 
aducts in vitro by rat and human microsomes: Evidence for the involvement of P450 lA l 
and P450 1A2. Journal of Biochemical Toxicology, 4: 79-86.
Vakkuri, O., Leppaluoto, J. and Kauppila, A. (1985). Oral administration and 
distribution of melatonin in human serum, saliva and urine. Life Science, 37: 489-495.
Vandenbranden, M., Wrighton, S.A., Ekins, S., Gillespie, J.S., Binkley, S.N., Ring, B.J., 
Gadberry, M.G., Mullins, D.C., Storm, S.C. and Jensen, C.B. (1998). Alterations of the 
catalytic activities of drug-metabolising enzymes in cultures of human liver slices. Drug 
Metabolism and Disposition, 26: 1063-1068.
Vickers, A.E.M., Connors, S., Zollinger, M., Biggi, W.A., Larrauri, A., Vogelaar, J.P.W. 
and Brendel, K. (1993). The biotransformation of the ergot derivative CQA 206-291 in 
human, dog, and rat liver slice cultures and prediction of in vivo plasma clearance. Drug 
Metabolism and Disposition, 21: 454-459.
Vickers, A.E.M., Fisher, V., Connors, S., Fisher, R.L., Maurer, G. and Brendel, K. (1992). 
Cyclosporin A metabolism in human liver, kidney and intestine slices. Comparison to rat 
and dog slices and human cell lines. Drug Metabolism and Disposition, 20: 802-809.
References_________________________________________________________________________________ 285
Vijayalamaxi, Meltz, MX., Reiter, R.J., Herman, T.S. and Kumar, S.K. (1999). 
Melatonin and protection from whole-body irradiation: survival studies in mice. 
Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 425: 21- 
27.
Villa, P., Arioli, P. and Guaitani, A. (1991). Mechanism of maintenance of liver-specific 
functions by DMSO in cultured rat hepatocytes. Experimental Cell Research, 194: 157- 
160.
Viscardi, R.M., Weinhold, P. A., Beals, T.M., and Simon, R.H. (1989). 
Cholinephosphate cytidylyl transferase in fetal and rat lung cells: activity and subcellular 
distributiion in response to dexamethasone, triiodothyronine, and fibroblast-conditioned 
medium. Experimental Lung Research, 15: 223-237.
Vons, C., Pegorier, J.P., Ivanov, M.A., Girard, J., Melcion, C., Cordier, A. and Franco, 
D. (1990). Comparison of cultured human hepatocytes isolated from surgical biopsies or 
cold-stored organ donor livers. Toxicology in Vitro, 4: 432-434.
Walsh, J.S., Patanella, J.E., Ham, K.A. and Facchine, K.L. (1995). An improved HPLC 
assay for the assessment of liver slice metabolic viability using 7-ethoxycoumarin. Drug 
Metabolism and Disposition, 23: 869-874.
Warburg, O. (1923). Versuche an uberlebendem karzinomgewebe. Biochemische Zeitung, 
142:317-333.
Waxman, D.J. and Azaroff, L. (1992). Phénobarbital induction of cytochrome P450 gene 
expression. BiochemicalJoumal, 281: 577-592.
Waxman, D.J., Lapenson, D.P., Nagata, K. and Conlon, H.D. (1990). Participation of 2 
structurally related enzymes in rat hepatic microsomal androstenedione 7 alpha- 
hydroxylation. BiochemicalJoumal, 16S: 187-194.
Waxman, D.J., LeBlanc, G.A., Morrissey, J.J., Staunton, J. and Lapenson, D.P. (1988). 
Adult male-specific and neonatally programmed rat hepatic P450 forms RLM2 and 2a are 
not dependent on pulsatile plasma growth hormone for expression. Journal of Biological 
Chemistry, 263: 11396-11406.
Williams, R.T (1959). Detoxication Mechanisms, 2"  ^ Ed., pp. 734-740. Chapman and 
Hall, London.
Williams, Jr. C.H. and Kamin, H. (1962). Microsomal triphosphopyrolidine nucleotide 
cytochrome c reductase of liver. Journal of Biological Chemistry, 237: 587-595.
Wishnies, S., Parrish, S.R., Sipes, I.G., Gandolfi, A.J., Putman, C., Krumdieck, C.L. and 
Brendel, K. (1991). Biotransformation activity in vitrified human liver slices. Cryobiology, 
28: 216-226.
Wolff, T., Distlerath, L., Worthington, M., Groopman, J.D., Hammons, G.J., Kadlubar, 
F.F., Prough, R.A., Martin, M.V. and Guengerich, F.P. (1985). Substrate specificity of
References_________________________________________________________________________________ 286
human liver cytochrome P450 debrisoquine 4-hydroxylase probed using immunochemical 
inhibition and chemical modelling. Cancer Research, 45: 2116-2122.
Wolthuis, O.L. and Kepner, L.A. (1978). Successful oxime therapy one hour after Soman 
intoxication. European Journal of Pharmacology, 49: 415.
Worboys, P.D., Bradbury, A. and Houston, J.B. (1995). Kinetics of drug metabolism in 
rat liver slices*. Drug Metabolism and Dispostion, 23: 393-397.
Worboys, P.D., Brennan, B., Bradbury, A. and Houston, J.B. (1996). Metabolite kinetics 
of cdansetron in rat. Comparison of hepatic microsomes, isolated hepatocytes and liver 
slices, with in vivo disposition. Xenobiotica, 26: 897-907.
Wortelboer, H.M., De Kruif, C.A., Van lersel, A.A.J., Falke, H.B., Noordhoek, J. and 
Blaauboer, B.J. (1991). Comparison of cytochrome P450 isoenzyme profile in rat liver 
and hepatocyte cultures. The effects of model inducers on apoproteins and 
biotransformation activities. Biochemical Pharmacology, 42: 381-390.
Wright, M.C. and Paine, A.J. (1992). Evidence that the loss of rat liver cytochrome 
P450 in vitro is not solely associated with the use of collagenase, the loss of cell-cell 
contacts and/or the absence of an extra cellular matrix. Biochemical Pharmacology, 43: 
237-243.
Yamamoto, C. and Mcllwain, H. (1966). Electrical activities in thin sections from 
mammalian brain maintained in chemically defined media in vitro. Journal of 
Neurochemistry, 13: 1333-1343.
Yamano, S., Tatsuno, J. and Gonzalez, F.J. (1990). The CYP2A3 gene product catalyses 
coumarin 7-hydroxylation in human liver microsomes. Biochemistry, 29: 1322-1329.
Yamazaki, H., Inui, H., Yun, C.H., Mimura, M., Guengerich, F.P. and Shimada, T.
(1992). Cytochrome P4502E1 and 2A6 enzymes as a major catalysts for metabolic 
activation of N-nitrosodialkylamine and tobacco-related nitrosamines in human liver 
microsomes. Carcinogenesis, 13: 1789-1794.
Yeleswaram, K., Vachharajari, N. and Santone, K. (1999). Involvement of cytochrome 
P450 isoenzymes in melatonin metabolism and clinical implications. Journal of Pineal 
Research, 26: 190-191.
Yeowell, H.N., Waxman, D.J., LeBlanc, G.A., Linko, P. and Goldstein, J.A. (1988). 
Induction of rat cytochrome P450 3 and its mRNA by 3, 4, 5, 3’, 4 ’ 5’- 
hexachlorobiphenyl. Molecular Pharmacology, 33: 272-278.
Young, S.M., Bittman, E.L., Ehman, M.N., Olster, D.H., Robinson, J.E. and Karsch, F.J.
(1985). Importance of duration of nocturnal melatonin secretion in determining the 
reproductive response to inductive photoperiod in the ewe. Biological Reproduction, 32: 
523-529.
Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high -  clearance I 
and low -  clearance compounds. |
References_________________________________________________________________________________ 287
Yun, C.H., Shimada, T. and Guengeri: h, F.P. (1991). Purification and characl^terisation 
of human liver microsomal cytochrome P450 2A6. Molecular Pharmacology, 40; 679- 
685.
Zhang, X. and Armstrong, D.T. (1990). Presence of amino acids and insulin in a 
chemically defined medium improves development of 8-cell rat embryos in vitro and 
subsequent implication in vivo. Biology of Reproduction, 42: 662-668.
Zimniak, P. and Waxman, D.J. (1993). Liver cytochrome P450 metabolism of 
endogenous steroid hormones, bile acids and fatty acids. In cytochrome P450, edited by 
J.B Schonkman ^nd H. Grien (Berlin:Springer), pp. 123-144.
UNIVERSITY OF SURREY LIBRARY
Reproduced with permission of copyright owner. Further reproduction prohibited without permission.
